Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",A1BG,Alpha-1B-glycoprotein,16032,63,4.50 [1.05-19.24],0.0422660640693088
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AAMDC,Mth938 domain-containing protein,15560,59,1.10 [0.68-1.77],0.7001028266406325
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AARSD1,Alanyl-tRNA editing protein Aarsd1,18344,71,1.91 [1.35-2.68],0.0002116662955099
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ABCA2,ATP-binding cassette sub-family A member 2,15485,61,1.22 [0.62-2.41],0.5585514303315036
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ABHD14B,Protein ABHD14B,18227,71,1.16 [0.80-1.68],0.4343734169429679
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ABL1,Tyrosine-protein kinase ABL1,18344,71,1.45 [1.10-1.92],0.0089253882196162
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ABO,Histo-blood group ABO system transferase,16029,64,1.07 [0.91-1.27],0.3900124483004975
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ABRAXAS2,BRISC complex subunit Abraxas 2,15485,61,1.04 [0.71-1.51],0.843080441020431
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",18014,68,0.95 [0.73-1.25],0.7333072414405086
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",15731,62,0.84 [0.55-1.29],0.4351442886701173
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",16007,62,0.91 [0.69-1.20],0.4922333579701312
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACAN,Aggrecan core protein,18235,69,0.85 [0.39-1.86],0.6843629281074385
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACE,Angiotensin-converting enzyme,16029,64,0.58 [0.25-1.36],0.2110828761003162
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACE2,Angiotensin-converting enzyme 2,18109,70,0.98 [0.65-1.46],0.910312215481646
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACHE,Acetylcholinesterase,15659,64,1.04 [0.52-2.11],0.9033849493043418
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACOT13,Acyl-coenzyme A thioesterase 13,15956,64,1.05 [0.85-1.29],0.66587003764386
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,18432,70,0.91 [0.59-1.40],0.6650843948007035
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACP1,Low molecular weight phosphotyrosine protein phosphatase,15528,61,1.25 [0.77-2.02],0.3644414940923561
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACP5,Tartrate-resistant acid phosphatase type 5,18511,72,0.99 [0.53-1.85],0.9675441414108604
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACP6,Lysophosphatidic acid phosphatase type 6,18583,70,1.50 [1.04-2.16],0.0291039761381265
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACRBP,Acrosin-binding protein,15951,63,0.73 [0.38-1.40],0.3465876144206294
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACRV1,Acrosomal protein SP-10,15528,61,1.18 [0.96-1.46],0.1219347551417429
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACSL1,Long-chain-fatty-acid--CoA ligase 1,15485,61,1.26 [0.70-2.25],0.4446591118786879
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACTA2,"Actin, aortic smooth muscle",18109,70,1.33 [0.88-2.02],0.169446457131158
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACTN2,Alpha-actinin-2,15485,61,0.68 [0.43-1.07],0.098471393541644
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACTN4,Alpha-actinin-4,18124,68,1.06 [0.56-2.00],0.8605166824222363
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACVRL1,Serine/threonine-protein kinase receptor R3,18250,71,2.64 [1.26-5.54],0.0100217491046192
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACY1,Aminoacylase-1,18432,70,0.93 [0.66-1.33],0.7036180531649744
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,15485,61,1.57 [1.06-2.32],0.0250882367002895
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACYP1,Acylphosphatase-1,15610,63,1.13 [0.78-1.63],0.5210239943855064
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADA,Adenosine deaminase,18653,71,1.19 [0.69-2.06],0.5307417673441093
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADA2,Adenosine deaminase 2,18349,68,1.37 [0.85-2.21],0.1979367182811441
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,15528,61,1.81 [0.99-3.32],0.0549263807118469
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,18109,70,2.94 [1.52-5.70],0.0013688567477734
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,18284,71,1.87 [1.05-3.33],0.0338833004296725
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,18653,71,1.50 [0.79-2.84],0.214261262538522
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,18567,71,13.34 [5.63-31.60],3.877133794828786e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,15956,64,3.20 [1.76-5.81],0.0001384788163701
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,15528,61,0.79 [0.34-1.80],0.5686834105358185
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,18663,72,0.62 [0.27-1.45],0.2693985593691989
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,18344,71,0.80 [0.49-1.31],0.3846941648779755
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,18109,70,0.68 [0.31-1.48],0.3313924199746064
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,15528,61,1.11 [0.57-2.18],0.7505898408857296
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,18477,72,1.21 [0.77-1.92],0.4136500838569633
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAMTSL2,ADAMTS-like protein 2,16018,64,0.64 [0.30-1.35],0.2384046501904314
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAMTSL4,ADAMTS-like protein 4,15560,59,1.17 [0.42-3.27],0.7704504683524167
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAMTSL5,ADAMTS-like protein 5,16007,62,0.78 [0.42-1.43],0.4153800581449325
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,18014,68,1.19 [0.73-1.95],0.4747194637625874
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADD1,Alpha-adducin,15659,64,1.21 [0.86-1.70],0.2720914189226063
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRB3,Adhesion G protein-coupled receptor B3,18250,71,0.98 [0.52-1.84],0.950506220269578
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRD1,Adhesion G-protein coupled receptor D1,15659,64,0.97 [0.53-1.77],0.9141693087930296
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,15956,64,1.76 [1.18-2.62],0.0054084479682063
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,18492,70,3.98 [2.15-7.36],1.0921842038447618e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,18572,71,2.90 [2.05-4.11],2.2468739483169957e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRF5,Adhesion G protein-coupled receptor F5,16007,62,0.57 [0.23-1.43],0.2325399142993405
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRG1,Adhesion G-protein coupled receptor G1,18344,71,0.93 [0.72-1.21],0.5938011755793449
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRG2,Adhesion G-protein coupled receptor G2,18432,70,1.06 [0.48-2.33],0.8900072303816211
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRV1,Adhesion G-protein coupled receptor V1,15523,61,0.75 [0.48-1.15],0.1864295280494234
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADH1B,All-trans-retinol dehydrogenase,15659,64,0.97 [0.71-1.34],0.8715649294289324
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,18109,70,0.85 [0.65-1.11],0.2414621405508086
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADIPOQ,Adiponectin,16032,63,1.20 [0.85-1.70],0.29451262127622
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADM,Pro-adrenomedullin,18606,70,1.96 [0.85-4.50],0.114347592648903
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADRA2A,Alpha-2A adrenergic receptor,15485,61,1.10 [0.80-1.51],0.568750233856684
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AFAP1,Actin filament-associated protein 1,15659,64,0.88 [0.65-1.19],0.4084078239447275
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AFM,Afamin,16032,63,0.43 [0.13-1.37],0.1514572943306336
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AFP,Alpha-fetoprotein,18216,70,1.52 [1.11-2.09],0.0088240849431908
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AGBL2,Cytosolic carboxypeptidase 2,15523,61,1.14 [0.87-1.50],0.3323682678889748
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AGER,Advanced glycosylation end product-specific receptor,18372,70,0.77 [0.45-1.30],0.3201756343766858
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AGR2,Anterior gradient protein 2 homolog,17908,70,1.13 [0.91-1.40],0.2679116954035478
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AGR3,Anterior gradient protein 3,17988,68,1.00 [0.69-1.44],0.9874036784151048
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AGRN,Agrin,18492,70,0.92 [0.49-1.72],0.7912393186391096
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AGRP,Agouti-related protein,18653,71,1.00 [0.67-1.50],0.9869703144665504
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AGT,Angiotensinogen,16029,64,0.42 [0.12-1.53],0.1903476237992575
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AGXT,Serine--pyruvate aminotransferase,18432,70,0.98 [0.74-1.31],0.9092984023110446
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AHCY,Adenosylhomocysteinase,18432,70,1.13 [0.83-1.54],0.4365371160037896
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AHNAK,Neuroblast differentiation-associated protein AHNAK,15560,59,4.56 [3.16-6.58],5.365531643133178e-16
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AHNAK2,Protein AHNAK2,15560,59,1.83 [0.98-3.43],0.0597745574659206
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,15951,63,0.87 [0.58-1.30],0.4892039928625992
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AHSG,Alpha-2-HS-glycoprotein,16029,64,1.53 [0.64-3.65],0.3382823470504661
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AHSP,Alpha-hemoglobin-stabilizing protein,18394,70,1.10 [0.85-1.43],0.4557114083326674
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AIDA,"Axin interactor, dorsalization-associated protein",15599,60,0.94 [0.70-1.28],0.7150833316337577
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AIF1,Allograft inflammatory factor 1,18014,68,0.88 [0.58-1.33],0.5488846255876152
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AIF1L,Allograft inflammatory factor 1-like,15560,59,0.66 [0.37-1.21],0.1784963686282878
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",18321,71,1.05 [0.87-1.28],0.6021982698866424
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AK1,Adenylate kinase isoenzyme 1,18432,70,1.01 [0.72-1.41],0.9529766115134174
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AK2,"Adenylate kinase 2, mitochondrial",15980,64,1.11 [0.89-1.39],0.3456711437747558
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AKAP12,A-kinase anchor protein 12,15659,64,2.25 [1.05-4.81],0.0359141638740512
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AKR1B1,Aldo-keto reductase family 1 member B1,18014,68,1.25 [0.95-1.65],0.1164196299901473
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AKR1B10,Aldo-keto reductase family 1 member B10,15599,60,0.95 [0.64-1.42],0.7979317705386961
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AKR1C4,Aldo-keto reductase family 1 member C4,18109,70,0.72 [0.44-1.19],0.2032695241436792
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AKR7L,Aflatoxin B1 aldehyde reductase member 4,15528,61,1.09 [0.76-1.55],0.6461157154126433
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AKT1S1,Proline-rich AKT1 substrate 1,18039,70,1.04 [0.75-1.43],0.8224318750255942
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AKT2,RAC-beta serine/threonine-protein kinase,15987,64,1.04 [0.86-1.26],0.6528524425364679
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AKT3,RAC-gamma serine/threonine-protein kinase,17928,68,0.90 [0.62-1.31],0.5833577380113449
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,18663,72,10.17 [4.04-25.63],8.619623672826231e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ALDH1A1,Retinal dehydrogenase 1,18432,70,1.20 [0.83-1.75],0.3390632341260088
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ALDH2,"Aldehyde dehydrogenase, mitochondrial",15951,63,1.14 [0.76-1.71],0.5308980826632896
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",18396,71,1.08 [0.81-1.44],0.595335148068053
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",15987,64,1.85 [1.23-2.78],0.0029318451037937
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ALMS1,Alstrom syndrome protein 1,15731,62,1.24 [0.76-2.04],0.3854488993010319
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ALPI,Intestinal-type alkaline phosphatase,15528,61,0.79 [0.64-0.98],0.0329415481101805
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ALPP,"Alkaline phosphatase, placental type",18344,71,0.87 [0.71-1.07],0.1820207706091051
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMBN,Ameloblastin,18124,68,1.38 [0.81-2.36],0.2328081580606424
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMBP,Protein AMBP,18580,70,1.60 [0.56-4.60],0.3799034198529453
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,16018,64,1.36 [0.54-3.44],0.5156106307252137
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMFR,E3 ubiquitin-protein ligase AMFR,18039,70,1.27 [0.95-1.68],0.1043060507398999
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMIGO1,Amphoterin-induced protein 1,15599,60,0.76 [0.42-1.37],0.3594582850889773
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMIGO2,Amphoterin-induced protein 2,18344,71,1.30 [0.53-3.18],0.5602311627192272
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMN,Protein amnionless,18124,68,1.35 [0.88-2.09],0.1727998010118151
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMOT,Angiomotin,15659,64,0.95 [0.50-1.82],0.8841112882829195
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMOTL2,Angiomotin-like protein 2,15885,63,1.15 [0.73-1.81],0.5395757833921229
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMPD3,AMP deaminase 3,15980,64,1.60 [1.16-2.21],0.0038760002832065
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,15009,60,0.70 [0.41-1.20],0.194175433245565
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMY2A,Pancreatic alpha-amylase,17765,71,0.73 [0.47-1.13],0.1597498615744125
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMY2B,Alpha-amylase 2B,17208,67,0.65 [0.41-1.02],0.0613339869500004
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANG,Angiogenin,18406,68,0.65 [0.33-1.28],0.2095934590587904
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANGPT1,Angiopoietin-1,18356,70,0.79 [0.62-1.02],0.0659352865215702
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANGPT2,Angiopoietin-2,18606,70,1.10 [0.63-1.94],0.7291771058075369
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANGPTL1,Angiopoietin-related protein 1,18154,70,0.96 [0.45-2.02],0.9114916527131124
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANGPTL2,Angiopoietin-related protein 2,18424,70,1.09 [0.64-1.87],0.7450583607222996
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANGPTL3,Angiopoietin-related protein 3,18465,68,1.31 [0.70-2.45],0.3981725251517812
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANGPTL4,Angiopoietin-related protein 4,18471,70,1.21 [0.75-1.95],0.4249222311445865
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANGPTL7,Angiopoietin-related protein 7,18606,70,0.80 [0.44-1.44],0.4567929458184353
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANK2,Ankyrin-2,15485,61,0.86 [0.57-1.28],0.4515082923086325
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,15528,61,1.06 [0.78-1.44],0.695540786578573
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANKRA2,Ankyrin repeat family A protein 2,15454,61,0.87 [0.55-1.39],0.5604388795773892
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANKRD54,Ankyrin repeat domain-containing protein 54,18014,68,1.08 [0.76-1.54],0.6719159408869892
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,15560,59,0.31 [0.12-0.84],0.0206664781899321
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANPEP,Aminopeptidase N,18495,69,1.24 [0.57-2.69],0.5839957404005895
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANXA1,Annexin A1,15579,63,1.11 [0.66-1.86],0.6919221762836156
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANXA10,Annexin A10,18039,70,1.07 [0.84-1.38],0.5747452327823104
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANXA11,Annexin A11,18389,70,1.13 [0.81-1.58],0.4546962978526011
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANXA2,Annexin A2,15336,58,1.89 [1.55-2.29],1.6466948757496175e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANXA3,Annexin A3,18567,71,0.88 [0.65-1.19],0.4180003575358
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANXA4,Annexin A4,18353,70,0.96 [0.71-1.29],0.787741458595832
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANXA5,Annexin A5,17976,70,1.11 [0.56-2.23],0.7619683154001744
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AOC1,Amiloride-sensitive amine oxidase [copper-containing],18124,68,0.75 [0.47-1.21],0.2371383346757668
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AOC3,Membrane primary amine oxidase,18520,69,0.74 [0.36-1.51],0.4068368177538499
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AP1G2,AP-1 complex subunit gamma-like 2,15951,63,1.18 [0.88-1.57],0.2779066321799047
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AP2B1,AP-2 complex subunit beta,15599,60,1.23 [0.76-2.00],0.4009396054458326
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AP3B1,AP-3 complex subunit beta-1,15956,64,1.25 [0.93-1.69],0.1403061072586073
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AP3S2,AP-3 complex subunit sigma-2,15980,64,1.22 [0.76-1.95],0.4192000711410455
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,18344,71,1.95 [1.46-2.59],4.896092737505665e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APCS,Serum amyloid P-component,15888,63,0.75 [0.36-1.56],0.440126175724
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,18555,70,2.94 [2.37-3.65],1.3449875722897561e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APLP1,Amyloid-like protein 1,18432,70,1.32 [0.88-1.98],0.1834154098095703
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOA1,Apolipoprotein A-I,16032,63,1.25 [0.53-2.93],0.6055137198274836
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOA2,Apolipoprotein A-II,16029,64,1.57 [0.99-2.51],0.0577196257802035
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOA4,Apolipoprotein A-IV,16032,63,1.70 [0.96-3.01],0.0706246515697908
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOB,Apolipoprotein B-100,16029,64,0.77 [0.28-2.13],0.616064000855665
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOBR,Apolipoprotein B receptor,15560,59,0.73 [0.42-1.29],0.2789284089889061
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOC1,Apolipoprotein C-I,16007,63,1.13 [0.61-2.11],0.6923233591953792
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOD,Apolipoprotein D,15320,60,1.43 [0.92-2.23],0.1079400065776571
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOE,Apolipoprotein E,16032,63,1.28 [1.01-1.61],0.0408418907881541
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOF,Apolipoprotein F,16029,64,1.35 [0.52-3.46],0.5354744728360208
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOH,Beta-2-glycoprotein 1,18432,70,0.93 [0.52-1.66],0.8025833749676088
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOL1,Apolipoprotein L1,16029,64,0.85 [0.52-1.36],0.4889909199822065
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOM,Apolipoprotein M,18498,69,0.65 [0.32-1.35],0.2500270117137786
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APP,Amyloid-beta precursor protein,18408,70,0.71 [0.51-0.99],0.0452965158634518
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APPL2,DCC-interacting protein 13-beta,15659,64,0.95 [0.76-1.17],0.6070951475399498
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APRT,Adenine phosphoribosyltransferase,18253,70,2.10 [1.29-3.41],0.002806538961675
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARAF,Serine/threonine-protein kinase A-Raf,15731,62,1.02 [0.71-1.45],0.9195291604559088
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AREG,Amphiregulin,18344,71,1.12 [0.65-1.92],0.6825505794593453
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARF6,ADP-ribosylation factor 6,15956,64,1.10 [0.88-1.38],0.3836852121039532
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARFIP1,Arfaptin-1,15987,64,1.22 [0.87-1.71],0.2542273236544559
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARG1,Arginase-1,18330,69,1.51 [1.00-2.26],0.0480942300395552
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARG2,"Arginase-2, mitochondrial",15951,63,1.27 [0.78-2.07],0.3454878333431007
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARHGAP1,Rho GTPase-activating protein 1,18014,68,1.11 [0.70-1.78],0.6522373543574904
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARHGAP25,Rho GTPase-activating protein 25,18014,68,1.90 [1.52-2.38],1.94575533579984e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARHGAP30,Rho GTPase-activating protein 30,15731,62,1.19 [0.72-1.97],0.4993278163188618
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARHGAP45,Rho GTPase-activating protein 45,15659,64,1.02 [0.76-1.37],0.8916623320822334
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARHGAP5,Rho GTPase-activating protein 5,15454,61,0.91 [0.64-1.28],0.5719613585307377
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARHGEF1,Rho guanine nucleotide exchange factor 1,15980,64,1.28 [0.97-1.67],0.0767221100665751
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARHGEF10,Rho guanine nucleotide exchange factor 10,15987,64,1.11 [0.86-1.43],0.4154205720601234
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARHGEF12,Rho guanine nucleotide exchange factor 12,18427,71,1.02 [0.83-1.25],0.8542222985373922
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARHGEF5,Rho guanine nucleotide exchange factor 5,15523,61,0.84 [0.58-1.21],0.3475827116146871
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARID3A,AT-rich interactive domain-containing protein 3A,15523,61,0.98 [0.53-1.82],0.956893623601958
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARID4B,AT-rich interactive domain-containing protein 4B,18039,70,2.04 [1.64-2.53],1.8181905638829016e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARL13B,ADP-ribosylation factor-like protein 13B,15485,61,1.03 [0.73-1.47],0.8493721671845889
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,15485,61,1.45 [0.83-2.54],0.1952159837595985
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARMCX2,Armadillo repeat-containing X-linked protein 2,15523,61,0.75 [0.44-1.27],0.2866477202896429
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARNT,Aryl hydrocarbon receptor nuclear translocator,18124,68,1.11 [0.64-1.95],0.70749418407949
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,15485,61,1.04 [0.65-1.66],0.8784407763149944
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARSA,Arylsulfatase A,18432,70,0.69 [0.42-1.14],0.1478394316371597
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARSB,Arylsulfatase B,18344,71,0.86 [0.58-1.27],0.4435758682977315
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ART3,Ecto-ADP-ribosyltransferase 3,18520,69,1.74 [0.98-3.09],0.0594439357648734
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ART5,Ecto-ADP-ribosyltransferase 5,15523,61,0.97 [0.64-1.46],0.8829682811058132
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARTN,Artemin,18124,68,1.42 [1.05-1.92],0.0221046955727372
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ASAH1,Acid ceramidase,15876,63,1.03 [0.61-1.74],0.8995847265364921
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ASAH2,Neutral ceramidase,18284,71,0.90 [0.62-1.32],0.5989007874048415
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ASGR1,Asialoglycoprotein receptor 1,18284,71,1.60 [0.83-3.09],0.1610481046197929
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ASGR2,Asialoglycoprotein receptor 2,16029,64,1.81 [0.76-4.31],0.1803160745639344
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ASPN,Asporin,16007,62,0.30 [0.12-0.79],0.0140321639242525
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ASPSCR1,Tether containing UBX domain for GLUT4,15987,64,1.21 [0.85-1.72],0.2960951306754348
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ASRGL1,Isoaspartyl peptidase/L-asparaginase,15560,59,1.00 [0.78-1.28],0.9759306357617858
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ASS1,Argininosuccinate synthase,15485,61,0.85 [0.61-1.18],0.3395410834826154
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATF2,Cyclic AMP-dependent transcription factor ATF-2,18039,70,1.09 [0.83-1.44],0.5302377892484067
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATF4,Cyclic AMP-dependent transcription factor ATF-4,15454,61,1.23 [0.62-2.47],0.5531011126451848
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATG16L1,Autophagy-related protein 16-1,15956,64,1.22 [0.93-1.61],0.1581484463024641
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATG4A,Cysteine protease ATG4A,18014,68,1.30 [0.93-1.82],0.1291526277511493
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATOX1,Copper transport protein ATOX1,18477,72,1.32 [0.98-1.78],0.0696600469758816
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,15485,61,0.90 [0.51-1.58],0.7040886928411887
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,15485,61,0.80 [0.35-1.80],0.5825745454829844
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,15485,61,0.47 [0.21-1.05],0.0652411918206415
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP1B4,Protein ATP1B4,15454,61,0.76 [0.40-1.45],0.4121331380853497
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP2B4,Plasma membrane calcium-transporting ATPase 4,15485,61,1.00 [0.67-1.48],0.981959933314296
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP5F1D,"ATP synthase subunit delta, mitochondrial",15485,61,0.83 [0.48-1.45],0.5107561127211565
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP5IF1,"ATPase inhibitor, mitochondrial",18492,70,0.98 [0.81-1.19],0.8711837249716183
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP5PO,"ATP synthase subunit O, mitochondrial",18039,70,1.43 [1.10-1.87],0.0077079444205697
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP6AP2,Renin receptor,18014,68,1.45 [0.96-2.19],0.0789302746183618
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP6V1D,V-type proton ATPase subunit D,18344,71,1.57 [0.86-2.84],0.140377384039115
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP6V1F,V-type proton ATPase subunit F,18011,70,1.02 [0.74-1.40],0.9039032344825204
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP6V1G1,V-type proton ATPase subunit G 1,15560,59,1.15 [0.82-1.61],0.4107969071070212
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP6V1G2,V-type proton ATPase subunit G 2,15485,61,1.22 [0.99-1.50],0.0669173912597183
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,15956,64,2.13 [1.49-3.03],2.889340574241879e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATRN,"Attractin, Isoform 2",16032,63,5.13 [1.31-20.05],0.0187275579352005
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATXN10,Ataxin-10,18039,70,1.10 [0.82-1.49],0.5105554760480444
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATXN2,Ataxin-2,15523,61,0.84 [0.64-1.11],0.2309386816729173
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATXN2L,Ataxin-2-like protein,15987,64,1.41 [0.95-2.10],0.0869691903358771
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATXN3,Ataxin-3,15980,64,1.37 [0.95-1.97],0.0969313983950727
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AXIN1,Axin-1,18427,71,1.06 [0.85-1.32],0.596657334955552
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AXL,Tyrosine-protein kinase receptor UFO,18520,69,1.76 [0.82-3.76],0.1483504928753378
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AZI2,5-azacytidine-induced protein 2,15987,64,1.67 [1.15-2.43],0.0072213790614535
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AZU1,Azurocidin,17895,70,1.01 [0.76-1.33],0.9513108609371846
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,16032,63,1.69 [1.25-2.29],0.0006665950688287
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,15485,61,0.85 [0.25-2.90],0.7977364142311085
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",15560,59,0.93 [0.48-1.83],0.8411532339392838
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",18492,70,12.54 [7.50-20.97],5.152099419985515e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",B4GAT1,"Beta-1,4-glucuronyltransferase 1",18432,70,1.32 [0.56-3.12],0.5268373067920091
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BABAM1,BRISC and BRCA1-A complex member 1,15528,61,1.14 [0.51-2.54],0.756469703561893
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BACH1,Transcription regulator protein BACH1,18427,71,1.18 [0.90-1.57],0.2345803268082232
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BAG3,BAG family molecular chaperone regulator 3,18250,71,0.83 [0.51-1.37],0.4684918523754908
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BAG4,BAG family molecular chaperone regulator 4,15528,61,2.03 [1.46-2.83],2.8851718543464063e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BAG6,Large proline-rich protein BAG6,18109,70,1.74 [1.00-3.03],0.0491192634110389
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,18014,68,1.12 [0.81-1.56],0.4984355224094993
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BAMBI,BMP and activin membrane-bound inhibitor homolog,18014,68,1.74 [0.88-3.42],0.1090887435440893
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BANK1,B-cell scaffold protein with ankyrin repeats,18427,71,1.24 [1.01-1.53],0.0403127378639556
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,15980,64,1.92 [1.67-2.20],1.3450014215564091e-20
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BATF,Basic leucine zipper transcriptional factor ATF-like,15599,60,1.12 [0.87-1.44],0.373031486438602
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BAX,Apoptosis regulator BAX,18009,70,1.17 [0.93-1.47],0.182770287261963
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCAM,Basal cell adhesion molecule,18432,70,1.85 [0.81-4.26],0.1466682786250902
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCAN,Brevican core protein,18284,71,1.00 [0.54-1.83],0.9954735017238274
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",16007,62,0.65 [0.28-1.53],0.325092622057311
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",15523,61,0.53 [0.28-1.01],0.0544227644900356
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCHE,Cholinesterase,15733,63,0.59 [0.24-1.42],0.2400554326692232
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,15956,64,2.53 [2.15-2.97],1.289229127561338e-29
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCL2L1,Bcl-2-like protein 1,15980,64,1.06 [0.83-1.35],0.6320115539932245
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",18427,71,1.03 [0.62-1.72],0.9019842083272424
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCL2L15,Bcl-2-like protein 15,15528,61,0.89 [0.57-1.40],0.6124383984006321
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCL7A,B-cell CLL/lymphoma 7 protein family member A,15454,61,0.88 [0.58-1.33],0.5435340608405114
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCL7B,B-cell CLL/lymphoma 7 protein family member B,15951,63,1.11 [0.70-1.77],0.6544565883220581
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCR,Breakpoint cluster region protein,18427,71,0.98 [0.78-1.23],0.8304384423112399
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BDNF,Brain-derived neurotrophic factor,16018,64,0.68 [0.52-0.89],0.0044021298289202
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BECN1,Beclin-1,15560,59,1.61 [1.10-2.35],0.014301976746882
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BEX3,Protein BEX3,15454,61,1.02 [0.59-1.75],0.9436225543656448
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BGLAP,Osteocalcin,16018,64,0.90 [0.68-1.19],0.454206457095327
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BGN,Biglycan,17988,68,1.19 [1.00-1.42],0.0474597015667879
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BHLHE40,Class E basic helix-loop-helix protein 40,15523,61,0.62 [0.43-0.89],0.008546751859954
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,15485,61,0.60 [0.24-1.53],0.2855588924689214
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BID,BH3-interacting domain death agonist,18427,71,0.99 [0.72-1.35],0.9442738205873856
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BIN2,Bridging integrator 2,18432,70,0.95 [0.75-1.21],0.6714375427891168
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BIRC2,Baculoviral IAP repeat-containing protein 2,18014,68,0.90 [0.64-1.28],0.5618299023631689
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BLMH,Bleomycin hydrolase,18663,72,1.23 [0.62-2.41],0.5539916499325594
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,15528,61,3.48 [2.94-4.10],5.544448011559757e-49
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,15523,61,0.88 [0.61-1.27],0.492537302901687
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,15980,64,1.48 [0.87-2.54],0.15089811595765
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BLVRB,Flavin reductase,18432,70,1.31 [0.98-1.75],0.0715439718383714
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BMP10,Bone morphogenetic protein 10,15659,64,1.35 [0.58-3.14],0.480002664259924
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BMP4,Bone morphogenetic protein 4,18250,71,0.79 [0.49-1.26],0.3202955377865673
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BMP6,Bone morphogenetic protein 6,18079,70,0.73 [0.43-1.24],0.2394909303879433
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BMPER,BMP-binding endothelial regulator protein,15659,64,0.95 [0.33-2.77],0.9265859274440624
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,16007,62,0.96 [0.47-1.97],0.9133086486243172
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,15528,61,3.06 [2.22-4.21],6.930347308297421e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BOC,Brother of CDO,18109,70,1.38 [0.55-3.44],0.4921105562685968
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BOLA1,BolA-like protein 1,15523,61,1.49 [1.05-2.10],0.0237688526767839
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BOLA2_BOLA2B,BolA-like protein 2,15560,59,1.34 [0.84-2.15],0.2212035523246762
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BPIFA2,BPI fold-containing family A member 2,15019,58,0.99 [0.78-1.25],0.9267415630375871
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BPIFB1,BPI fold-containing family B member 1,18405,70,0.85 [0.61-1.17],0.3184119702744285
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BPIFB2,BPI fold-containing family B member 2,15979,62,0.73 [0.48-1.12],0.1489656706325654
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BRAP,BRCA1-associated protein,15794,64,1.23 [0.98-1.55],0.0709025955363145
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BRD1,Bromodomain-containing protein 1,15731,62,1.28 [0.61-2.69],0.519025433323631
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BRD2,Bromodomain-containing protein 2,15523,61,1.13 [0.59-2.15],0.7155138487797765
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BRD3,Bromodomain-containing protein 3,15485,61,0.96 [0.57-1.61],0.8676792428772973
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BRDT,Bromodomain testis-specific protein,15485,61,1.09 [0.56-2.12],0.7911229296919124
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BRK1,Protein BRICK1,18039,70,1.04 [0.65-1.66],0.8712722489036165
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BRME1,Break repair meiotic recombinase recruitment factor 1,15523,61,1.22 [0.71-2.10],0.4823318954707259
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BRSK2,Serine/threonine-protein kinase BRSK2,15987,64,1.09 [0.58-2.06],0.7897788259238906
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BSG,Basigin,18620,71,3.70 [1.42-9.65],0.0074714878724361
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BSND,Barttin,15454,61,0.65 [0.28-1.50],0.3108517364219539
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,18597,71,1.68 [0.92-3.09],0.0922708250642873
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BST2,Bone marrow stromal antigen 2,18597,71,1.71 [1.25-2.35],0.0008894872487909
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BTC,Probetacellulin,18014,68,0.75 [0.55-1.04],0.0819260938076547
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BTD,Biotinidase,16032,63,1.14 [0.35-3.72],0.8303702981238492
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BTLA,B- and T-lymphocyte attenuator,15454,61,0.90 [0.66-1.25],0.5364420166561208
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BTN1A1,Butyrophilin subfamily 1 member A1,15918,63,1.05 [0.57-1.94],0.8735054772304791
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,18492,70,4.02 [2.14-7.56],1.558795467338003e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,18427,71,2.10 [1.37-3.22],0.0006330338305859
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BTNL10,Butyrophilin-like protein 10,15454,61,1.22 [0.74-2.01],0.4256140920657704
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C19orf12,Protein C19orf12,18039,70,1.15 [0.86-1.54],0.3408037211003162
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1GALT1C1,C1GALT1-specific chaperone 1,15485,61,1.09 [0.52-2.31],0.8174735847402875
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1QA,Complement C1q subcomponent subunit A,18562,71,3.03 [1.32-6.95],0.0089205770972143
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",15987,64,0.97 [0.68-1.39],0.8715569191371755
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1QL2,Complement C1q-like protein 2,15528,61,0.45 [0.24-0.86],0.0154765494549251
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,18520,69,1.21 [0.74-1.95],0.446862133928767
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,15659,64,1.03 [0.53-2.03],0.9256401533574212
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,15987,64,1.49 [0.82-2.72],0.1949423863403613
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,15635,64,1.12 [0.67-1.86],0.666274201266096
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1R,Complement C1r subcomponent,16032,63,1.96 [0.77-4.96],0.1553790157211861
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,15997,63,7.84 [2.33-26.39],0.0008755530253769
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1S,Complement C1s subcomponent,16032,63,1.70 [0.57-5.09],0.3459092295319217
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C2,Complement C2,18498,69,0.62 [0.32-1.18],0.1464894005492637
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C2CD2L,Phospholipid transfer protein C2CD2L,18011,70,1.22 [0.78-1.93],0.3822806865318409
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C2orf69,UPF0565 protein C2orf69,15599,60,1.10 [0.75-1.62],0.6208924570399448
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C3,Complement C3,15221,61,1.06 [0.61-1.83],0.8315665819662648
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C4BPB,C4b-binding protein beta chain,18477,72,0.98 [0.57-1.71],0.955892657512273
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C5,Complement C5,16032,63,2.26 [0.49-10.37],0.2924011217627882
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,15653,63,1.82 [0.86-3.85],0.1171582589133538
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C7orf50,Uncharacterized protein C7orf50,15980,64,3.27 [2.60-4.10],2.287492947519362e-24
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C8B,Complement component C8 beta chain,16032,63,1.14 [0.51-2.54],0.7523899888399734
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C9,Complement component C9,16029,64,1.29 [0.84-1.98],0.2503064056574883
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C9orf40,Uncharacterized protein C9orf40,15956,64,1.30 [0.98-1.73],0.0726340929430658
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA1,Carbonic anhydrase 1,18070,67,1.38 [0.95-2.00],0.087835596376249
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA11,Carbonic anhydrase-related protein 11,18014,68,1.16 [0.61-2.20],0.6498984556175103
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA12,Carbonic anhydrase 12,18344,71,1.21 [0.64-2.29],0.5643144285691679
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA13,Carbonic anhydrase 13,18210,70,0.90 [0.74-1.10],0.300134978656417
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA14,Carbonic anhydrase 14,18606,70,1.38 [0.77-2.47],0.2743842598963018
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA2,Carbonic anhydrase 2,18373,69,1.28 [0.95-1.73],0.1053496255766495
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA3,Carbonic anhydrase 3,18638,72,1.22 [0.87-1.70],0.2421341234014981
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA4,Carbonic anhydrase 4,18663,72,1.10 [0.47-2.59],0.8269233229072188
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA5A,"Carbonic anhydrase 5A, mitochondrial",18109,70,0.98 [0.77-1.25],0.8846756761347923
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA6,Carbonic anhydrase 6,18373,69,1.03 [0.73-1.45],0.8652140247221168
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA7,Carbonic anhydrase 7,15731,62,0.85 [0.39-1.82],0.6698647403416063
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA8,Carbonic anhydrase-related protein,15528,61,1.16 [0.48-2.79],0.738929662071311
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CA9,Carbonic anhydrase 9,18606,70,0.76 [0.48-1.22],0.2534933877272688
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CABP2,Calcium-binding protein 2,15599,60,0.89 [0.59-1.33],0.5704476362578028
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,15523,61,0.57 [0.23-1.38],0.2109380116333353
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,15485,61,0.72 [0.40-1.28],0.2626783686095527
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,15523,61,0.91 [0.59-1.41],0.6849101534303386
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,15987,64,1.10 [0.83-1.46],0.4909553693381264
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CACYBP,Calcyclin-binding protein,15632,64,1.08 [0.85-1.37],0.5317995326605361
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CADPS,Calcium-dependent secretion activator 1,15599,60,0.60 [0.28-1.31],0.2030944828788617
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CALB1,Calbindin,18344,71,1.35 [0.84-2.17],0.2099891538355264
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CALB2,Calretinin,18039,70,0.75 [0.34-1.65],0.4774618013014975
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CALCA,Calcitonin,18256,71,0.83 [0.60-1.15],0.2732654510403666
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CALCB,Calcitonin gene-related peptide 2,15980,64,1.27 [0.74-2.16],0.3854221107835739
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,18552,70,1.05 [0.86-1.29],0.6328856552931252
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,15560,59,1.55 [1.13-2.12],0.0059833336843299
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CALY,Neuron-specific vesicular protein calcyon,15485,61,0.49 [0.22-1.10],0.0848845936023691
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,18014,68,1.34 [0.86-2.09],0.1931992488616665
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,15599,60,0.98 [0.61-1.57],0.9319566746110486
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,15987,64,1.14 [0.92-1.43],0.2375283339864968
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,18369,70,19.40 [7.42-50.71],1.4542729701687543e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CAPG,Macrophage-capping protein,18320,70,1.80 [1.34-2.42],8.297215696145679e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CAPN3,Calpain-3,15951,63,0.81 [0.40-1.64],0.5641028444241236
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CAPS,Calcyphosin,15980,64,0.78 [0.54-1.13],0.1859428378214166
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CARHSP1,Calcium-regulated heat-stable protein 1,18039,70,1.19 [0.80-1.78],0.3815852585079577
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASC3,Protein CASC3,15599,60,1.48 [0.87-2.51],0.1502689776996911
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASP1,Caspase-1,18039,70,1.18 [0.90-1.54],0.2301599235766329
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASP10,Caspase-10,18039,70,0.91 [0.67-1.23],0.5328860994295068
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASP2,Caspase-2,18427,71,1.02 [0.75-1.39],0.890339593571408
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASP3,Caspase-3,18663,72,0.98 [0.78-1.25],0.8908018752841549
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASP4,Caspase-4,15731,62,0.76 [0.62-0.93],0.0067225053986088
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASP7,Caspase-7,15980,64,1.15 [0.86-1.52],0.3479739037152857
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASP8,Caspase-8,18557,70,1.33 [0.98-1.80],0.0695060806334638
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASP9,Caspase-9,15528,61,1.08 [0.73-1.59],0.7038294171468404
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASQ2,Calsequestrin-2,15485,61,0.34 [0.15-0.76],0.0081823946543139
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CAT,Catalase,15796,63,1.38 [0.91-2.10],0.1258975473352344
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CBLIF,Cobalamin binding intrinsic factor,18412,70,0.71 [0.57-0.89],0.0028908390383708
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CBLN1,Cerebellin-1,15523,61,0.67 [0.45-1.00],0.0524100223597742
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CBLN4,Cerebellin-4,18606,70,0.83 [0.43-1.60],0.5778110666752244
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CBS,Cystathionine beta-synthase,15560,59,1.19 [0.75-1.87],0.4668021975066013
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CBX2,Chromobox protein homolog 2,15485,61,1.05 [0.57-1.93],0.8734986078620741
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,18284,71,1.17 [0.88-1.54],0.2824473296755574
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCAR2,Cell cycle and apoptosis regulator protein 2,15980,64,1.39 [1.08-1.80],0.0114399154847185
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCDC134,Coiled-coil domain-containing protein 134,15951,63,0.79 [0.47-1.32],0.3660543412169452
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCDC28A,Coiled-coil domain-containing protein 28A,15599,60,1.35 [0.58-3.13],0.480095952336479
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCDC50,Coiled-coil domain-containing protein 50,15987,64,1.68 [1.43-1.97],3.633429720032063e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCDC80,Coiled-coil domain-containing protein 80,18432,70,0.78 [0.42-1.44],0.4258877670571001
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,15560,59,1.35 [0.93-1.96],0.1147635572558999
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL11,Eotaxin,18653,71,0.64 [0.38-1.06],0.0828362202763445
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL13,C-C motif chemokine 13,18626,71,0.74 [0.54-1.01],0.054397822118583
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL14,C-C motif chemokine 14,18406,68,1.30 [0.79-2.13],0.3030680828583321
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL15,C-C motif chemokine 15,18663,72,1.06 [0.66-1.70],0.8031534900612491
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL16,C-C motif chemokine 16,18663,72,1.40 [0.91-2.14],0.1212965107682122
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL17,C-C motif chemokine 17,18374,70,0.74 [0.59-0.94],0.0128881860729943
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL18,C-C motif chemokine 18,18206,67,1.16 [0.88-1.52],0.2870711314252648
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL19,C-C motif chemokine 19,18597,71,1.11 [0.95-1.28],0.1923820518514548
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL2,C-C motif chemokine 2,18250,71,1.35 [0.92-1.98],0.1255592653102714
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL20,C-C motif chemokine 20,18653,71,0.81 [0.61-1.07],0.131210172513494
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL21,C-C motif chemokine 21,18492,70,0.89 [0.50-1.57],0.6781197568060096
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL22,C-C motif chemokine 22,18215,70,1.04 [0.70-1.57],0.833872859103046
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL23,C-C motif chemokine 23,18492,70,1.28 [0.78-2.12],0.3315262045482491
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL24,C-C motif chemokine 24,18471,70,1.02 [0.79-1.31],0.8928657557317362
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL25,C-C motif chemokine 25,18653,71,0.82 [0.53-1.26],0.3602861517006823
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL26,C-C motif chemokine 26,18427,71,0.79 [0.61-1.02],0.0720846722394253
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL27,C-C motif chemokine 27,18432,70,0.72 [0.52-1.01],0.0562956408045707
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL28,C-C motif chemokine 28,18364,71,0.74 [0.50-1.09],0.1265152028523729
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,18427,71,1.60 [1.38-1.85],3.262106066475151e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL4,C-C motif chemokine 4,18434,70,1.37 [1.10-1.72],0.0058075932419299
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL5,C-C motif chemokine 5,18520,69,0.73 [0.59-0.89],0.0024962887186498
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL7,C-C motif chemokine 7,18427,71,0.68 [0.44-1.03],0.0703229171935791
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL8,C-C motif chemokine 8,18580,70,0.76 [0.55-1.06],0.1070204229980718
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCN1,CCN family member 1,18318,71,0.68 [0.52-0.89],0.004601083437157
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCN2,CCN family member 2,18417,69,0.52 [0.35-0.78],0.0013669238029872
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCN3,CCN family member 3,18626,72,1.16 [0.62-2.17],0.639835880501398
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCN4,CCN family member 4,18606,70,0.88 [0.50-1.54],0.6538172025089564
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCN5,CCN family member 5,18432,70,1.62 [0.95-2.78],0.0777598197612689
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCND2,G1/S-specific cyclin-D2,15731,62,3.44 [1.69-6.98],0.0006417215465837
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCNE1,G1/S-specific cyclin-E1,15528,61,1.12 [0.90-1.40],0.306338333841361
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCS,Copper chaperone for superoxide dismutase,18284,71,1.28 [0.83-1.98],0.2710895489537225
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCT5,T-complex protein 1 subunit epsilon,18014,68,1.03 [0.64-1.66],0.8996598696278232
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD101,Immunoglobulin superfamily member 2,15956,64,1.37 [0.78-2.38],0.2707958968090145
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD109,CD109 antigen,18432,70,0.63 [0.35-1.14],0.1233965941096194
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,18094,67,2.00 [1.24-3.23],0.0047385686817186
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD160,CD160 antigen,18653,71,1.09 [0.70-1.69],0.7134901930745758
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,18520,69,2.02 [1.29-3.17],0.0022305979548872
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD164,Sialomucin core protein 24,18432,70,1.31 [0.71-2.43],0.3846962622935498
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD164L2,CD164 sialomucin-like 2 protein,15599,60,0.92 [0.46-1.84],0.8196444371140573
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD177,CD177 antigen,18400,70,1.32 [1.09-1.60],0.0037846973346351
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD1C,T-cell surface glycoprotein CD1c,18477,72,3.27 [1.38-7.78],0.0072351497637233
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD2,T-cell surface antigen CD2,15485,61,1.16 [0.67-2.02],0.5982362164902131
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,18427,71,4.95 [3.98-6.14],2.6602143002628653e-47
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD200R1,Cell surface glycoprotein CD200 receptor 1,18361,71,1.82 [1.05-3.16],0.0337893145688333
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD207,C-type lectin domain family 4 member K,18005,71,0.75 [0.43-1.30],0.3031330490565386
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD209,CD209 antigen,18482,72,1.11 [0.65-1.90],0.6973911826033732
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,18653,71,3.79 [3.01-4.76],3.1342275574121703e-30
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD226,CD226 antigen,15528,61,0.64 [0.35-1.16],0.1404021245802825
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD244,Natural killer cell receptor 2B4,18653,71,1.09 [0.51-2.33],0.817830259631684
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD248,Endosialin,16018,64,1.13 [0.63-2.04],0.6848769386500049
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,18477,72,7.05 [5.21-9.52],5.390237159785394e-37
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD274,Programmed cell death 1 ligand 1,18284,71,1.83 [1.07-3.16],0.0286531190971531
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD276,CD276 antigen,18402,70,0.91 [0.51-1.64],0.7622644569706019
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,18014,68,2.38 [1.84-3.07],3.031647528605997e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD2AP,CD2-associated protein,18432,70,1.30 [0.94-1.80],0.1069343450477817
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD300A,CMRF35-like molecule 8,15659,64,2.71 [1.33-5.52],0.0059051299478284
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD300C,CMRF35-like molecule 6,18597,71,2.32 [1.33-4.05],0.0030507110174566
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD300E,CMRF35-like molecule 2,18552,70,1.61 [0.99-2.62],0.0528197490929297
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD300LF,CMRF35-like molecule 1,18606,70,1.60 [1.08-2.38],0.0204589535513504
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD300LG,CMRF35-like molecule 9,18432,70,1.70 [0.98-2.96],0.0594963323844858
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD302,CD302 antigen,18344,71,1.71 [0.90-3.25],0.098432257592369
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD33,Myeloid cell surface antigen CD33,18477,72,0.99 [0.77-1.29],0.9596874091080464
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD34,Hematopoietic progenitor cell antigen CD34,18537,71,1.91 [0.82-4.48],0.1350894357335535
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD36,Platelet glycoprotein 4,15528,61,0.97 [0.57-1.67],0.9178510965907072
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,18344,71,0.88 [0.45-1.69],0.6908668587281113
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD3D,T-cell surface glycoprotein CD3 delta chain,15523,61,0.68 [0.29-1.60],0.3799526127080186
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD3E,T-cell surface glycoprotein CD3 epsilon chain,15731,62,0.89 [0.43-1.86],0.7604614501081917
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD3G,T-cell surface glycoprotein CD3 gamma chain,15528,61,0.79 [0.54-1.15],0.2195722142732323
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD4,T-cell surface glycoprotein CD4,18395,71,1.22 [0.63-2.38],0.5564478889768321
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD40,Tumor necrosis factor receptor superfamily member 5,18413,70,1.47 [0.99-2.18],0.055196573833798
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD40LG,CD40 ligand,18653,71,0.73 [0.56-0.94],0.0158092274845983
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD46,Membrane cofactor protein,18352,68,3.38 [1.99-5.71],5.851482143820566e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,18471,70,20.23 [13.49-30.34],5.928745916623256e-48
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,18580,70,4.96 [4.16-5.92],2.000473217231505e-70
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD55,Complement decay-accelerating factor,17811,66,1.66 [0.79-3.51],0.1820569620803671
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD58,Lymphocyte function-associated antigen 3,18368,70,1.62 [0.48-5.44],0.4322960153085756
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD59,CD59 glycoprotein,17792,67,2.71 [1.31-5.62],0.00746634709894
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,15963,62,0.40 [0.24-0.68],0.0006961360177797
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,18620,71,5.60 [3.98-7.88],5.808791068616979e-23
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD63,CD63 antigen,18250,71,0.64 [0.42-0.96],0.0315038152939619
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD69,Early activation antigen CD69,18339,69,0.95 [0.75-1.21],0.7053309622093467
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD7,T-cell antigen CD7,15501,61,1.64 [1.01-2.65],0.0433621738862532
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,18427,71,5.70 [4.53-7.17],5.126821329636285e-50
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,15659,64,7.74 [5.90-10.17],4.535583433443921e-49
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,18597,71,10.70 [7.32-15.64],2.161029121393215e-34
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,18653,71,6.35 [5.18-7.79],1.646843146246969e-70
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,16007,62,7.68 [5.44-10.85],5.69947617209877e-31
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD82,CD82 antigen,15731,62,0.42 [0.18-0.96],0.0407823696305926
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,18427,71,5.97 [3.74-9.54],8.127691696299649e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD84,SLAM family member 5,18427,71,0.74 [0.39-1.42],0.3663195794405995
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,15956,64,4.22 [2.31-7.74],3.0466823600601253e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD8A,T-cell surface glycoprotein CD8 alpha chain,18597,71,1.85 [1.33-2.59],0.0002885975994763
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD93,Complement component C1q receptor,17762,67,1.53 [0.77-3.04],0.219487104230925
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD99,CD99 antigen,18432,70,1.74 [0.61-4.97],0.3012636703406106
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD99L2,CD99 antigen-like protein 2,18432,70,1.36 [0.58-3.22],0.4784294818287684
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDA,Cytidine deaminase,15985,61,0.62 [0.36-1.07],0.0841308377615945
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDAN1,Codanin-1,15980,64,1.31 [0.52-3.31],0.5621154395408015
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDC123,Cell division cycle protein 123 homolog,15454,61,0.98 [0.65-1.46],0.904750309833132
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDC25A,M-phase inducer phosphatase 1,15454,61,0.93 [0.48-1.80],0.8370697021895905
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDC26,Anaphase-promoting complex subunit CDC26,15918,64,1.24 [0.89-1.73],0.2029632798582673
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDC27,Cell division cycle protein 27 homolog,18014,68,1.51 [1.12-2.04],0.0075056043785908
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDC37,Hsp90 co-chaperone Cdc37,18477,72,1.10 [0.86-1.42],0.4320098338743326
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDC42BPB,Serine/threonine-protein kinase MRCK beta,15956,64,1.03 [0.81-1.30],0.8191963507510538
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,18284,71,1.44 [1.02-2.03],0.0380343866536472
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH1,Cadherin-1,17836,68,0.83 [0.46-1.49],0.5385493453694619
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH15,Cadherin-15,18569,71,0.68 [0.48-0.95],0.0261758316076369
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH17,Cadherin-17,18432,70,0.64 [0.46-0.90],0.0109198189110379
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH2,Cadherin-2,18432,70,1.23 [0.68-2.22],0.5007038437433995
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH22,Cadherin-22,15731,62,0.44 [0.17-1.18],0.1020572558188581
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH23,Cadherin-23,15980,64,1.26 [0.53-2.96],0.6002882310516222
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,18597,71,3.58 [2.21-5.81],2.395469617900915e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH4,Cadherin-4,15523,61,0.80 [0.45-1.43],0.4478041557138899
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH5,Cadherin-5,18663,72,1.22 [0.62-2.41],0.5658704709064253
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH6,Cadherin-6,18432,70,1.30 [0.75-2.23],0.3493348095875027
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDHR1,Cadherin-related family member 1,18039,70,0.95 [0.56-1.60],0.8395627354124785
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDHR2,Cadherin-related family member 2,18344,71,1.15 [0.83-1.60],0.4059037602343986
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDHR5,Cadherin-related family member 5,18432,70,1.22 [0.70-2.12],0.492276006937079
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDK1,Cyclin-dependent kinase 1,15454,61,2.76 [1.49-5.11],0.0012086237406369
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,15987,64,0.77 [0.49-1.21],0.2533830663398807
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDKL5,Cyclin-dependent kinase-like 5,15523,61,0.78 [0.45-1.35],0.3775965574328798
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDKN1A,Cyclin-dependent kinase inhibitor 1,18344,71,0.94 [0.77-1.15],0.5503321031638841
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,18344,71,0.90 [0.73-1.12],0.3560574965913812
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDNF,Cerebral dopamine neurotrophic factor,18344,71,1.28 [0.71-2.32],0.4064300899902169
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,18432,70,0.54 [0.25-1.15],0.1075438385658584
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDSN,Corneodesmosin,18602,71,1.26 [0.78-2.03],0.3542492950486627
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,18450,72,3.80 [1.49-9.67],0.0051089853827106
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,15956,64,1.19 [0.89-1.59],0.2499560764832084
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,15731,62,0.75 [0.47-1.19],0.2266937127245339
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,15956,64,1.11 [0.62-2.01],0.71967975105735
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,15731,62,1.04 [0.60-1.82],0.8881018079257407
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,18427,71,1.11 [0.88-1.41],0.3773684231756666
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,18014,68,1.11 [0.72-1.71],0.6296233166640468
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,17779,68,1.11 [0.78-1.58],0.5552030580391554
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,16018,64,0.44 [0.23-0.84],0.0133385211806094
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,18109,70,1.31 [0.87-1.96],0.1939822047711473
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEBPA,CCAAT/enhancer-binding protein alpha,15528,61,0.79 [0.35-1.77],0.5729375895549993
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEBPB,CCAAT/enhancer-binding protein beta,18109,70,1.25 [0.74-2.12],0.4065747953652927
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CELA2A,Chymotrypsin-like elastase family member 2A,16018,64,0.81 [0.56-1.16],0.2498381031591594
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CELA3A,Chymotrypsin-like elastase family member 3A,18632,72,1.03 [0.73-1.45],0.8856528613501744
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,15659,64,0.81 [0.35-1.90],0.6353512840006392
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEMIP2,Cell surface hyaluronidase,15528,61,1.58 [0.86-2.90],0.1409133768655897
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEND1,Cell cycle exit and neuronal differentiation protein 1,15523,61,0.69 [0.40-1.20],0.1890816285752991
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CENPF,Centromere protein F,15731,62,1.46 [0.99-2.13],0.0535346436564314
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CENPJ,Centromere protein J,15731,62,1.07 [0.76-1.49],0.7080346743183378
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP112,Centrosomal protein of 112 kDa,15485,61,0.50 [0.22-1.14],0.1011432799519691
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP152,Centrosomal protein of 152 kDa,15454,61,1.10 [0.63-1.90],0.7375297692020581
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP164,Centrosomal protein of 164 kDa,18124,68,1.29 [1.02-1.62],0.0304995047972796
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP170,Centrosomal protein of 170 kDa,15560,59,1.07 [0.77-1.47],0.7015851889272731
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP20,Centrosomal protein 20,18014,68,1.15 [0.87-1.52],0.3369695617744767
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP290,Centrosomal protein of 290 kDa,15731,62,0.91 [0.56-1.48],0.7092601086464914
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP350,Centrosome-associated protein 350,15454,61,1.39 [0.77-2.50],0.2785532033349268
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP43,Centrosomal protein 43,17969,70,1.42 [1.06-1.90],0.0186561855291234
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP85,Centrosomal protein of 85 kDa,18014,68,1.53 [1.17-2.02],0.0022989715260828
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CERT,Ceramide transfer protein,18039,70,0.99 [0.70-1.40],0.9614755375324646
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CES1,Liver carboxylesterase 1,18477,71,0.94 [0.73-1.21],0.6199988774493415
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CES2,Cocaine esterase,18344,71,0.71 [0.47-1.07],0.1042848455094235
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CES3,Carboxylesterase 3,18344,71,0.75 [0.53-1.06],0.1046948501854856
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CETN2,Centrin-2,18039,70,1.32 [0.99-1.77],0.0600158633010608
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CETN3,Centrin-3,15956,64,1.21 [0.90-1.64],0.2086154389483775
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CFB,Complement factor B,15760,61,2.14 [1.00-4.58],0.051233971264069
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CFC1,Cryptic protein,18014,68,0.68 [0.41-1.14],0.1464602704828307
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CFD,Complement factor D,16032,63,1.59 [0.58-4.40],0.3686150834363492
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CFH,Complement factor H,15131,60,1.91 [0.66-5.51],0.2292665198673312
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CFHR2,Complement factor H-related protein 2,15918,63,1.16 [0.74-1.82],0.5174839802874474
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CFHR4,Complement factor H-related protein 4,15998,63,1.09 [0.78-1.54],0.6113044008568098
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CFHR5,Complement factor H-related protein 5,15830,63,0.75 [0.42-1.31],0.308048958224378
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CFI,Complement factor I,16032,63,1.39 [0.40-4.83],0.6005157326219797
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CFP,Properdin,16032,63,1.37 [0.57-3.29],0.4853483183054184
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CGA,Glycoprotein hormones alpha chain,18432,70,1.40 [1.03-1.91],0.0303137746540075
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,16029,64,0.93 [0.49-1.79],0.8387443987059895
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CGN,Cingulin,15599,60,0.83 [0.41-1.69],0.6161535677817244
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CGREF1,Cell growth regulator with EF hand domain protein 1,18432,70,1.21 [0.74-1.98],0.4369306186841166
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,18014,68,1.05 [0.73-1.51],0.8020049370292448
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHAD,Chondroadherin,15659,64,0.41 [0.25-0.67],0.0003165205876647
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",15980,64,2.62 [2.00-3.45],4.103807820646019e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHCHD6,MICOS complex subunit MIC25,15951,63,2.37 [1.38-4.08],0.001863611689148
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHEK2,Serine/threonine-protein kinase Chk2,18109,70,1.08 [0.56-2.06],0.8236022397795643
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHGA,Chromogranin-A,16018,64,0.93 [0.69-1.24],0.6057385686721526
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHGB,Secretogranin-1,18547,71,1.35 [0.82-2.23],0.2315345627269088
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHI3L1,Chitinase-3-like protein 1,18055,66,0.98 [0.75-1.27],0.8536651603590872
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHIT1,Chitotriosidase-1,18520,71,1.01 [0.89-1.15],0.8820492932532374
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHL1,Neural cell adhesion molecule L1-like protein,18493,69,1.97 [1.04-3.74],0.0376787318778955
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHM,Rab proteins geranylgeranyltransferase component A 1,15599,60,1.15 [0.78-1.70],0.4810706324892552
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHMP1A,Charged multivesicular body protein 1a,18284,71,0.95 [0.73-1.24],0.7016035867938
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHMP6,Charged multivesicular body protein 6,16007,62,0.93 [0.60-1.42],0.7267205148494458
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHP1,Calcineurin B homologous protein 1,15523,61,0.89 [0.61-1.28],0.5165410567198605
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHRDL1,Chordin-like protein 1,18471,70,1.13 [0.58-2.19],0.714420522266686
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHRDL2,Chordin-like protein 2,18432,70,0.85 [0.53-1.35],0.4864777347286633
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHRM1,Muscarinic acetylcholine receptor M1,15599,60,0.71 [0.32-1.57],0.3980147605072271
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CIAPIN1,Anamorsin,18477,72,1.18 [0.84-1.66],0.3321224620622485
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CILP,Cartilage intermediate layer protein 1,16018,64,0.97 [0.63-1.49],0.8753431555824414
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CINP,Cyclin-dependent kinase 2-interacting protein,15731,62,0.95 [0.54-1.68],0.8678137455013647
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CIRBP,Cold-inducible RNA-binding protein,15956,64,1.24 [0.96-1.59],0.1008312472324526
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CIT,Citron Rho-interacting kinase,15599,60,1.66 [1.13-2.44],0.0092873107495462
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,18562,71,3.46 [2.55-4.68],9.891409404142223e-16
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CKB,Creatine kinase B-type,16018,64,1.39 [0.92-2.10],0.1169042473361343
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",18349,70,1.00 [0.72-1.40],0.9870190915035256
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLASP1,CLIP-associating protein 1,15454,61,1.04 [0.76-1.42],0.8191560173302417
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLC,Galectin-10,18403,70,0.71 [0.50-1.00],0.0495506916698411
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC10A,C-type lectin domain family 10 member A,18284,71,1.05 [0.58-1.88],0.8745922391155716
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC11A,C-type lectin domain family 11 member A,18404,70,0.60 [0.39-0.93],0.0206388361534399
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,15528,61,4.16 [2.68-6.47],2.2054360888742158e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC14A,C-type lectin domain family 14 member A,18432,70,1.22 [0.63-2.34],0.5579582075731937
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC1A,C-type lectin domain family 1 member A,18109,70,2.11 [1.18-3.77],0.0117097398379721
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC1B,C-type lectin domain family 1 member B,18597,71,0.87 [0.70-1.08],0.2070567310473816
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC2L,C-type lectin domain family 2 member L,15599,60,1.16 [0.76-1.76],0.4953220741217295
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC3B,Tetranectin,15672,61,1.32 [0.48-3.59],0.5918492646542453
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC4A,C-type lectin domain family 4 member A,18427,71,1.44 [0.79-2.65],0.2346236381620866
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC4C,C-type lectin domain family 4 member C,18427,71,2.91 [2.05-4.13],2.1429405609701754e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC4D,C-type lectin domain family 4 member D,18427,71,1.28 [0.92-1.79],0.1404535863078298
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC4G,C-type lectin domain family 4 member G,18427,71,1.22 [0.65-2.28],0.5341970657429318
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC4M,C-type lectin domain family 4 member M,15995,63,1.05 [0.64-1.72],0.8396715380327543
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC5A,C-type lectin domain family 5 member A,18372,70,1.44 [0.73-2.84],0.2903714182857672
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC6A,C-type lectin domain family 6 member A,18014,68,1.43 [0.93-2.19],0.1020143458512276
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC7A,C-type lectin domain family 7 member A,18653,71,1.32 [0.86-2.02],0.2031561614496785
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLGN,Calmegin,15599,60,0.89 [0.51-1.58],0.6988595060740728
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLIC5,Chloride intracellular channel protein 5,15599,60,1.13 [0.54-2.35],0.7464563072788771
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLINT1,Clathrin interactor 1,15454,61,1.24 [0.83-1.84],0.290735007432777
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLIP2,CAP-Gly domain-containing linker protein 2,18427,71,0.99 [0.82-1.19],0.906908681018738
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLMP,CXADR-like membrane protein,18606,70,1.45 [0.56-3.78],0.442005578851291
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLNS1A,Methylosome subunit pICln,15599,60,1.08 [0.53-2.18],0.8319532151970946
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",18256,71,1.01 [0.81-1.25],0.9460171713063767
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLPS,Colipase,18394,70,1.10 [0.83-1.47],0.5089994749537121
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLSPN,Claspin,18011,70,0.89 [0.47-1.69],0.7201710261836308
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLSTN1,Calsyntenin-1,18039,70,1.00 [0.66-1.51],0.992194556347476
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLSTN2,Calsyntenin-2,18653,71,1.26 [0.76-2.07],0.365590473018387
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,15980,64,4.16 [2.65-6.52],5.144209748852256e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLTA,Clathrin light chain A,18109,70,1.10 [0.70-1.72],0.6813470366359433
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLU,Clusterin,16032,63,1.64 [1.04-2.59],0.0345837578080481
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLUL1,Clusterin-like protein 1,18398,70,0.87 [0.54-1.41],0.5835858162531282
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CMC1,COX assembly mitochondrial protein homolog,16007,62,0.95 [0.73-1.25],0.7299726700369755
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CMIP,C-Maf-inducing protein,15951,63,1.03 [0.77-1.37],0.8412655301181857
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNDP1,Beta-Ala-His dipeptidase,18520,69,0.92 [0.58-1.45],0.7145870910373544
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNGB3,Cyclic nucleotide-gated cation channel beta-3,15523,61,0.92 [0.56-1.53],0.752452370421961
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",15532,59,1.20 [0.87-1.65],0.2640999924303888
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNPY2,Protein canopy homolog 2,18109,70,0.90 [0.61-1.33],0.5998117772639715
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNPY4,Protein canopy homolog 4,18344,71,0.90 [0.68-1.19],0.4618023541227666
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNST,Consortin,18432,70,0.98 [0.81-1.19],0.8551966243710643
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNTF,Ciliary neurotrophic factor,15523,61,1.21 [0.60-2.43],0.5951427711550931
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNTN1,Contactin-1,18663,72,2.24 [1.02-4.89],0.0437363770321281
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNTN2,Contactin-2,18606,70,0.77 [0.47-1.25],0.2909378848373248
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNTN3,Contactin-3,18432,70,1.02 [0.48-2.16],0.960168554647624
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNTN4,Contactin-4,18432,70,0.82 [0.34-2.02],0.6691663264309111
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNTN5,Contactin-5,18482,71,1.00 [0.56-1.77],0.9882945524352248
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNTNAP2,Contactin-associated protein-like 2,18427,71,1.94 [1.25-3.02],0.0030502037461239
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNTNAP4,Contactin-associated protein-like 4,15599,60,1.15 [0.95-1.39],0.1608510405856601
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COCH,Cochlin,16007,62,3.51 [2.38-5.17],2.0743647935477384e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL15A1,Collagen alpha-1(XV) chain,16018,64,1.28 [0.52-3.14],0.5869304511612168
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL18A1,Collagen alpha-1(XVIII) chain,18506,70,2.88 [1.20-6.90],0.017825942205207
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL1A1,Collagen alpha-1(I) chain,18663,72,0.56 [0.23-1.40],0.2168481056178045
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL24A1,Collagen alpha-1(XXIV) chain,15956,64,0.86 [0.58-1.27],0.4467009695562042
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL28A1,Collagen alpha-1(XXVIII) chain,15599,60,1.07 [0.79-1.44],0.6693466619888719
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL2A1,Collagen alpha-1(II) chain,15560,59,0.77 [0.55-1.07],0.1227424128664113
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL3A1,Collagen alpha-1(III) chain,16018,64,0.88 [0.32-2.46],0.8141236356006291
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,18432,70,2.05 [1.27-3.32],0.0032489017067294
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL4A4,Collagen alpha-4(IV) chain,15702,62,1.26 [0.78-2.03],0.3520067684059003
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL5A1,Collagen alpha-1(V) chain,15659,64,0.78 [0.41-1.49],0.4522327973565241
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL6A3,Collagen alpha-3(VI) chain,18663,72,1.59 [0.91-2.76],0.1011684860396861
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL9A1,Collagen alpha-1(IX) chain,18427,71,0.76 [0.46-1.26],0.291437695598674
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL9A2,Collagen alpha-2(IX) chain,15731,62,1.84 [1.44-2.36],1.4275645663278277e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,18402,70,1.79 [0.84-3.85],0.1342822709457642
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COMMD1,COMM domain-containing protein 1,15560,59,1.39 [0.93-2.06],0.1079740164904105
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COMMD9,COMM domain-containing protein 9,15951,63,1.18 [0.68-2.03],0.55966069638814
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COMP,Cartilage oligomeric matrix protein,18258,67,0.66 [0.34-1.26],0.2054450324755078
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COMT,Catechol O-methyltransferase,17910,68,1.07 [0.83-1.40],0.5979069942151133
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COPB2,Coatomer subunit beta',15485,61,1.11 [0.65-1.90],0.6913007447753354
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COPE,Coatomer subunit epsilon,18039,70,0.76 [0.45-1.29],0.3086938174094232
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",15560,59,1.58 [1.06-2.35],0.0235080215726169
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CORO1A,Coronin-1A,18069,69,1.22 [0.99-1.50],0.0687619175212385
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CORO6,Coronin-6,15523,61,0.75 [0.37-1.53],0.4311834693509974
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",18344,71,1.01 [0.75-1.37],0.9437584081980852
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COX6B1,Cytochrome c oxidase subunit 6B1,16007,62,1.00 [0.47-2.09],0.9933172865705968
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPA1,Carboxypeptidase A1,18663,72,0.98 [0.71-1.35],0.9044147289292184
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPA2,Carboxypeptidase A2,18544,71,0.91 [0.66-1.25],0.5579997361809186
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPA4,Carboxypeptidase A4,15357,62,1.10 [0.62-1.96],0.7378179872674044
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPB1,Carboxypeptidase B,18663,72,0.95 [0.68-1.34],0.7883842759601917
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPB2,Carboxypeptidase B2,16007,63,1.48 [0.51-4.33],0.4726621181511141
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPE,Carboxypeptidase E,18445,69,1.07 [0.62-1.84],0.8203873016485677
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPLX2,Complexin-2,15454,61,0.86 [0.38-1.94],0.7123838077926608
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPM,Carboxypeptidase M,18511,71,1.16 [0.63-2.11],0.6362833874552889
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",15528,61,1.47 [0.68-3.18],0.3281805486610828
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPPED1,Serine/threonine-protein phosphatase CPPED1,18597,71,1.15 [0.84-1.57],0.3912156839281787
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPQ,Carboxypeptidase Q,15991,64,0.60 [0.34-1.08],0.0908783820583754
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPTP,Ceramide-1-phosphate transfer protein,15485,61,0.59 [0.28-1.24],0.1645907046533922
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPVL,Probable serine carboxypeptidase CPVL,18571,70,1.34 [0.79-2.29],0.2773084299498556
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPXM1,Probable carboxypeptidase X1,18477,72,0.67 [0.49-0.91],0.011465476670466
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPXM2,Inactive carboxypeptidase-like protein X2,16007,62,1.99 [0.80-4.96],0.1373524224284372
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,15972,63,3.46 [1.90-6.32],5.238228556933279e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,18520,69,3.31 [2.24-4.89],1.7280881808983975e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,18014,68,1.14 [0.89-1.45],0.2994243820595997
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRADD,Death domain-containing protein CRADD,18256,71,0.95 [0.71-1.26],0.7136444142487262
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CREB3,Cyclic AMP-responsive element-binding protein 3,15454,61,0.88 [0.54-1.44],0.6118012251789374
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CREBZF,CREB/ATF bZIP transcription factor,15454,61,1.50 [0.64-3.51],0.3500224309168284
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CREG1,Protein CREG1,18191,71,0.96 [0.57-1.61],0.8689213674946968
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRELD1,Protein disulfide isomerase CRELD1,15659,64,1.12 [0.58-2.16],0.7420523542016266
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRELD2,Protein disulfide isomerase CRELD2,18471,70,1.35 [0.91-1.99],0.1375481854263052
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRH,Corticoliberin,17988,68,1.95 [1.56-2.43],4.1186510624004755e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRHBP,Corticotropin-releasing factor-binding protein,18402,70,1.38 [0.63-2.99],0.4183771287991165
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRHR1,Corticotropin-releasing factor receptor 1,18109,70,0.71 [0.47-1.07],0.1018829285923793
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRIM1,Cysteine-rich motor neuron 1 protein,18492,70,4.66 [1.82-11.93],0.0013450617982985
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRIP2,Cysteine-rich protein 2,18284,71,1.06 [0.61-1.87],0.8276323318143018
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRISP2,Cysteine-rich secretory protein 2,18606,70,1.24 [0.83-1.87],0.2984765633436539
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRISP3,Cysteine-rich secretory protein 3,15875,64,0.53 [0.30-0.95],0.0325971552171828
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRKL,Crk-like protein,18437,70,1.01 [0.83-1.24],0.901042882323438
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRLF1,Cytokine receptor-like factor 1,18492,70,7.32 [3.24-16.55],1.724007642037617e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRNN,Cornulin,17911,69,0.95 [0.70-1.31],0.7717184009685791
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRTAC1,Cartilage acidic protein 1,18663,72,0.81 [0.42-1.56],0.5240769861232919
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,18284,71,4.51 [3.18-6.39],2.239994398991996e-17
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRTAP,Cartilage-associated protein,15599,60,0.72 [0.40-1.32],0.2911983113958153
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRX,Cone-rod homeobox protein,18109,70,0.94 [0.75-1.17],0.5598036114859755
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRYBB1,Beta-crystallin B1,16007,62,1.15 [0.80-1.66],0.4546566522974952
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRYBB2,Beta-crystallin B2,15980,64,0.87 [0.59-1.29],0.4959955525097589
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRYGD,Gamma-crystallin D,15980,64,1.05 [0.82-1.35],0.6741971976609347
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRYM,Ketimine reductase mu-crystallin,15523,61,1.14 [0.84-1.55],0.3963908402458094
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRYZL1,Quinone oxidoreductase-like protein 1,15560,59,1.09 [0.82-1.45],0.535067223427079
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSDE1,Cold shock domain-containing protein E1,15485,61,1.17 [0.98-1.38],0.0775140459181218
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,18492,70,5.41 [2.78-10.53],6.713668960905128e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,16029,64,2.23 [1.50-3.32],7.100209021730193e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSF2,Granulocyte-macrophage colony-stimulating factor,15485,61,1.18 [0.63-2.23],0.6022359298455797
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,18284,71,0.79 [0.55-1.13],0.1903633643449677
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSF2RB,Cytokine receptor common subunit beta,15528,61,1.73 [0.96-3.12],0.0658515450042997
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSF3,Granulocyte colony-stimulating factor,18124,68,1.34 [0.88-2.02],0.1697838734456006
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSF3R,Granulocyte colony-stimulating factor receptor,15528,61,1.02 [0.44-2.36],0.9615399769828052
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSH1,Chorionic somatomammotropin hormone 1,16029,64,0.87 [0.38-2.00],0.7482406963897076
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSNK1D,Casein kinase I isoform delta,15528,61,1.28 [0.90-1.81],0.1706839434368036
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSNK2A1,Casein kinase II subunit alpha,15987,64,1.53 [0.91-2.55],0.1083974610729276
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSPG4,Chondroitin sulfate proteoglycan 4,16018,64,1.36 [0.66-2.80],0.3993524969506716
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSPG5,Chondroitin sulfate proteoglycan 5,15523,61,1.22 [0.79-1.89],0.3772980948752276
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSRP3,Cysteine and glycine-rich protein 3,15485,61,0.76 [0.57-1.02],0.0710168309798563
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CST1,Cystatin-SN,13904,55,0.96 [0.74-1.25],0.7473966775479411
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CST3,Cystatin-C,18485,69,1.43 [0.69-2.96],0.3301610584624476
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CST5,Cystatin-D,18053,70,0.97 [0.66-1.43],0.8870043214131421
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CST6,Cystatin-M,17957,68,0.78 [0.50-1.21],0.2621171994533489
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CST7,Cystatin-F,18434,70,1.15 [0.95-1.38],0.1537271032716781
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSTB,Cystatin-B,18182,70,1.89 [1.25-2.87],0.0027116897315227
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTAG1A_CTAG1B,Cancer/testis antigen 1,15704,62,1.17 [0.74-1.86],0.4997569469851642
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTBS,Di-N-acetylchitobiase,15805,61,0.90 [0.36-2.24],0.8178349074677722
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTF1,Cardiotrophin-1,18109,70,0.84 [0.65-1.08],0.1730098228558435
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTHRC1,Collagen triple helix repeat-containing protein 1,16018,64,0.83 [0.35-1.95],0.6676941430988372
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTLA4,Cytotoxic T-lymphocyte protein 4,16018,64,1.08 [0.51-2.26],0.8479579318330156
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTNNA1,Catenin alpha-1,15523,61,0.52 [0.20-1.39],0.1928074541020707
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTRB1,Chymotrypsinogen B,18432,70,0.82 [0.57-1.18],0.2916599546268159
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTRC,Chymotrypsin-C,18402,70,0.75 [0.54-1.02],0.0666519631092338
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTRL,Chymotrypsin-like protease CTRL-1,15980,64,0.95 [0.68-1.33],0.7532008724045913
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSB,Cathepsin B,18439,71,1.36 [0.93-2.00],0.1139382185200871
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSC,Dipeptidyl peptidase 1,18366,68,0.97 [0.60-1.57],0.9118214477414828
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSD,Cathepsin D,17250,65,0.91 [0.52-1.60],0.7505330949368161
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSE,Cathepsin E,15659,64,0.99 [0.63-1.56],0.9811068062398656
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSF,Cathepsin F,18477,72,0.96 [0.56-1.62],0.8649538727825696
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSH,Pro-cathepsin H,18046,69,1.29 [0.97-1.71],0.0803228644459654
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,18432,70,4.15 [1.97-8.71],0.0001733763199983
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,18653,71,1.56 [0.81-2.99],0.1818965040758334
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSS,Cathepsin S,14555,62,3.75 [1.42-9.87],0.0074264052161295
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSV,Cathepsin L2,18536,69,0.51 [0.29-0.90],0.0206078263225966
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,18462,69,1.81 [0.94-3.47],0.0754249039867791
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CUZD1,CUB and zona pellucida-like domain-containing protein 1,15599,60,0.94 [0.49-1.80],0.8544710012033625
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,15864,63,2.11 [1.77-2.51],2.6933971890506402e-17
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CX3CL1,Fractalkine,18284,71,1.34 [0.71-2.50],0.3648525600628653
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXADR,Coxsackievirus and adenovirus receptor,18427,71,0.98 [0.63-1.54],0.9433807789480296
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL1,Growth-regulated alpha protein,18381,69,0.95 [0.75-1.20],0.6806629076378781
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL10,C-X-C motif chemokine 10,18492,70,1.17 [0.86-1.59],0.3187208147982761
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL11,C-X-C motif chemokine 11,18597,71,0.98 [0.75-1.29],0.8947081974370747
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL12,Stromal cell-derived factor 1,18124,68,0.78 [0.44-1.35],0.3709270645627074
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,18597,71,1.52 [1.27-1.82],5.95122908657249e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL14,C-X-C motif chemokine 14,18124,68,0.72 [0.45-1.13],0.1559607812898696
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL16,C-X-C motif chemokine 16,18632,72,0.76 [0.30-1.88],0.5468835190692216
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL17,C-X-C motif chemokine 17,18653,71,0.96 [0.58-1.58],0.8798272010479
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL3,C-X-C motif chemokine 3,18413,70,0.74 [0.60-0.91],0.0052541274764875
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL5,C-X-C motif chemokine 5,18370,70,0.75 [0.63-0.91],0.0025767619216036
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL6,C-X-C motif chemokine 6,18653,71,1.03 [0.78-1.36],0.8543956029551806
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL8,Interleukin-8,18326,70,1.01 [0.74-1.37],0.966294443411143
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,18492,70,1.44 [1.10-1.88],0.0076761105791536
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CYB5A,Cytochrome b5,15454,61,0.80 [0.53-1.21],0.2910112111546307
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CYB5R2,NADH-cytochrome b5 reductase 2,15792,64,3.43 [2.70-4.35],4.110714276100687e-24
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",15485,61,0.53 [0.33-0.85],0.0081793552582483
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CYTH3,Cytohesin-3,15454,61,0.99 [0.70-1.39],0.94657253262139
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CYTL1,Cytokine-like protein 1,16018,64,0.77 [0.29-2.01],0.5922206661298595
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DAAM1,Disheveled-associated activator of morphogenesis 1,15659,64,0.96 [0.71-1.28],0.7635696033155055
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DAB2,Disabled homolog 2,18606,70,0.93 [0.77-1.12],0.4589149865392745
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DAG1,Dystroglycan,18492,70,0.87 [0.55-1.37],0.5483321498007332
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DAND5,DAN domain family member 5,15528,61,1.01 [0.66-1.54],0.9731962375402032
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DAPK2,Death-associated protein kinase 2,15528,61,1.21 [0.83-1.76],0.3332473003512784
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,18427,71,0.99 [0.83-1.17],0.8794073477249029
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DARS1,"Aspartate--tRNA ligase, cytoplasmic",18256,71,1.00 [0.75-1.35],0.9734049047733954
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DBH,Dopamine beta-hydroxylase,16007,63,0.95 [0.78-1.16],0.599805758862119
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DBI,Acyl-CoA-binding protein,18344,69,1.43 [1.10-1.86],0.0078067636746837
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DBN1,Drebrin,15528,61,0.99 [0.60-1.62],0.9547590493235384
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DBNL,Drebrin-like protein,18492,70,1.05 [0.84-1.32],0.6597815320791842
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",18477,72,1.40 [0.78-2.49],0.2581206157349204
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCC,Netrin receptor DCC,15599,60,1.32 [0.53-3.27],0.5538895802089039
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCDC2C,Doublecortin domain-containing protein 2C,15454,61,0.69 [0.43-1.09],0.1083081693374955
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCLRE1C,Protein artemis,15454,61,1.42 [0.69-2.93],0.3423348426876747
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCN,Decorin,18109,70,1.74 [0.71-4.23],0.2230062449640056
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCTD,Deoxycytidylate deaminase,15659,64,1.03 [0.80-1.33],0.8258186484899575
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCTN1,Dynactin subunit 1,18606,70,1.12 [0.81-1.55],0.5034796067054216
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCTN2,Dynactin subunit 2,18344,71,1.01 [0.81-1.27],0.9063578536611976
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCTN6,Dynactin subunit 6,18039,70,0.79 [0.56-1.10],0.1674740013107281
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,18432,70,5.16 [3.11-8.56],2.18388679696374e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCUN1D1,DCN1-like protein 1,15523,61,1.00 [0.72-1.39],0.9788203193351804
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCUN1D2,DCN1-like protein 2,15454,61,0.78 [0.54-1.13],0.1887519125107805
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCXR,L-xylulose reductase,18477,72,0.98 [0.67-1.45],0.934933773206016
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDA1,DET1- and DDB1-associated protein 1,15485,61,1.98 [1.36-2.88],0.0003824984651675
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",18344,71,1.01 [0.63-1.63],0.9632738506829144
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDC,Aromatic-L-amino-acid decarboxylase,18412,70,1.26 [0.81-1.95],0.3067226198681324
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDHD2,Phospholipase DDHD2,15987,64,1.38 [0.96-1.98],0.0786897471981221
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDI2,Protein DDI1 homolog 2,15659,64,1.21 [0.89-1.64],0.2249036173436827
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,18597,71,7.06 [3.54-14.05],2.6749510719268444e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDT,D-dopachrome decarboxylase,16018,64,1.81 [1.11-2.94],0.0176177856974315
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDX1,ATP-dependent RNA helicase DDX1,15956,64,0.90 [0.53-1.51],0.6821111330345176
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDX25,ATP-dependent RNA helicase DDX25,15599,60,0.51 [0.21-1.19],0.1180145250966833
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDX39A,ATP-dependent RNA helicase DDX39A,15528,61,2.16 [1.32-3.52],0.0021238503777506
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDX4,Probable ATP-dependent RNA helicase DDX4,15528,61,1.03 [0.66-1.60],0.8991864237647011
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDX53,Probable ATP-dependent RNA helicase DDX53,15599,60,0.77 [0.38-1.57],0.4677883398425966
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDX58,Antiviral innate immune response receptor RIG-I,18014,68,1.60 [1.27-2.01],7.702463690209747e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",18427,71,1.02 [0.82-1.27],0.8851951203350341
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DEFA1_DEFA1B,Neutrophil defensin 1,18089,69,0.68 [0.44-1.07],0.0932039897826484
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DEFB103A_DEFB103B,Beta-defensin 103,15420,60,0.70 [0.35-1.41],0.3143584906621072
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DEFB104A_DEFB104B,Beta-defensin 104,15523,61,1.05 [0.67-1.62],0.8426380530742441
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DEFB116,Beta-defensin 116,15523,61,0.93 [0.65-1.35],0.7114308123101585
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DEFB118,Beta-defensin 118,15523,61,0.36 [0.17-0.78],0.0092445771743873
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DEFB4A_DEFB4B,Beta-defensin 4A,18149,71,0.93 [0.81-1.08],0.3530551220015779
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DENND2B,DENN domain-containing protein 2B,15485,61,0.56 [0.27-1.15],0.1151683354050109
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DENR,Density-regulated protein,15528,61,1.19 [0.81-1.75],0.37320872377707
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DFFA,DNA fragmentation factor subunit alpha,18653,71,1.74 [1.32-2.29],9.003834602266798e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DGCR6,Protein DGCR6,15523,61,0.49 [0.22-1.07],0.0747299685475052
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DGKA,Diacylglycerol kinase alpha,15528,61,1.62 [1.08-2.44],0.0200717992770445
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DGKZ,Diacylglycerol kinase zeta,18124,68,0.55 [0.29-1.03],0.061053097729951
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DHODH,Dihydroorotate dehydrogenase,15485,61,0.66 [0.35-1.24],0.1984220406440474
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DHPS,Deoxyhypusine synthase,15951,63,2.32 [1.83-2.93],3.270816730709641e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,15980,64,1.00 [0.60-1.67],0.9896566363576568
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DIABLO,"Diablo homolog, mitochondrial",18372,70,0.96 [0.79-1.16],0.6425481429397912
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DIPK1C,Divergent protein kinase domain 1C,15599,60,0.78 [0.40-1.50],0.4508492075580252
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DIPK2B,Divergent protein kinase domain 2B,15659,64,1.04 [0.45-2.38],0.9346838493609612
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DKK1,Dickkopf-related protein 1,18597,71,0.68 [0.48-0.97],0.03245159000348
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DKK3,Dickkopf-related protein 3,18663,72,1.22 [0.61-2.45],0.5799195670535147
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DKK4,Dickkopf-related protein 4,18251,71,0.94 [0.59-1.49],0.7807319800704949
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DKKL1,Dickkopf-like protein 1,18344,71,1.73 [1.26-2.39],0.0007950892804256
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DLG4,Disks large homolog 4,15980,64,1.00 [0.71-1.39],0.97686330168784
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DLGAP5,Disks large-associated protein 5,15987,64,1.03 [0.65-1.63],0.9119359616487968
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DLK1,Protein delta homolog 1,18663,72,1.15 [0.80-1.65],0.4415164215950777
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,18477,72,2.81 [1.50-5.26],0.0012494882917304
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DLL4,Delta-like protein 4,15560,59,0.37 [0.19-0.72],0.0033469833052885
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DMD,Dystrophin,15560,59,1.83 [1.31-2.56],0.0004457500952726
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DMP1,Dentin matrix acidic phosphoprotein 1,15560,59,0.75 [0.50-1.12],0.1589454218802336
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJA1,DnaJ homolog subfamily A member 1,15454,61,1.00 [0.58-1.73],0.9900302189258416
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJA2,DnaJ homolog subfamily A member 2,18595,71,1.02 [0.79-1.32],0.886788650706414
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJA4,DnaJ homolog subfamily A member 4,15980,64,1.30 [0.94-1.79],0.1091313141902438
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJB1,DnaJ homolog subfamily B member 1,18344,71,1.01 [0.79-1.30],0.9157975024725804
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJB14,DnaJ homolog subfamily B member 14,15956,64,1.27 [0.89-1.79],0.1835945876258386
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJB2,DnaJ homolog subfamily B member 2,15659,64,1.12 [0.72-1.74],0.6164463334393103
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJB6,DnaJ homolog subfamily B member 6,15515,62,0.91 [0.68-1.23],0.5440210040279441
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJB8,DnaJ homolog subfamily B member 8,18109,70,0.90 [0.59-1.35],0.6018212318497072
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJC21,DnaJ homolog subfamily C member 21,15980,64,1.58 [0.97-2.58],0.0651212175821311
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJC6,Putative tyrosine-protein phosphatase auxilin,15560,59,1.19 [0.89-1.59],0.2449636516798438
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJC9,DnaJ homolog subfamily C member 9,15956,64,1.58 [1.17-2.12],0.0027415497465765
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNER,Delta and Notch-like epidermal growth factor-related receptor,18373,70,0.74 [0.32-1.66],0.4604134665018944
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNLZ,DNL-type zinc finger protein,15523,61,0.71 [0.47-1.07],0.1037337658742655
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNM1,Dynamin-1,15956,64,0.87 [0.71-1.06],0.1643820781944053
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNM3,Dynamin-3,15987,64,1.10 [0.72-1.66],0.665687994532728
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNMBP,Dynamin-binding protein,18284,71,2.15 [1.68-2.75],1.649490742759635e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNPEP,Aspartyl aminopeptidase,15980,64,1.41 [0.92-2.16],0.1157637671132419
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,18458,70,1.50 [1.01-2.24],0.0470755364635222
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DOC2B,Double C2-like domain-containing protein beta,15599,60,0.79 [0.36-1.75],0.5584078702557427
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DOCK9,Dedicator of cytokinesis protein 9,15523,61,0.87 [0.67-1.12],0.2727626274645899
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DOK1,Docking protein 1,15980,64,1.03 [0.87-1.23],0.7116850715868753
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DOK2,Docking protein 2,18432,70,0.98 [0.83-1.17],0.8429375434561657
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPEP1,Dipeptidase 1,18256,71,1.21 [0.76-1.92],0.4201988535322583
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPEP2,Dipeptidase 2,18344,71,5.02 [3.08-8.17],9.090514533566212e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPP10,Inactive dipeptidyl peptidase 10,18427,71,0.97 [0.54-1.74],0.9193105058955432
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPP4,Dipeptidyl peptidase 4,18111,67,0.76 [0.34-1.69],0.4989053116066165
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPP6,Dipeptidyl aminopeptidase-like protein 6,18344,71,0.78 [0.42-1.44],0.4242106253946135
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPP7,Dipeptidyl peptidase 2,18292,69,0.73 [0.52-1.02],0.0647223724891754
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPT,Dermatopontin,18663,72,1.39 [0.59-3.25],0.4492544196956959
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,18555,70,1.87 [1.48-2.36],1.738433422487811e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DRAXIN,Draxin,18284,71,1.21 [0.74-1.99],0.441286198271083
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DRG2,Developmentally-regulated GTP-binding protein 2,18344,71,1.02 [0.71-1.48],0.9128726416058112
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,18202,69,1.84 [1.02-3.29],0.0413231998582041
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DSCAM,Down syndrome cell adhesion molecule,15987,64,3.02 [1.64-5.58],0.0004163726822078
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DSG2,Desmoglein-2,18432,70,1.10 [0.51-2.39],0.8103345262913318
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DSG3,Desmoglein-3,18547,70,0.87 [0.47-1.60],0.6512701612219799
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DSG4,Desmoglein-4,18279,71,0.91 [0.59-1.41],0.6852005436599806
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DTD1,D-aminoacyl-tRNA deacylase 1,15659,64,0.98 [0.74-1.30],0.9000334256702258
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DTNB,Dystrobrevin beta,15913,63,1.86 [1.22-2.86],0.0042926533936231
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DTX2,Probable E3 ubiquitin-protein ligase DTX2,15599,60,0.73 [0.44-1.21],0.2192649031965421
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,18344,71,7.04 [4.53-10.94],3.7380146972071385e-18
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DTYMK,Thymidylate kinase,16007,62,1.04 [0.72-1.49],0.8332977132130395
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DUOX2,Dual oxidase 2,18109,70,0.78 [0.54-1.12],0.1829462541343625
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DUSP13,Dual specificity protein phosphatase 13 isoform A,15951,63,0.89 [0.50-1.58],0.681710342841535
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DUSP29,Dual specificity phosphatase 29,15599,60,0.85 [0.56-1.30],0.4620776632973153
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DUSP3,Dual specificity protein phosphatase 3,18039,70,0.81 [0.61-1.09],0.1652880692106354
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",15956,64,1.00 [0.79-1.26],0.9913651352438132
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DXO,Decapping and exoribonuclease protein,15980,64,2.29 [1.45-3.62],0.0003622917901182
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,15951,63,1.05 [0.64-1.73],0.8430134697781004
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DYNLT1,Dynein light chain Tctex-type 1,15599,60,1.39 [1.07-1.81],0.0146284780650584
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DYNLT3,Dynein light chain Tctex-type 3,15951,63,1.45 [0.86-2.44],0.1631889958280904
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,18284,71,1.16 [0.93-1.45],0.1840347901072795
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,18583,70,3.49 [1.85-6.57],0.0001132469040516
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ECE1,Endothelin-converting enzyme 1,18039,70,0.86 [0.47-1.57],0.6236514641391209
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",16007,62,1.16 [0.85-1.59],0.3377725610524379
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ECHS1,"Enoyl-CoA hydratase, mitochondrial",15560,59,1.15 [0.89-1.49],0.2773024052546794
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ECI2,Enoyl-CoA delta isomerase 2,15485,61,0.96 [0.64-1.45],0.8591257282364515
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ECM1,Extracellular matrix protein 1,15611,62,0.84 [0.45-1.57],0.5848168246396082
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ECSCR,Endothelial cell-specific chemotaxis regulator,15523,61,0.88 [0.52-1.51],0.6441417750293121
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,18606,70,1.89 [1.14-3.15],0.0143369147483184
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EDAR,Tumor necrosis factor receptor superfamily member EDAR,18427,71,0.79 [0.63-1.01],0.0562678101500085
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EDDM3B,Epididymal secretory protein E3-beta,15951,63,0.82 [0.54-1.26],0.3664595889478809
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,15485,61,0.65 [0.40-1.06],0.0828214097677231
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EDF1,Endothelial differentiation-related factor 1,15987,64,1.17 [0.86-1.60],0.3079161289613717
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,18109,70,1.03 [0.56-1.90],0.921819926432438
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EDN1,Endothelin-1,15560,59,2.14 [0.95-4.81],0.065094318702902
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EDNRB,Endothelin receptor type B,15528,61,0.44 [0.20-0.96],0.0404885009571742
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EEF1D,Elongation factor 1-delta,16007,62,1.26 [0.98-1.62],0.0739230223884499
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFCAB14,EF-hand calcium-binding domain-containing protein 14,15956,64,1.79 [1.13-2.84],0.0134499926482318
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFCAB2,Dynein regulatory complex protein 8,15731,62,0.83 [0.40-1.70],0.6103057625504513
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,18490,69,0.80 [0.40-1.59],0.5207732279045527
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFHD1,EF-hand domain-containing protein D1,15987,64,1.35 [0.74-2.45],0.3297125319522377
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,18400,69,2.82 [1.53-5.19],0.0008950023432088
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,18250,71,9.41 [6.99-12.67],2.1472761662590146e-49
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFNB2,Ephrin-B2,15599,60,0.93 [0.58-1.48],0.7496652912492525
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EGF,Pro-epidermal growth factor,18381,69,0.88 [0.72-1.07],0.1981243218153015
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EGFL7,Epidermal growth factor-like protein 7,18014,68,0.43 [0.24-0.77],0.0048227878286866
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EGFLAM,Pikachurin,15956,64,1.44 [0.69-3.00],0.3309033897466987
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EGFR,Epidermal growth factor receptor,18663,72,1.64 [0.45-5.99],0.4566749868614181
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,18427,71,1.90 [1.65-2.20],1.607615006600753e-18
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EHBP1,EH domain-binding protein 1,16007,62,1.05 [0.76-1.45],0.7608140980033917
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EHD3,EH domain-containing protein 3,15560,59,0.87 [0.71-1.08],0.2079702476544087
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",15980,64,1.09 [0.73-1.62],0.6654235762425981
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",15900,64,1.05 [0.84-1.30],0.6817500281170727
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,15485,61,1.14 [0.79-1.63],0.4903069395047633
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,15560,59,1.19 [0.69-2.05],0.527509951386221
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF4B,Eukaryotic translation initiation factor 4B,18284,71,1.10 [0.75-1.62],0.6146289085684788
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF4E,Eukaryotic translation initiation factor 4E,15528,61,1.13 [0.85-1.48],0.4009988470827105
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,18432,70,1.19 [0.87-1.62],0.2865361518501575
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,18653,71,1.08 [0.87-1.34],0.48138214029958
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,15987,64,0.87 [0.59-1.28],0.4769709971921417
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF5,Eukaryotic translation initiation factor 5,15485,61,0.86 [0.46-1.58],0.616514922361886
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EIF5A,Eukaryotic translation initiation factor 5A-1,18124,68,0.77 [0.36-1.65],0.5069594924378045
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ELAC1,Zinc phosphodiesterase ELAC protein 1,15987,64,1.27 [0.95-1.68],0.1039281124053399
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ELAVL4,ELAV-like protein 4,15523,61,0.79 [0.57-1.10],0.1656512502335383
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ELN,Elastin,16007,62,1.09 [0.53-2.23],0.8163470954544361
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ELOA,Elongin-A,18344,71,2.25 [1.99-2.56],1.3027646089953896e-36
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ELOB,Elongin-B,15485,61,0.81 [0.40-1.65],0.5680287105687216
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENAH,Protein enabled homolog,18124,68,1.11 [0.71-1.73],0.6569182764435403
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENDOU,Poly(U)-specific endoribonuclease,14772,61,0.89 [0.57-1.39],0.605045195156259
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENG,Endoglin,18663,72,6.37 [2.47-16.41],0.000124857961596
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENO1,Alpha-enolase,18418,71,1.02 [0.78-1.34],0.8692196956337489
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENO2,Gamma-enolase,18597,71,1.07 [0.78-1.48],0.6755442494825145
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENO3,Beta-enolase,15560,59,0.86 [0.56-1.33],0.4986260227699248
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENOPH1,Enolase-phosphatase E1,15951,63,1.10 [0.73-1.65],0.6424095234158083
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,15485,61,3.64 [2.44-5.44],2.4228764359884776e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENPEP,Glutamyl aminopeptidase,15485,61,1.01 [0.57-1.78],0.986363457879021
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,18663,72,4.08 [1.91-8.74],0.0002938236727922
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,18492,70,1.11 [0.67-1.84],0.6764093009231965
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,15560,59,1.24 [0.61-2.52],0.5519644834323634
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,17848,66,1.15 [0.88-1.49],0.3095941672699129
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENSA,Alpha-endosulfine,15951,63,1.05 [0.67-1.64],0.8429496472385789
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,18014,68,0.98 [0.59-1.63],0.9507436616703384
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,18109,70,0.51 [0.20-1.29],0.1555309244183564
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,18109,70,3.14 [1.28-7.72],0.0126323647512687
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENTR1,Endosome-associated-trafficking regulator 1,15560,59,1.96 [1.49-2.58],1.4228699695480098e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EP300,Histone acetyltransferase p300,15528,61,1.66 [0.92-3.01],0.092584600932667
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPB41L5,Band 4.1-like protein 5,15599,60,0.81 [0.52-1.28],0.3749140002918213
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPCAM,Epithelial cell adhesion molecule,18397,70,0.72 [0.56-0.92],0.0076306002347687
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPGN,Epigen,15951,63,0.98 [0.58-1.68],0.9524150377158208
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHA1,Ephrin type-A receptor 1,18458,70,1.12 [0.57-2.19],0.7491566440695276
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHA10,Ephrin type-A receptor 10,18039,70,1.13 [0.85-1.50],0.3959813938250954
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,17790,69,3.58 [2.16-5.94],7.718318180700733e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHA4,Ephrin type-A receptor 4,15659,64,4.57 [2.05-10.17],0.0001955424917545
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,18663,72,2.75 [1.32-5.73],0.006852262516693
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,18256,71,4.47 [2.55-7.82],1.6391629933616945e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHX2,Bifunctional epoxide hydrolase 2,18109,70,0.84 [0.57-1.24],0.3707339299311115
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPN1,Epsin-1,15731,62,0.80 [0.42-1.50],0.4824033487103842
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,18427,71,1.53 [1.26-1.87],2.1102343549644057e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPPK1,Epiplakin,15560,59,1.20 [0.87-1.67],0.269591045622034
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,18578,70,5.71 [3.81-8.56],3.425108432197204e-17
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERBB2,Receptor tyrosine-protein kinase erbB-2,18477,72,1.30 [0.55-3.09],0.5489929416913006
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERBB3,Receptor tyrosine-protein kinase erbB-3,18340,70,2.07 [0.76-5.64],0.1550267647193138
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERBB4,Receptor tyrosine-protein kinase erbB-4,18477,72,0.56 [0.24-1.28],0.1671170027233196
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERBIN,Erbin,18344,71,0.93 [0.76-1.14],0.500264943360228
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERC2,ERC protein 2,15599,60,1.24 [0.96-1.59],0.1001152770051624
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERCC1,DNA excision repair protein ERCC-1,15454,61,1.07 [0.55-2.12],0.8350555052379475
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EREG,Proepiregulin,18256,71,0.61 [0.45-0.82],0.0014361930826484
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERI1,3'-5' exoribonuclease 1,15731,62,3.55 [2.69-4.69],4.6487569052595695e-19
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERMAP,Erythroid membrane-associated protein,15528,61,1.11 [0.64-1.93],0.7017557013377681
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,15951,63,1.16 [0.61-2.21],0.651680339423633
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERP29,Endoplasmic reticulum resident protein 29,15659,64,1.00 [0.82-1.23],0.9711278432191384
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERP44,Endoplasmic reticulum resident protein 44,18318,71,0.72 [0.32-1.64],0.4401729437520427
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,15485,61,0.61 [0.32-1.19],0.1464757262050323
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ESAM,Endothelial cell-selective adhesion molecule,18663,72,1.25 [0.67-2.36],0.4840733891776608
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ESM1,Endothelial cell-specific molecule 1,18402,70,1.19 [0.64-2.19],0.5794130254609948
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ESPL1,Separin,15454,61,1.21 [0.85-1.73],0.2948811542186593
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ESR1,Estrogen receptor,15528,61,0.95 [0.60-1.50],0.8330025337801051
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ESYT2,Extended synaptotagmin-2,15980,64,1.03 [0.77-1.38],0.8281949187333694
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EVI2B,Protein EVI2B,15454,61,1.10 [0.61-1.96],0.7552081396524049
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EVI5,Ecotropic viral integration site 5 protein homolog,15528,61,1.31 [1.00-1.71],0.047604606015974
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EVPL,Envoplakin,15731,62,1.21 [0.60-2.41],0.5962881268011981
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EXOSC10,Exosome component 10,15485,61,1.37 [1.00-1.86],0.0473458305779113
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EXTL1,Exostosin-like 1,15485,61,0.80 [0.44-1.44],0.4494354245852433
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,18597,71,6.73 [4.62-9.81],2.933980458920329e-23
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",F10,Coagulation factor X,16029,64,0.96 [0.42-2.18],0.9247559272317376
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",F11,Coagulation factor XI,15806,62,1.20 [0.60-2.40],0.5986015675445957
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",F11R,Junctional adhesion molecule A,18432,70,1.05 [0.72-1.53],0.7994575340909392
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",F12,Coagulation factor XII,16032,63,1.54 [0.82-2.87],0.1760121453981484
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",F13B,Coagulation factor XIII B chain,15963,62,1.04 [0.40-2.70],0.9419774288944204
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",F2,Prothrombin,16032,63,2.15 [0.44-10.49],0.3439814655122691
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",F2R,Proteinase-activated receptor 1,18471,70,0.83 [0.57-1.21],0.3302658536421688
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",F3,Tissue factor,18486,70,0.97 [0.42-2.20],0.9350215097004811
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",F7,Coagulation factor VII,18491,69,1.28 [0.64-2.57],0.4886459992358927
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",F9,Coagulation factor IX,18498,69,0.51 [0.17-1.57],0.2413778708457659
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FABP1,"Fatty acid-binding protein, liver",18402,70,1.09 [0.87-1.35],0.453088392937621
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FABP2,"Fatty acid-binding protein, intestinal",18432,70,1.03 [0.79-1.34],0.8440898116962735
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FABP3,"Fatty acid-binding protein, heart",16007,62,1.13 [0.72-1.75],0.5985899513170365
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FABP4,"Fatty acid-binding protein, adipocyte",18663,72,1.28 [0.85-1.92],0.2425316808003444
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FABP5,Fatty acid-binding protein 5,18536,70,1.04 [0.76-1.42],0.8101212341237163
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FABP6,Gastrotropin,18079,70,0.96 [0.66-1.41],0.8484856748479244
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FABP9,Fatty acid-binding protein 9,18427,71,0.83 [0.57-1.22],0.3400126671722661
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FADD,FAS-associated death domain protein,18432,70,0.95 [0.71-1.25],0.7008835144638388
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAM13A,Protein FAM13A,15956,64,0.95 [0.66-1.36],0.7855113457917029
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAM171A2,Protein FAM171A2,15987,64,0.97 [0.83-1.14],0.7215631678632741
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAM171B,Protein FAM171B,15951,63,1.17 [0.53-2.62],0.6957046707050165
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAM172A,Cotranscriptional regulator FAM172A,15560,59,1.17 [0.78-1.76],0.448334760241006
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAM20A,Pseudokinase FAM20A,16007,62,1.10 [0.46-2.60],0.8305607558790937
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAM3B,Protein FAM3B,18344,71,1.57 [0.84-2.92],0.158206958068359
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAM3C,Protein FAM3C,18412,70,2.71 [1.42-5.16],0.0025010541299352
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAM3D,Protein FAM3D,15956,64,1.24 [0.95-1.63],0.1177327249872781
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAP,Prolyl endopeptidase FAP,18663,72,0.81 [0.38-1.74],0.5834403367008973
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FARSA,Phenylalanine--tRNA ligase alpha subunit,15599,60,1.11 [0.79-1.55],0.5608004993049863
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAS,Tumor necrosis factor receptor superfamily member 6,18603,72,1.59 [1.07-2.36],0.0215262636856697
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FASLG,Tumor necrosis factor ligand superfamily member 6,18653,71,1.66 [0.94-2.93],0.0782700779445302
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FBLN2,Fibulin-2,16018,64,1.89 [0.90-3.98],0.0940528208653772
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FBN2,Fibrillin-2,15599,60,1.26 [0.84-1.90],0.2655909260992413
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FBP1,"Fructose-1,6-bisphosphatase 1",18432,70,0.96 [0.72-1.29],0.7857683748014729
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,16007,62,2.02 [1.48-2.75],7.721772684889052e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCAR,Immunoglobulin alpha Fc receptor,18427,71,0.75 [0.49-1.17],0.210456503404035
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,15987,64,2.32 [1.05-5.16],0.0382517860762011
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,18432,70,3.66 [3.28-4.09],3.2690046693060525e-116
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,18374,68,1.31 [0.86-2.00],0.2077688124745131
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,18014,68,1.71 [1.29-2.26],0.0001694375905451
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,18464,69,1.02 [0.66-1.58],0.915678124519016
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCN1,Ficolin-1,16007,63,0.96 [0.64-1.46],0.8544924167196454
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCN2,Ficolin-2,18371,68,0.93 [0.55-1.57],0.7793955296632312
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,18432,70,3.36 [2.75-4.10],8.096191424632299e-33
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,18569,71,3.66 [3.16-4.24],1.0081244649909783e-67
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,18124,68,3.95 [3.31-4.70],1.4554728566499972e-53
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,18432,70,4.93 [3.72-6.55],1.8861470190351447e-28
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL6,Fc receptor-like protein 6,18427,71,1.15 [0.84-1.56],0.3760047095677831
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,18014,68,1.51 [1.20-1.90],0.0004134006269553
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FDX1,"Adrenodoxin, mitochondrial",15485,61,1.11 [0.77-1.59],0.5802914968719814
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FDX2,"Ferredoxin-2, mitochondrial",15485,61,0.95 [0.61-1.50],0.8394694730024377
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FEN1,Flap endonuclease 1,18014,68,1.58 [1.36-1.82],6.365796423060042e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FES,Tyrosine-protein kinase Fes/Fps,18014,68,1.22 [0.82-1.80],0.3337109544285
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FETUB,Fetuin-B,18498,69,1.31 [0.65-2.63],0.4447616211875292
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGA,Fibrinogen alpha chain,15667,62,2.07 [0.97-4.40],0.0586912223576174
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",15987,64,1.14 [0.85-1.53],0.3647438540641852
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF12,Fibroblast growth factor 12,15528,61,0.57 [0.24-1.36],0.2028649186024755
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF16,Fibroblast growth factor 16,15528,61,0.97 [0.56-1.68],0.9147573465090992
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF19,Fibroblast growth factor 19,18492,70,1.04 [0.80-1.36],0.7635163595947503
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF2,Fibroblast growth factor 2,18427,71,2.02 [1.58-2.59],2.1866096938109453e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF20,Fibroblast growth factor 20,15528,61,0.47 [0.21-1.05],0.0655213324446762
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF21,Fibroblast growth factor 21,18583,70,1.02 [0.86-1.22],0.8038105595731241
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF23,Fibroblast growth factor 23,18576,70,1.39 [1.01-1.93],0.0434950714262063
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF3,Fibroblast growth factor 3,15528,61,0.81 [0.33-2.01],0.6510729078542382
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF5,Fibroblast growth factor 5,18124,68,1.80 [1.01-3.21],0.0454915979772456
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF6,Fibroblast growth factor 6,15528,61,0.49 [0.21-1.14],0.0983289507935138
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF7,Fibroblast growth factor 7,15454,61,0.48 [0.29-0.82],0.0064997511650602
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF9,Fibroblast growth factor 9,15427,61,1.39 [0.76-2.56],0.2848887430588315
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGFBP1,Fibroblast growth factor-binding protein 1,18477,72,0.77 [0.41-1.44],0.4138963062522627
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGFBP2,Fibroblast growth factor-binding protein 2,16018,64,0.71 [0.44-1.15],0.163509166269158
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGFBP3,Fibroblast growth factor-binding protein 3,15980,64,0.63 [0.33-1.22],0.1710317164221325
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGFR2,Fibroblast growth factor receptor 2,18477,72,1.92 [0.78-4.72],0.1548647003096176
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGFR4,Fibroblast growth factor receptor 4,15659,64,1.19 [0.75-1.89],0.4580440510151495
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGL1,Fibrinogen-like protein 1,16029,64,1.09 [0.75-1.57],0.6659612161063332
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGR,Tyrosine-protein kinase Fgr,18039,70,1.11 [0.81-1.53],0.4988404701419179
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FH,"Fumarate hydratase, mitochondrial",15523,61,1.16 [0.91-1.48],0.2456585712703684
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FHIP2A,FHF complex subunit HOOK interacting protein 2A,15485,61,0.81 [0.46-1.43],0.4745089441580415
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FHIT,Bis(5'-adenosyl)-triphosphatase,18039,70,0.96 [0.71-1.29],0.7705513332784235
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FIS1,Mitochondrial fission 1 protein,18400,70,1.12 [0.85-1.47],0.4108052857656376
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,15987,64,0.92 [0.72-1.17],0.4880339695235112
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,18502,71,0.98 [0.82-1.19],0.8731853062231516
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,18284,71,1.60 [0.97-2.63],0.0643440932855122
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,18284,71,1.02 [0.81-1.27],0.889251624200501
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,18011,70,0.96 [0.60-1.54],0.8732342953078153
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FKBPL,FK506-binding protein-like,15956,64,1.20 [0.81-1.78],0.3641688836407832
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FLI1,Friend leukemia integration 1 transcription factor,18014,68,1.05 [0.86-1.27],0.6493307524548128
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,18284,71,1.20 [0.58-2.50],0.6192371341574205
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FLT1,Vascular endothelial growth factor receptor 1,18307,71,1.38 [0.56-3.39],0.4789623036942292
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FLT3,Receptor-type tyrosine-protein kinase FLT3,18014,68,1.59 [0.89-2.84],0.1140795530674692
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FLT3LG,Fms-related tyrosine kinase 3 ligand,18653,71,2.05 [1.14-3.68],0.0164340946421368
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FLT4,Vascular endothelial growth factor receptor 3,18477,72,0.90 [0.49-1.65],0.7383778154363903
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FMNL1,Formin-like protein 1,18039,70,1.31 [1.05-1.62],0.015027414731488
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FMR1,Synaptic functional regulator FMR1,18014,68,1.09 [0.59-2.00],0.7826142536624061
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FN1,Fibronectin,16032,63,1.07 [0.44-2.61],0.8841581635365403
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FNDC1,Fibronectin type III domain-containing protein 1,15980,64,0.71 [0.43-1.17],0.1830507003772238
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,15951,63,1.61 [0.93-2.77],0.0879364413762599
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOLH1,Glutamate carboxypeptidase 2,15528,61,0.96 [0.74-1.24],0.7425395984102446
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOLR1,Folate receptor alpha,18395,72,1.49 [0.74-3.00],0.259335243674988
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOLR2,Folate receptor beta,18597,71,1.54 [0.76-3.12],0.2361093006083859
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOLR3,Folate receptor gamma,18421,72,0.98 [0.88-1.10],0.7763620104463549
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOS,Proto-oncogene c-Fos,15427,61,1.67 [0.90-3.09],0.1021369028041316
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOSB,Protein fosB,18039,70,0.99 [0.56-1.73],0.9661743498810818
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOXJ3,Forkhead box protein J3,15528,61,2.00 [1.42-2.81],7.439376885762322e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOXO1,Forkhead box protein O1,18427,71,1.68 [1.33-2.12],1.0773903550999554e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOXO3,Forkhead box protein O3,18014,68,0.88 [0.69-1.12],0.2891694162076831
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FRMD4B,FERM domain-containing protein 4B,15485,61,0.93 [0.64-1.34],0.7015426957774138
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FRMD7,FERM domain-containing protein 7,15599,60,0.71 [0.35-1.45],0.3461868140364768
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FRZB,Secreted frizzled-related protein 3,18228,71,1.54 [0.63-3.73],0.3419844645670026
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FSHB,Follitropin subunit beta,15560,59,1.61 [1.10-2.34],0.013504406720269
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FST,Follistatin,18471,70,1.06 [0.68-1.64],0.8008583799675393
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FSTL1,Follistatin-related protein 1,15560,59,1.62 [0.54-4.90],0.3911893623582604
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,18372,70,2.16 [1.19-3.92],0.0112313447963496
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FTCD,Formimidoyltransferase-cyclodeaminase,15942,64,0.94 [0.70-1.24],0.6500043025501008
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FUCA1,Tissue alpha-L-fucosidase,18533,71,1.03 [0.80-1.34],0.8047667876964026
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FUOM,Fucose mutarotase,15659,64,1.23 [0.84-1.78],0.2856567363562933
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FURIN,Furin,18477,72,0.59 [0.31-1.11],0.1026249750985899
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FUS,RNA-binding protein FUS,17984,68,3.98 [3.10-5.11],3.3185369129501386e-27
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",15704,62,1.01 [0.67-1.50],0.9801063322709096
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,18597,71,1.56 [1.00-2.41],0.0477883033822785
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FUT8,"Alpha-(1,6)-fucosyltransferase",18284,71,0.88 [0.61-1.28],0.5114597518055404
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FXN,"Frataxin, mitochondrial",18606,70,0.93 [0.69-1.24],0.6217697572962448
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FXYD5,FXYD domain-containing ion transport regulator 5,18124,68,1.01 [0.72-1.42],0.9411420670648464
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FYB1,FYN-binding protein 1,18394,70,1.00 [0.80-1.26],0.9668842141838392
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FZD10,Frizzled-10,15599,60,0.55 [0.30-1.00],0.0497673455472626
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FZD8,Frizzled-8,15523,61,1.06 [0.61-1.84],0.8286175877629514
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GABARAP,Gamma-aminobutyric acid receptor-associated protein,15951,63,1.10 [0.68-1.80],0.690244060056157
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,15731,62,1.05 [0.74-1.49],0.7688796709184952
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,15523,61,0.96 [0.64-1.44],0.8402793900127319
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GAD1,Glutamate decarboxylase 1,15454,61,1.23 [0.48-3.17],0.665762114129959
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GAD2,Glutamate decarboxylase 2,15528,61,0.93 [0.53-1.65],0.8117060025806249
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,15731,62,0.66 [0.33-1.33],0.2447136892201392
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,15560,59,1.25 [0.80-1.95],0.3317178123726692
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GAGE2A,G antigen 2A,15454,61,1.02 [0.71-1.48],0.8999254976302571
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GAL,Galanin peptides,18492,70,0.75 [0.55-1.04],0.0833373004725923
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,18344,71,1.32 [0.62-2.81],0.463873222907802
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,18606,70,1.33 [0.60-2.93],0.477216710560415
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,18124,68,3.23 [2.39-4.37],2.3946870477208887e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,16007,62,1.28 [0.57-2.91],0.5505604029598568
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GALNT7,N-acetylgalactosaminyltransferase 7,18344,71,12.66 [4.99-32.09],8.840384483599198e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GAMT,Guanidinoacetate N-methyltransferase,15485,61,0.50 [0.20-1.29],0.1513065915568475
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,15315,62,0.83 [0.38-1.82],0.6463231668267639
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GART,Trifunctional purine biosynthetic protein adenosine-3,15987,64,1.21 [0.53-2.75],0.6542417787465782
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GAS2,Growth arrest-specific protein 2,15731,62,0.69 [0.38-1.24],0.2104602507607265
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GAS6,Growth arrest-specific protein 6,18543,71,2.36 [1.03-5.41],0.0429120004426319
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GASK1A,Golgi-associated kinase 1A,15485,61,0.73 [0.41-1.29],0.2771842864355413
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GAST,Gastrin,15980,64,1.01 [0.85-1.21],0.917549795742561
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,15454,61,1.06 [0.42-2.72],0.8954756018290895
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",15560,59,1.36 [1.00-1.85],0.0537603588218081
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GBA,Lysosomal acid glucosylceramidase,15599,60,1.08 [0.69-1.69],0.7374884647952875
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,15952,64,1.71 [1.26-2.32],0.0006326140347964
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GBP2,Guanylate-binding protein 2,18124,68,1.43 [1.06-1.93],0.0189731407022792
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GBP4,Guanylate-binding protein 4,18039,70,0.91 [0.58-1.42],0.6705912092065458
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GBP6,Guanylate-binding protein 6,15485,61,0.64 [0.32-1.30],0.2203109452088311
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GC,Vitamin D-binding protein,16032,63,0.91 [0.36-2.32],0.8484542434152669
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GCC1,GRIP and coiled-coil domain-containing protein 1,15980,64,1.03 [0.82-1.28],0.8012434280707573
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GCG,Pro-glucagon,18014,68,0.93 [0.79-1.11],0.4417567717983631
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,15282,61,2.04 [1.56-2.65],1.3326133158357013e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GCLM,Glutamate--cysteine ligase regulatory subunit,15485,61,1.01 [0.58-1.75],0.9817381000983476
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",18344,71,1.68 [0.93-3.04],0.085146814880414
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,18663,72,1.35 [0.87-2.07],0.1777998691817565
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GDF2,Growth/differentiation factor 2,18432,70,0.49 [0.27-0.90],0.0208055167190575
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GDNF,Glial cell line-derived neurotrophic factor,18039,70,1.45 [0.86-2.43],0.1639648134408038
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GET3,ATPase GET3,16007,62,0.82 [0.50-1.36],0.4494281948405813
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GFAP,Glial fibrillary acidic protein,17984,68,1.23 [0.78-1.95],0.3742057921426188
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GFER,FAD-linked sulfhydryl oxidase ALR,18014,68,1.45 [1.05-1.99],0.0233299691933548
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,18014,68,0.95 [0.78-1.15],0.5801512105590625
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,18583,70,3.47 [1.84-6.55],0.0001208888237452
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GFRA2,GDNF family receptor alpha-2,18344,71,2.31 [0.86-6.21],0.0960262645607161
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GFRA3,GDNF family receptor alpha-3,18227,70,0.72 [0.33-1.56],0.4030568781947936
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GFRAL,GDNF family receptor alpha-like,15520,64,0.91 [0.61-1.36],0.658158131844985
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GGA1,ADP-ribosylation factor-binding protein GGA1,18039,70,0.66 [0.43-1.01],0.0532158672164955
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GGACT,Gamma-glutamylaminecyclotransferase,16007,62,1.13 [0.81-1.59],0.472116714162516
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GGCT,Gamma-glutamylcyclotransferase,15980,62,1.15 [0.70-1.88],0.5911924839869955
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GGH,Gamma-glutamyl hydrolase,18136,66,1.09 [0.57-2.06],0.80142852274895
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GGT1,Glutathione hydrolase 1 proenzyme,18400,69,1.22 [0.82-1.83],0.324375127585314
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GGT5,Glutathione hydrolase 5 proenzyme,18284,71,2.44 [1.12-5.33],0.0248106864600547
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GH1,Somatotropin,18412,70,1.04 [0.92-1.16],0.5543346723581172
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GH2,Growth hormone variant,18014,68,0.66 [0.53-0.82],0.0002121026135205
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GHR,Growth hormone receptor,15659,64,0.74 [0.32-1.75],0.4990669533643644
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GHRHR,Growth hormone-releasing hormone receptor,18039,70,0.86 [0.55-1.34],0.4932976793457884
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GHRL,Appetite-regulating hormone,18432,70,0.91 [0.70-1.16],0.435154224798765
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GID8,Glucose-induced degradation protein 8 homolog,15987,64,0.82 [0.37-1.86],0.6418070945684053
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GIGYF2,GRB10-interacting GYF protein 2,15987,64,1.38 [1.03-1.85],0.0311287128588491
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GIMAP7,GTPase IMAP family member 7,15659,64,1.39 [0.73-2.65],0.3151895535290311
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GIMAP8,GTPase IMAP family member 8,15454,61,1.39 [0.92-2.09],0.1149900446907313
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GIP,Gastric inhibitory polypeptide,15560,59,1.08 [0.68-1.71],0.7433517396360227
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,15980,64,2.72 [1.53-4.84],0.0006794603728694
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GIPC3,PDZ domain-containing protein GIPC3,15956,64,1.02 [0.80-1.31],0.8599951724769177
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GIPR,Gastric inhibitory polypeptide receptor,15528,61,0.64 [0.33-1.24],0.1899177293492075
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GIT1,ARF GTPase-activating protein GIT1,15528,61,1.16 [0.90-1.50],0.2433217934075405
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GJA8,Gap junction alpha-8 protein,15454,61,0.96 [0.64-1.45],0.8575849117158091
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GKN1,Gastrokine-1,17697,69,1.09 [0.50-2.38],0.82050890659994
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLA,Alpha-galactosidase A,15632,64,0.70 [0.38-1.30],0.2648266335531509
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLB1,Beta-galactosidase,18284,71,0.89 [0.54-1.47],0.653646517644328
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLI2,Zinc finger protein GLI2,15528,61,0.69 [0.29-1.63],0.3993410649794668
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLO1,Lactoylglutathione lyase,18109,70,1.06 [0.73-1.53],0.7666228870239663
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLOD4,Glyoxalase domain-containing protein 4,18379,70,1.74 [0.94-3.22],0.076455673578033
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLP1R,Glucagon-like peptide 1 receptor,15523,61,0.94 [0.47-1.87],0.856812967436039
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLRX,Glutaredoxin-1,18311,69,1.00 [0.69-1.45],0.9964719505664972
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",15659,64,1.03 [0.78-1.35],0.8551554858932583
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,18039,70,1.26 [0.91-1.76],0.1691796412521223
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLYR1,Putative oxidoreductase GLYR1,15951,63,1.91 [1.54-2.38],5.7287322772877366e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GM2A,Ganglioside GM2 activator,15629,61,1.92 [1.30-2.85],0.0010960153778237
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GMFG,Glia maturation factor gamma,16007,62,1.03 [0.74-1.45],0.8452244611781289
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GMPR,GMP reductase 1,18653,71,1.39 [0.88-2.18],0.1570883326274392
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GMPR2,GMP reductase 2,15659,64,1.10 [0.77-1.58],0.6072444596702541
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GNAS,Neuroendocrine secretory protein 55,15987,64,0.72 [0.51-1.02],0.0610971023705627
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,18014,68,1.18 [0.86-1.62],0.3148589693528238
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,15599,60,1.16 [0.75-1.80],0.4947834756705145
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GNLY,Granulysin,18432,70,1.46 [1.00-2.12],0.0492472992661326
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GNPDA1,Glucosamine-6-phosphate isomerase 1,15560,59,1.30 [0.79-2.16],0.3024658485221112
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GNPDA2,Glucosamine-6-phosphate isomerase 2,15659,64,0.90 [0.47-1.76],0.7663439099135053
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GOLGA3,Golgin subfamily A member 3,15987,64,1.44 [1.09-1.91],0.0113999199630401
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,18597,71,1.89 [1.01-3.56],0.0475733137795817
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,18427,71,0.98 [0.80-1.20],0.8563643898121072
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GORASP2,Golgi reassembly-stacking protein 2,15956,64,1.32 [0.82-2.13],0.2586583315031212
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GOT1,"Aspartate aminotransferase, cytoplasmic",16018,64,1.44 [0.88-2.36],0.1461314870385394
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GP1BA,Platelet glycoprotein Ib alpha chain,18379,68,0.88 [0.46-1.68],0.6985824032450485
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GP1BB,Platelet glycoprotein Ib beta chain,15485,61,0.87 [0.60-1.25],0.4428611173484578
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,17876,68,0.98 [0.75-1.27],0.8553427714105042
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GP5,Platelet glycoprotein V,15659,64,0.43 [0.24-0.78],0.0052966968149853
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GP6,Platelet glycoprotein VI,18394,70,0.89 [0.70-1.13],0.331437851035015
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPA33,Cell surface A33 antigen,18344,71,0.88 [0.75-1.03],0.103081875155104
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPC1,Glypican-1,18606,70,1.11 [0.54-2.28],0.7783885370602882
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPC5,Glypican-5,18284,71,1.04 [0.71-1.51],0.8433687734083252
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPD1,Glycerol-3-phosphate dehydrogenase,15951,63,1.27 [0.83-1.95],0.270567746946814
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPHA2,Glycoprotein hormone alpha-2,15956,64,0.82 [0.44-1.54],0.5404532540325551
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPI,Glucose-6-phosphate isomerase,16029,64,0.90 [0.53-1.51],0.6819797758046449
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,15956,64,1.45 [0.99-2.13],0.0572915061817996
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPKOW,G-patch domain and KOW motifs-containing protein,18039,70,2.32 [1.74-3.09],8.764481981054419e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPNMB,Transmembrane glycoprotein NMB,17943,68,0.73 [0.35-1.54],0.4063789211868466
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPR101,Probable G-protein coupled receptor 101,15523,61,0.50 [0.26-0.96],0.0376559454649447
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPR158,Probable G-protein coupled receptor 158,15987,64,0.98 [0.48-1.99],0.9465826413980828
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPR15L,Protein GPR15L,15956,64,0.70 [0.49-1.01],0.0567539296459913
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPR37,Prosaposin receptor GPR37,18109,70,1.14 [0.82-1.59],0.4329248513556973
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPRC5C,G-protein coupled receptor family C group 5 member C,15951,63,1.31 [0.92-1.85],0.1300200815620327
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRAP2,GRB2-related adapter protein 2,18432,70,0.98 [0.83-1.15],0.7723251606090201
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,16007,62,1.27 [0.86-1.87],0.2283120081556454
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRIK2,"Glutamate receptor ionotropic, kainate 2",15987,64,1.03 [0.60-1.77],0.9179744460866072
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",15523,61,0.96 [0.60-1.53],0.862539375825662
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRK5,G protein-coupled receptor kinase 5,18109,70,1.24 [0.86-1.77],0.2514248287041133
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,18332,69,9.30 [6.50-13.30],2.6252932094855047e-34
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRP,Gastrin-releasing peptide,15560,59,0.74 [0.47-1.15],0.175894859577647
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",18344,71,1.32 [0.96-1.82],0.0876793182257194
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRSF1,G-rich sequence factor 1,15367,61,0.88 [0.64-1.20],0.4279638452637984
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GSAP,Gamma-secretase-activating protein,18014,68,0.80 [0.57-1.12],0.1936347287598571
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GSN,Gelsolin,15961,64,0.45 [0.13-1.52],0.198688481475883
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GSR,"Glutathione reductase, mitochondrial",15944,63,1.06 [0.36-3.16],0.915716654692895
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GSTA1,Glutathione S-transferase A1,18403,70,0.96 [0.74-1.24],0.7328225611087371
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GSTA3,Glutathione S-transferase A3,18014,68,0.96 [0.72-1.28],0.7604595601283285
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GSTM4,Glutathione S-transferase Mu 4,15485,61,1.10 [0.82-1.48],0.5340460367882593
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GSTP1,Glutathione S-transferase P,17926,70,0.99 [0.73-1.35],0.9562493660908437
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GSTT2B,Glutathione S-transferase theta-2B,15980,64,0.98 [0.89-1.09],0.7650269839135233
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,15731,62,0.72 [0.44-1.18],0.1915218302560566
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GTPBP2,GTP-binding protein 2,15599,60,1.04 [0.77-1.42],0.7896878666650238
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GUCA2A,Guanylin,18331,70,1.08 [0.58-2.01],0.8065950179926796
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GUCY2C,Heat-stable enterotoxin receptor,15731,62,0.79 [0.54-1.16],0.228791028406528
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GUK1,Guanylate kinase,15485,61,1.40 [0.91-2.15],0.1279030366929656
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GUSB,Beta-glucuronidase,18511,72,0.73 [0.51-1.03],0.0710406121644181
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GYS1,"Glycogen [starch] synthase, muscle",18109,70,1.09 [0.87-1.37],0.4424288698511734
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,18653,71,2.69 [1.75-4.14],6.378035855734826e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GZMB,Granzyme B,18427,71,1.04 [0.76-1.41],0.8130451396900635
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,18109,70,1.37 [1.16-1.63],0.0002601536163788
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",H2AP,Huntingtin-interacting protein M,15454,61,0.96 [0.58-1.61],0.8898934081820372
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",15485,61,0.62 [0.35-1.11],0.106619571186013
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",18557,70,1.10 [0.82-1.48],0.5070976523940838
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HAO1,Hydroxyacid oxidase 1,18606,70,1.02 [0.86-1.22],0.797496790893779
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HARS1,"Histidine--tRNA ligase, cytoplasmic",18432,70,1.04 [0.79-1.38],0.7633059759304541
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HAVCR1,Hepatitis A virus cellular receptor 1,18580,70,1.14 [0.82-1.59],0.4475302895267211
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,18432,70,2.79 [1.71-4.55],3.7760863750540416e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HBEGF,Proheparin-binding EGF-like growth factor,18557,70,0.60 [0.45-0.80],0.0004793814604255
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HBQ1,Hemoglobin subunit theta-1,18606,70,1.29 [0.95-1.76],0.1023684381377484
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HBZ,Hemoglobin subunit zeta,16007,62,1.07 [0.86-1.33],0.5518951258325564
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HCG22,Protein PBMUCL2,15485,61,0.98 [0.62-1.54],0.918553978753908
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HCLS1,Hematopoietic lineage cell-specific protein,18653,71,1.58 [1.08-2.33],0.0194808516544383
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HDAC8,Histone deacetylase 8,15528,61,0.89 [0.56-1.41],0.6195672008631248
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HDAC9,Histone deacetylase 9,15523,61,0.86 [0.56-1.33],0.5038334629006291
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HDDC2,5'-deoxynucleotidase HDDC2,15956,64,1.62 [0.99-2.64],0.0559469090156153
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HDGF,Hepatoma-derived growth factor,18571,70,1.18 [0.94-1.48],0.1556231904327208
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HDGFL2,Hepatoma-derived growth factor-related protein 2,15980,64,2.42 [1.97-2.97],3.682138930066411e-17
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HEBP1,Heme-binding protein 1,18109,70,0.84 [0.54-1.30],0.4218513998445562
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HEG1,Protein HEG homolog 1,15659,64,2.11 [0.88-5.06],0.0959502975723518
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HEPACAM2,HEPACAM family member 2,15980,64,0.97 [0.56-1.68],0.9011307826736424
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HEPH,Hephaestin,16007,62,0.74 [0.38-1.47],0.3948576731987219
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HEXIM1,Protein HEXIM1,18427,71,1.20 [0.93-1.55],0.1675668913925657
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HGF,Hepatocyte growth factor,18653,71,1.24 [0.68-2.25],0.4787401957019385
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HGFAC,Hepatocyte growth factor activator,15888,63,0.58 [0.25-1.33],0.1982856674322999
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,18014,68,0.93 [0.70-1.24],0.6278661243985069
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HHEX,Hematopoietically-expressed homeobox protein HHEX,15980,64,1.57 [1.16-2.11],0.0032298894244475
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HIF1A,Hypoxia-inducible factor 1-alpha,15528,61,0.92 [0.60-1.42],0.7134619877872856
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HIP1,Huntingtin-interacting protein 1,15485,61,1.02 [0.50-2.09],0.946683882614982
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,15945,64,1.49 [1.10-2.02],0.0098782392407818
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HJV,Hemojuvelin,15987,64,0.83 [0.46-1.52],0.5513238370751214
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HK2,Hexokinase-2,18109,70,1.05 [0.48-2.27],0.90643309800063
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",15987,64,2.06 [0.99-4.32],0.0548161113437453
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",18364,70,2.13 [1.28-3.55],0.0037128244485831
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",18427,71,3.09 [1.81-5.27],3.597081282496369e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HMBS,Porphobilinogen deaminase,18606,70,1.43 [0.85-2.40],0.180865359413502
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HMCN2,Hemicentin-2,15629,64,0.69 [0.46-1.04],0.073583781214246
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",15560,59,0.84 [0.49-1.44],0.5312624682479495
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",15485,61,0.59 [0.31-1.12],0.1058021991520983
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HMMR,Hyaluronan mediated motility receptor,15416,61,0.56 [0.29-1.09],0.0870368153492108
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HMOX1,Heme oxygenase 1,18235,70,1.31 [0.86-1.98],0.2073002702207074
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,18039,70,2.08 [1.66-2.61],1.8277396064729358e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HNF1A,Hepatocyte nuclear factor 1-alpha,15599,60,1.15 [0.87-1.54],0.3217738230099338
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HNMT,Histamine N-methyltransferase,18200,71,1.27 [0.82-1.98],0.2821442723013915
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,18043,69,1.46 [1.13-1.88],0.0034856870923205
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,15987,64,2.02 [1.64-2.49],2.6983924015486947e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HPCAL1,Hippocalcin-like protein 1,18653,71,0.95 [0.72-1.25],0.7068696064520059
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HPGDS,Hematopoietic prostaglandin D synthase,18014,68,1.17 [0.68-2.04],0.5686768953726966
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HPSE,Heparanase,15822,62,0.91 [0.71-1.18],0.4962853192028965
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HRAS,GTPase Hras,15702,62,0.92 [0.69-1.23],0.5794262762347643
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,15560,59,1.63 [0.85-3.14],0.1442201973796691
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HRG,Histidine-rich glycoprotein,15963,62,1.59 [0.77-3.28],0.2090210423821551
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HS1BP3,HCLS1-binding protein 3,15560,59,1.11 [0.84-1.47],0.4530054546558459
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,18344,71,1.00 [0.57-1.75],0.9894997175210344
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,18606,70,1.66 [1.10-2.51],0.0155364188917697
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,15528,61,1.31 [0.69-2.49],0.4009242333927351
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSBP1,Heat shock factor-binding protein 1,15560,59,1.10 [0.85-1.43],0.4726456844025093
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,18427,71,1.00 [0.59-1.69],0.9985866156815358
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,15980,64,1.10 [0.75-1.62],0.6195242973027435
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSD17B3,Testosterone 17-beta-dehydrogenase 3,15485,61,1.05 [0.64-1.71],0.860850427305717
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,15560,59,1.32 [0.81-2.18],0.2674209915488453
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSP90B1,Endoplasmin,17956,70,0.74 [0.48-1.14],0.1762701813837008
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSPA1A,Heat shock 70 kDa protein 1A,18458,70,1.06 [0.79-1.43],0.6839027655919825
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSPA2,Heat shock-related 70 kDa protein 2,15951,63,1.10 [0.56-2.15],0.7831003862500086
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSPB1,Heat shock protein beta-1,18143,70,0.89 [0.67-1.19],0.4426370057109121
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSPB6,Heat shock protein beta-6,18606,70,1.11 [0.66-1.87],0.6918981421136366
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,18319,68,1.51 [0.70-3.25],0.2934609088999118
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HTR1A,5-hydroxytryptamine receptor 1A,15523,61,0.63 [0.38-1.03],0.0673883920017214
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HTR1B,5-hydroxytryptamine receptor 1B,15523,61,0.82 [0.45-1.52],0.5316903667905497
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HTRA2,"Serine protease HTRA2, mitochondrial",18477,72,1.14 [0.81-1.59],0.4609654739432611
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HYAL1,Hyaluronidase-1,18358,69,0.91 [0.36-2.33],0.84652169083965
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HYOU1,Hypoxia up-regulated protein 1,18663,72,4.39 [1.86-10.39],0.0007554806073558
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICA1,Islet cell autoantigen 1,18124,68,0.96 [0.73-1.26],0.7577392221851207
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,18374,68,4.04 [2.20-7.41],6.631651041496177e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICAM2,Intercellular adhesion molecule 2,18663,72,1.95 [1.02-3.73],0.0442995761397677
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,18663,72,22.24 [15.61-31.67],3.0526670423003124e-66
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICAM4,Intercellular adhesion molecule 4,18427,71,0.75 [0.50-1.10],0.1411488745292067
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICAM5,Intercellular adhesion molecule 5,18432,70,0.68 [0.44-1.06],0.0920238002516745
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICOSLG,ICOS ligand,18344,71,10.46 [3.57-30.64],1.836834165648631e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ID4,DNA-binding protein inhibitor ID-4,15731,62,1.11 [0.66-1.86],0.7021619180949787
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IDI2,Isopentenyl-diphosphate delta-isomerase 2,18039,70,0.81 [0.51-1.28],0.3740066515053847
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IDO1,"Indoleamine 2,3-dioxygenase 1",15560,59,0.87 [0.58-1.32],0.5177544231538465
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IDS,Iduronate 2-sulfatase,18653,71,1.10 [0.11-11.49],0.9353349385842072
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IDUA,Alpha-L-iduronidase,18606,70,0.88 [0.57-1.37],0.5805496834706202
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,15594,64,3.98 [2.64-5.99],3.971678750640568e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,15731,62,1.10 [0.70-1.75],0.6744636350822317
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,15731,62,1.09 [0.58-2.05],0.7857058222115325
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNAR1,Interferon alpha/beta receptor 1,15956,64,2.50 [1.29-4.82],0.0063957169656352
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNG,Interferon gamma,18124,68,0.96 [0.79-1.15],0.6403152458125778
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,18492,70,3.18 [1.85-5.48],3.080085093674548e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNGR2,Interferon gamma receptor 2,18284,71,0.90 [0.60-1.35],0.608002909156642
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNL1,Interferon lambda-1,18039,70,1.28 [0.82-2.00],0.2785440251550586
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNL2,Interferon lambda-2,15523,61,1.17 [0.83-1.66],0.3629337613454169
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,18427,71,2.78 [2.19-3.54],8.761341755561712e-17
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNW1,Interferon omega-1,15485,61,0.33 [0.12-0.89],0.0283084334708339
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFT20,Intraflagellar transport protein 20 homolog,15599,60,1.49 [0.92-2.41],0.1044140880580117
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGBP1,Immunoglobulin-binding protein 1,15987,64,1.25 [0.85-1.84],0.2538570966511279
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,15523,61,0.90 [0.51-1.58],0.7091658188397425
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,16018,64,0.94 [0.39-2.26],0.8881181403918422
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGF1R,Insulin-like growth factor 1 receptor,18344,71,1.57 [0.63-3.91],0.331083744165999
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,15485,61,1.01 [0.59-1.73],0.9662237064766964
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGF2R,Cation-independent mannose-6-phosphate receptor,18432,70,6.47 [2.97-14.13],2.7570944269724338e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGFBP1,Insulin-like growth factor-binding protein 1,18638,72,1.03 [0.87-1.22],0.7295235907116053
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGFBP2,Insulin-like growth factor-binding protein 2,18632,71,1.34 [0.94-1.90],0.1049185821094522
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGFBP3,Insulin-like growth factor-binding protein 3,18520,69,1.36 [0.69-2.67],0.3759186756334792
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,18209,70,1.59 [1.05-2.43],0.03021648634472
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGFBP6,Insulin-like growth factor-binding protein 6,18371,68,1.17 [0.59-2.31],0.6533659349939646
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGFBP7,Insulin-like growth factor-binding protein 7,18663,72,1.87 [1.18-2.98],0.0078496836991294
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGFBPL1,Insulin-like growth factor-binding protein-like 1,18432,70,1.43 [0.78-2.63],0.2486400221223698
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGFL4,Insulin growth factor-like family member 4,15528,61,0.94 [0.64-1.36],0.727966760811796
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGHMBP2,DNA-binding protein SMUBP-2,15485,61,1.13 [0.76-1.69],0.5515547183005272
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGLC2,Immunoglobulin lambda constant 2,16010,63,1.55 [0.85-2.83],0.1518739063718908
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGLON5,IgLON family member 5,15454,61,1.05 [0.82-1.35],0.6834242327370813
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGSF21,Immunoglobulin superfamily member 21,15560,59,1.11 [0.61-1.99],0.737536318225681
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,18344,71,4.82 [4.05-5.75],1.5415928470991078e-69
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGSF8,Immunoglobulin superfamily member 8,18432,70,1.81 [1.03-3.19],0.0390671488619551
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGSF9,Protein turtle homolog A,16007,62,0.89 [0.67-1.19],0.4407325786113135
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IKBKG,NF-kappa-B essential modulator,18427,71,1.33 [1.06-1.68],0.0154736325328251
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IKZF2,Zinc finger protein Helios,18014,68,0.93 [0.71-1.22],0.5920442485918285
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,18124,68,1.55 [1.31-1.83],3.2359405503679865e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL10RA,Interleukin-10 receptor subunit alpha,18124,68,0.99 [0.67-1.46],0.9633875539282466
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,18492,70,2.56 [1.72-3.81],3.954691203249269e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL11,Interleukin-11,18124,68,0.83 [0.56-1.24],0.363959636422652
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,18344,71,1.79 [1.41-2.28],2.400357376558175e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,18653,71,2.28 [1.58-3.28],1.0782338345492104e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,18124,68,3.65 [2.53-5.28],5.95924785889668e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL12RB2,Interleukin-12 receptor subunit beta-2,15528,61,1.93 [1.28-2.90],0.0016084221683165
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL13,Interleukin-13,18124,68,0.94 [0.59-1.50],0.7951930255748016
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL13RA1,Interleukin-13 receptor subunit alpha-1,18192,71,1.80 [0.75-4.32],0.1886185586960407
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL13RA2,Interleukin-13 receptor subunit alpha-2,15523,61,0.74 [0.32-1.69],0.4732874715693907
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL15,Interleukin-15,18427,71,0.72 [0.37-1.38],0.3180275746899316
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,18124,68,4.52 [2.67-7.67],2.031504687668372e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL16,Pro-interleukin-16,18653,71,2.63 [2.06-3.36],1.0583102142715344e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL17A,Interleukin-17A,18084,68,0.65 [0.36-1.18],0.1542054795013507
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL17C,Interleukin-17C,18124,68,1.32 [1.03-1.69],0.0312534948589866
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL17D,Interleukin-17D,18124,68,0.80 [0.39-1.64],0.5483473651623885
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL17F,Interleukin-17F,18124,68,1.04 [0.79-1.38],0.7614434341696396
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL17RA,Interleukin-17 receptor A,18432,70,1.03 [0.64-1.66],0.8952163957255924
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL17RB,Interleukin-17 receptor B,18203,70,1.39 [0.94-2.05],0.1000028099386034
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL18,Interleukin-18,18338,69,1.46 [0.93-2.30],0.1011435854100466
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,18520,69,5.65 [3.44-9.28],8.227318751013179e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL18R1,Interleukin-18 receptor 1,18653,71,1.78 [0.95-3.30],0.0699876240820332
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL18RAP,Interleukin-18 receptor accessory protein,18171,71,0.83 [0.71-0.96],0.0133900695858079
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL19,Interleukin-19,17970,69,0.99 [0.74-1.33],0.9489035811104314
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL1A,Interleukin-1 alpha,18124,68,0.69 [0.44-1.07],0.098331496027216
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL1B,Interleukin-1 beta,18038,67,1.02 [0.70-1.49],0.9121519155434636
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,18400,69,2.90 [1.33-6.36],0.0077137513696019
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL1R2,Interleukin-1 receptor type 2,18373,70,0.40 [0.14-1.11],0.0792697025713696
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL1RAP,Interleukin-1 receptor accessory protein,18432,70,1.64 [1.06-2.53],0.0273598793269269
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL1RL1,Interleukin-1 receptor-like 1,18603,72,1.12 [0.72-1.76],0.6134282316499338
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL1RL2,Interleukin-1 receptor-like 2,18124,68,1.22 [0.69-2.18],0.4922800348247954
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL1RN,Interleukin-1 receptor antagonist protein,18371,70,1.15 [0.79-1.67],0.4741342586264883
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL2,Interleukin-2,18124,68,1.59 [0.82-3.09],0.1730290635194236
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL20,Interleukin-20,18124,68,1.05 [0.69-1.61],0.8111290870415326
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL20RA,Interleukin-20 receptor subunit alpha,18124,68,1.10 [0.70-1.74],0.6666907689368247
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL20RB,Interleukin-20 receptor subunit beta,15528,61,1.24 [0.71-2.18],0.4561281372349196
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL21R,Interleukin-21 receptor,15528,61,0.51 [0.25-1.03],0.0599379318365441
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL22,Interleukin-22,15951,63,1.02 [0.72-1.45],0.9076552864135712
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL22RA1,Interleukin-22 receptor subunit alpha-1,18124,68,0.67 [0.37-1.22],0.1942387217661036
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL24,Interleukin-24,18124,68,0.92 [0.58-1.45],0.7081313655440546
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL25,Interleukin-25,15396,61,0.88 [0.43-1.82],0.7366391066607645
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,18317,71,4.51 [3.51-5.79],6.241724427176763e-32
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL2RB,Interleukin-2 receptor subunit beta,18124,68,0.97 [0.54-1.76],0.9328071294688168
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,15951,63,2.27 [1.68-3.08],1.2246491806513329e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL3,Interleukin-3,15454,61,1.03 [0.69-1.54],0.8869623133503841
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL31,Interleukin-31,15528,61,0.80 [0.47-1.35],0.4027537139656564
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL31RA,Interleukin-31 receptor subunit alpha,15472,61,1.00 [0.52-1.95],0.990142001828836
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL32,Interleukin-32,18427,71,1.42 [0.91-2.20],0.1192531972031752
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL33,Interleukin-33,18124,68,1.06 [0.61-1.82],0.8412124226008277
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL34,Interleukin-34,18009,70,1.00 [0.55-1.81],0.9986784811059228
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL36A,Interleukin-36 alpha,15528,61,0.96 [0.61-1.50],0.8507515932311882
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL36G,Interleukin-36 gamma,15482,60,1.12 [0.80-1.56],0.5042089672446912
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL3RA,Interleukin-3 receptor subunit alpha,18124,68,1.06 [0.54-2.09],0.8694152228711423
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL4,Interleukin-4,18124,68,0.86 [0.72-1.04],0.1183653953130122
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,18427,71,4.82 [3.52-6.61],1.3463182379242758e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL5,Interleukin-5,18124,68,0.87 [0.72-1.04],0.1183119975706675
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL5RA,Interleukin-5 receptor subunit alpha,18427,71,0.37 [0.25-0.55],6.805316356042561e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL6,Interleukin-6,18344,71,1.15 [0.90-1.48],0.267926510885392
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL6R,Interleukin-6 receptor subunit alpha,18349,68,2.18 [1.18-4.05],0.0133619178487215
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL6ST,Interleukin-6 receptor subunit beta,18432,70,0.85 [0.25-2.92],0.8023773431115473
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL7,Interleukin-7,18427,71,0.52 [0.37-0.73],0.0002141381641812
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL7R,Interleukin-7 receptor subunit alpha,18432,70,0.75 [0.51-1.11],0.1497841418937943
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL9,Interleukin-9,15731,62,0.93 [0.57-1.50],0.7558427963211831
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,18007,69,1.77 [1.46-2.14],6.464963829193295e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,15951,63,1.53 [1.01-2.31],0.0436363732549004
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IMPA1,Inositol monophosphatase 1,18284,71,0.98 [0.69-1.39],0.9119340685904854
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IMPACT,Protein IMPACT,15980,64,1.39 [0.90-2.13],0.1366426812517372
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IMPG1,Interphotoreceptor matrix proteoglycan 1,15523,61,0.58 [0.23-1.47],0.2506042892682213
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ING1,Inhibitor of growth protein 1,18011,70,2.18 [1.84-2.58],1.3527241768798422e-19
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INHBB,Inhibin beta B chain,15659,64,1.76 [1.15-2.69],0.0088440195631009
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INHBC,Inhibin beta C chain,18432,70,1.00 [0.58-1.71],0.9911191266135292
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INPP1,Inositol polyphosphate 1-phosphatase,18344,71,1.16 [0.79-1.70],0.4537048461712892
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",15560,59,3.44 [2.48-4.78],1.4599767769083782e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",15987,64,1.20 [0.72-1.99],0.4859275225445403
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",18344,71,0.99 [0.80-1.23],0.9139900290340388
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INSL3,Insulin-like 3,15980,64,0.78 [0.61-1.01],0.0567747641912183
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INSL4,Early placenta insulin-like peptide,15951,63,0.73 [0.40-1.33],0.310304451793945
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INSL5,Insulin-like peptide INSL5,15956,64,0.89 [0.69-1.14],0.3441169094379417
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INSR,Insulin receptor,15528,61,5.93 [1.62-21.66],0.0070879824779297
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IPCEF1,Interactor protein for cytohesin exchange factors 1,18250,71,1.06 [0.84-1.35],0.6056341337215103
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IQGAP2,Ras GTPase-activating-like protein IQGAP2,18344,71,0.91 [0.61-1.35],0.6435266285353147
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",18109,70,1.64 [1.38-1.94],1.7405041783892288e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IRAK1,Interleukin-1 receptor-associated kinase 1,18124,68,1.12 [0.83-1.53],0.4538062082429461
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IRAK4,Interleukin-1 receptor-associated kinase 4,18427,71,1.01 [0.83-1.24],0.9125621652210584
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,17763,68,0.45 [0.25-0.78],0.0048783498128257
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ISM1,Isthmin-1,18427,71,1.23 [0.73-2.07],0.4317587213809366
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ISM2,Isthmin-2,16018,64,0.88 [0.49-1.58],0.67303763824506
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IST1,IST1 homolog,15830,64,1.09 [0.85-1.40],0.4796715737558615
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGA11,Integrin alpha-11,18427,71,0.51 [0.28-0.95],0.0332474660344543
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGA2,Integrin alpha-2,15659,64,0.71 [0.35-1.43],0.3366439525353568
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGA5,Integrin alpha-5,18432,70,2.26 [0.99-5.16],0.0540161783942181
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGA6,Integrin alpha-6,18427,71,0.57 [0.36-0.90],0.0164354684114382
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGAL,Integrin alpha-L,15528,61,3.51 [1.97-6.26],2.0175531072351337e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGAM,Integrin alpha-M,18432,70,0.83 [0.42-1.63],0.5853326382901354
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGAV,Integrin alpha-V,18606,70,0.60 [0.27-1.34],0.2092171786475747
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGAX,Integrin alpha-X,15731,62,0.61 [0.41-0.90],0.011790180716437
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGB1,Integrin beta-1,18435,69,1.52 [0.57-4.01],0.4017398542922769
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGB1BP1,Integrin beta-1-binding protein 1,18014,68,0.70 [0.41-1.19],0.1836235739569354
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGB1BP2,Integrin beta-1-binding protein 2,18109,70,1.05 [0.86-1.27],0.650695797060344
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGB2,Integrin beta-2,18344,71,1.91 [0.99-3.69],0.0521445306669688
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGB5,Integrin beta-5,18477,72,0.81 [0.46-1.43],0.4727286707944755
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGB6,Integrin beta-6,18124,68,0.80 [0.40-1.61],0.5311657516153138
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGB7,Integrin beta-7,18606,70,1.21 [0.78-1.88],0.3984811359020124
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGBL1,Integrin beta-like protein 1,16018,64,1.68 [0.97-2.93],0.0650909436186874
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,16032,63,1.02 [0.28-3.71],0.979004589893084
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,18520,69,2.16 [1.24-3.77],0.0064808485908652
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,16032,63,1.29 [0.49-3.42],0.6053795113149621
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,15951,63,0.64 [0.34-1.17],0.1479587144316037
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITM2A,Integral membrane protein 2A,18427,71,1.19 [0.85-1.66],0.3098931396824681
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITPA,Inosine triphosphate pyrophosphatase,15485,61,1.24 [0.87-1.77],0.2387801773513858
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",15560,59,0.67 [0.43-1.04],0.0728683865312655
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",15523,61,0.63 [0.32-1.24],0.1825957499440948
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",18039,70,1.14 [0.77-1.69],0.5019991578986132
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IZUMO1,Izumo sperm-egg fusion protein 1,15454,61,0.81 [0.45-1.48],0.4990312287900437
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",JAM2,Junctional adhesion molecule B,18597,71,2.17 [1.06-4.42],0.0339130892025512
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",JAM3,Junctional adhesion molecule C,15659,64,0.93 [0.57-1.52],0.7869392336537449
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",JCHAIN,Immunoglobulin J chain,18124,68,0.80 [0.56-1.13],0.2062425862803232
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,15454,61,0.86 [0.54-1.38],0.5413455726464671
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",JPT2,Jupiter microtubule associated homolog 2,15956,64,1.14 [0.86-1.50],0.3559646106952263
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",JUN,Transcription factor AP-1,18124,68,1.54 [1.20-1.99],0.0008270836287661
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,18344,71,2.29 [1.39-3.77],0.0011230720576311
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KAZN,Kazrin,15956,64,1.05 [0.84-1.33],0.6531031434289428
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KCNC4,Potassium voltage-gated channel subfamily C member 4,15523,61,0.37 [0.18-0.76],0.0069452165275539
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KCNH2,Potassium voltage-gated channel subfamily H member 2,15599,60,0.56 [0.33-0.96],0.0347069077128207
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KCNIP4,Kv channel-interacting protein 4,18039,70,0.95 [0.61-1.47],0.803229550222704
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,15663,61,0.37 [0.18-0.76],0.0071473339055472
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KDM3A,Lysine-specific demethylase 3A,15528,61,0.77 [0.53-1.13],0.1861579598088809
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KDR,Vascular endothelial growth factor receptor 2,18477,72,1.09 [0.48-2.47],0.8412227022103043
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KEL,Kell blood group glycoprotein,18039,70,1.99 [1.12-3.54],0.0184000591544495
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KHDC3L,KH domain-containing protein 3,15454,61,0.74 [0.45-1.20],0.2207667439793581
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KHK,Ketohexokinase,15560,59,0.96 [0.64-1.44],0.8331653868341033
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIAA0319,Dyslexia-associated protein KIAA0319,15980,64,1.63 [0.88-3.02],0.1207270494299105
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIAA1549,UPF0606 protein KIAA1549,15731,62,0.91 [0.64-1.30],0.6152400838766403
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIAA1549L,UPF0606 protein KIAA1549L,15731,62,1.33 [0.59-2.96],0.4902190991034063
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIAA2013,Uncharacterized protein KIAA2013,15951,63,1.21 [0.84-1.75],0.3079308013206225
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIF1C,Kinesin-like protein KIF1C,15485,61,1.68 [1.05-2.68],0.0294565935666198
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIF20B,Kinesin-like protein KIF20B,15523,61,1.21 [0.91-1.59],0.1883700298230702
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIF22,Kinesin-like protein KIF22,15485,61,1.48 [1.18-1.85],0.000635981046963
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIFBP,KIF-binding protein,18344,71,1.06 [0.82-1.37],0.6561451881583025
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,15951,63,1.33 [1.02-1.73],0.0356665614557362
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,18014,68,1.28 [0.98-1.67],0.0690275827028621
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,15956,64,0.91 [0.79-1.05],0.2095089434069665
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,18014,68,0.87 [0.73-1.04],0.1223210804484352
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,15454,61,0.83 [0.57-1.22],0.3428280735510921
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIRREL1,Kin of IRRE-like protein 1,15523,61,0.90 [0.56-1.46],0.6736966615833571
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIRREL2,Kin of IRRE-like protein 2,18039,70,0.83 [0.48-1.42],0.4931449545441011
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIT,Mast/stem cell growth factor receptor Kit,18498,69,0.55 [0.27-1.13],0.1049139602192168
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KITLG,Kit ligand,18432,70,1.01 [0.57-1.78],0.98248549733457
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLB,Beta-klotho,18039,70,0.96 [0.72-1.27],0.7688278035653767
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLF4,Krueppel-like factor 4,15523,61,1.81 [1.28-2.57],0.0007958505250795
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLHL41,Kelch-like protein 41,15987,64,0.83 [0.49-1.39],0.4694764116341391
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK1,Kallikrein-1,18259,70,1.03 [0.87-1.21],0.7413942243100431
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK10,Kallikrein-10,18424,72,0.43 [0.26-0.72],0.0014277105388697
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK11,Kallikrein-11,18293,72,1.12 [0.60-2.11],0.7231911249340691
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK12,Kallikrein-12,18014,68,0.96 [0.82-1.12],0.5954374851667362
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK13,Kallikrein-13,18007,71,0.80 [0.50-1.28],0.3454032574808047
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK14,Kallikrein-14,18606,70,0.68 [0.43-1.09],0.1070232221451736
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK15,Kallikrein-15,15920,63,1.24 [0.78-1.98],0.3662496571774408
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK3,Prostate-specific antigen,16018,64,0.93 [0.75-1.16],0.5230265520979831
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK4,Kallikrein-4,18606,70,1.30 [0.96-1.76],0.0892938935676105
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK6,Kallikrein-6,18440,72,1.28 [0.65-2.51],0.4807406598622165
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK7,Kallikrein-7,15277,62,0.31 [0.16-0.60],0.000577137035528
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK8,Kallikrein-8,17810,70,1.01 [0.56-1.83],0.9696762926603132
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLKB1,Plasma kallikrein,15716,62,2.16 [0.80-5.85],0.1295107839274275
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,18653,71,1.95 [1.16-3.26],0.0112886825600768
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,15523,61,0.93 [0.60-1.45],0.7399976819784848
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLRD1,Natural killer cells antigen CD94,18653,71,1.22 [0.78-1.89],0.3868392044201524
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLRF1,Killer cell lectin-like receptor subfamily F member 1,15528,61,1.35 [0.91-2.01],0.1402405679843113
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,15980,64,1.69 [1.15-2.48],0.0072445802020724
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KRT14,"Keratin, type I cytoskeletal 14",17486,67,1.56 [0.93-2.60],0.0917840229833574
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KRT17,"Keratin, type I cytoskeletal 17",15485,61,1.36 [0.83-2.21],0.2230560197347142
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KRT18,"Keratin, type I cytoskeletal 18",18344,71,1.13 [0.89-1.44],0.3181000319493638
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KRT19,"Keratin, type I cytoskeletal 19",18396,71,1.11 [0.81-1.51],0.5160052756045306
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KRT5,"Keratin, type II cytoskeletal 5",18039,70,0.69 [0.45-1.07],0.1000214273247034
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KRT6C,"Keratin, type II cytoskeletal 6C",15485,61,0.74 [0.35-1.59],0.4453211121217223
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KRT8,"Keratin, type II cytoskeletal 8",15523,61,0.99 [0.73-1.34],0.9575643866791458
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KYAT1,Kynurenine--oxoglutarate transaminase 1,18401,70,1.70 [1.23-2.36],0.0013546050037081
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KYNU,Kynureninase,18653,71,1.41 [0.90-2.21],0.1375359191685283
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",L1CAM,Neural cell adhesion molecule L1,18477,72,5.48 [2.91-10.34],1.4623288260215946e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,16007,62,1.14 [0.87-1.49],0.3401143068486785
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LACRT,Extracellular glycoprotein lacritin,15917,63,1.00 [0.59-1.70],0.9984173918315628
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LACTB2,Endoribonuclease LACTB2,18432,70,1.01 [0.73-1.39],0.9615603488694268
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,18344,71,2.63 [2.05-3.39],5.81991677414281e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,18402,70,2.11 [1.41-3.15],0.0002976456548511
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,18284,71,1.18 [0.96-1.46],0.1220559478791467
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAMA1,Laminin subunit alpha-1,15485,61,0.80 [0.45-1.42],0.4443410560636269
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAMA4,Laminin subunit alpha-4,18492,70,0.67 [0.35-1.26],0.2132317078110079
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAMB1,Laminin subunit beta-1,15560,59,0.92 [0.41-2.08],0.8474921440267071
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAMP1,Lysosome-associated membrane glycoprotein 1,15586,62,0.83 [0.30-2.30],0.7273761643626608
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAMP2,Lysosome-associated membrane glycoprotein 2,17873,66,0.76 [0.27-2.14],0.5991775341948538
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAMP3,Lysosome-associated membrane glycoprotein 3,18620,71,1.44 [0.98-2.14],0.0664724911924403
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAMTOR5,Ragulator complex protein LAMTOR5,15951,63,1.04 [0.57-1.89],0.8951429152330496
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAP3,Cytosol aminopeptidase,18124,68,1.02 [0.65-1.60],0.9318668884712104
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LARP1,La-related protein 1,15951,63,1.29 [0.94-1.78],0.1196897583707762
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAT,Linker for activation of T-cells family member 1,18653,71,0.84 [0.65-1.10],0.2000838054221767
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAT2,Linker for activation of T-cells family member 2,18344,71,0.97 [0.82-1.15],0.7128049778037115
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LATS1,Serine/threonine-protein kinase LATS1,15528,61,1.03 [0.77-1.37],0.8381850067911729
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,18256,71,2.34 [1.42-3.87],0.0009032194187339
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LBP,Lipopolysaccharide-binding protein,18520,69,1.14 [0.79-1.64],0.4797103542256923
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LBR,Delta(14)-sterol reductase LBR,18597,71,1.26 [0.99-1.62],0.0632999824084294
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LCAT,Phosphatidylcholine-sterol acyltransferase,16029,64,0.93 [0.31-2.79],0.8932905071164385
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LCN15,Lipocalin-15,15987,64,1.11 [0.77-1.59],0.5808219965272715
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LCN2,Neutrophil gelatinase-associated lipocalin,17907,69,0.70 [0.39-1.25],0.2266777481564297
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LCP1,Plastin-2,16018,64,1.22 [0.75-1.96],0.4226170692697126
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LDLR,Low-density lipoprotein receptor,18481,72,1.01 [0.67-1.53],0.9478407163108106
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LDLRAP1,Low density lipoprotein receptor adapter protein 1,15987,64,0.91 [0.71-1.16],0.4323482426592002
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LECT2,Leukocyte cell-derived chemotaxin-2,16007,62,0.75 [0.51-1.10],0.1402391047144808
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LEFTY2,Left-right determination factor 2,18583,70,0.62 [0.41-0.92],0.0192181759401827
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LEG1,Protein LEG1 homolog,15118,62,0.84 [0.59-1.22],0.3646163040115905
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LELP1,Late cornified envelope-like proline-rich protein 1,15523,61,1.03 [0.73-1.45],0.8541038503481115
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LEO1,RNA polymerase-associated protein LEO1,15987,64,1.32 [0.74-2.34],0.3479401579713769
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LEP,Leptin,18432,70,0.72 [0.53-0.97],0.0306972580809273
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LEPR,Leptin receptor,18432,70,1.13 [0.59-2.17],0.7214890080549669
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LETM1,Mitochondrial proton/calcium exchanger protein,15987,64,1.36 [0.92-2.00],0.1234959549794131
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LGALS1,Galectin-1,18432,70,1.30 [0.72-2.34],0.3883080110032735
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LGALS3,Galectin-3,18488,71,1.44 [0.71-2.92],0.3069506594281359
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LGALS3BP,Galectin-3-binding protein,16032,63,1.66 [0.86-3.19],0.1293283724234107
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LGALS4,Galectin-4,18402,70,1.11 [0.77-1.61],0.5659280835543026
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LGALS7_LGALS7B,Galectin-7,18402,69,1.07 [0.65-1.75],0.7890967533393667
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LGALS8,Galectin-8,18597,71,1.07 [0.76-1.51],0.6869148124789122
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,18413,70,3.52 [1.97-6.29],2.2073741698428705e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LGMN,Legumain,18492,70,0.60 [0.33-1.10],0.0976379139332934
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LHB,Lutropin subunit beta,18014,68,0.93 [0.72-1.21],0.5981845534409976
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,18429,70,1.44 [1.04-1.99],0.0287051479444773
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LIF,Leukemia inhibitory factor,18039,70,1.28 [0.92-1.78],0.1367662350334313
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LIFR,Leukemia inhibitory factor receptor,18427,71,1.03 [0.42-2.49],0.9564450948080918
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,18432,70,1.54 [0.84-2.85],0.1641012041131422
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,16018,64,0.97 [0.83-1.14],0.7217797026478983
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,15485,61,0.71 [0.40-1.28],0.2593130296438904
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,18412,70,1.30 [0.68-2.49],0.4248531055296107
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,16007,62,0.88 [0.64-1.21],0.4252225958396399
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,18663,72,10.90 [5.82-20.41],8.243305374595985e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,18572,71,3.37 [1.79-6.33],0.0001663515068576
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,18124,68,2.96 [1.95-4.50],3.371726646997685e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,18663,72,1.15 [0.84-1.56],0.3883356225109043
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LIPF,Gastric triacylglycerol lipase,15560,59,1.00 [0.67-1.50],0.9839883035520668
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LMNB1,Lamin-B1,15929,64,1.59 [1.26-2.01],7.99976562813524e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,15980,64,3.20 [1.86-5.49],2.5495675234455862e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LMOD1,Leiomodin-1,15987,64,1.34 [0.73-2.47],0.34980020145454
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LMOD2,Leiomodin-2,15523,61,0.72 [0.45-1.15],0.1732523286502266
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LONP1,"Lon protease homolog, mitochondrial",15560,59,1.24 [0.94-1.64],0.1332200041008632
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LPA,Apolipoprotein(a),15679,62,1.12 [0.98-1.28],0.0987021322664863
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LPCAT2,Lysophosphatidylcholine acyltransferase 2,18344,71,1.05 [0.67-1.66],0.8330200318482299
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LPL,Lipoprotein lipase,18432,70,0.91 [0.59-1.40],0.6717857264887771
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LPO,Lactoperoxidase,17791,69,0.98 [0.69-1.40],0.9244286327602071
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LPP,Lipoma-preferred partner,15485,61,0.96 [0.66-1.41],0.8431661984094492
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,15485,61,1.82 [1.40-2.38],1.0689450858438412e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,15599,60,0.55 [0.27-1.14],0.1082353117903222
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,16032,63,4.98 [2.24-11.04],7.912243687389236e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,18557,70,1.32 [0.73-2.38],0.356825313258739
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,15479,60,1.61 [0.78-3.30],0.1944789966919536
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRP1,Prolow-density lipoprotein receptor-related protein 1,18344,71,1.01 [0.46-2.21],0.9872079029275924
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRP11,Low-density lipoprotein receptor-related protein 11,18432,70,1.74 [1.00-3.02],0.0490320435434184
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRP2,Low-density lipoprotein receptor-related protein 2,15599,60,0.76 [0.36-1.60],0.4661254530306939
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRP2BP,LRP2-binding protein,15599,60,1.12 [0.85-1.46],0.42991849059827
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,18597,71,0.65 [0.40-1.07],0.0880772199816228
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,18344,71,1.78 [1.25-2.54],0.0012907131047152
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRRC37A2,Leucine-rich repeat-containing protein 37A2,15956,64,6.60 [3.99-10.92],2.078891029831017e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRRC38,Leucine-rich repeat-containing protein 38,15599,60,1.01 [0.60-1.70],0.9652903578469866
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRRC59,Leucine-rich repeat-containing protein 59,16007,62,1.13 [0.70-1.83],0.6197819453396491
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,15951,63,1.69 [1.10-2.58],0.0159395768126277
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRRN1,Leucine-rich repeat neuronal protein 1,18124,68,1.84 [1.06-3.18],0.0298432721200628
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,15599,60,0.88 [0.46-1.67],0.6976986485501069
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,15987,64,1.62 [0.70-3.72],0.2580230865912714
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LSM1,U6 snRNA-associated Sm-like protein LSm1,18014,68,0.50 [0.30-0.83],0.007334983357496
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LSM8,U6 snRNA-associated Sm-like protein LSm8,15731,62,0.98 [0.72-1.34],0.8918989258879267
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LSP1,Lymphocyte-specific protein 1,18427,71,6.84 [4.93-9.49],1.4470091120168123e-30
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,18427,71,0.58 [0.28-1.22],0.152125087065661
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTA4H,Leukotriene A-4 hydrolase,18606,70,1.13 [0.80-1.60],0.4762184126203936
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTB,Lymphotoxin-beta,15951,63,1.82 [1.29-2.57],0.000633337897688
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,18663,72,1.95 [1.04-3.66],0.0380286201938807
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTBP3,Latent-transforming growth factor beta-binding protein 3,18014,68,1.63 [1.26-2.10],0.0002048673164746
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,18310,70,2.36 [1.26-4.45],0.0076303078221206
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTO1,Protein LTO1 homolog,18124,68,0.80 [0.44-1.44],0.4540403282909832
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LUZP2,Leucine zipper protein 2,15951,63,1.62 [1.08-2.43],0.0189200692014137
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LXN,Latexin,18201,71,1.07 [0.80-1.44],0.6396100372712628
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LY6D,Lymphocyte antigen 6D,18315,69,1.12 [0.65-1.94],0.688037052021637
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,18427,71,5.49 [3.04-9.90],1.493588661211916e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,18205,71,24.58 [17.25-35.01],2.1864261146341183e-70
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LY96,Lymphocyte antigen 96,18284,71,0.31 [0.17-0.57],0.0001747935085026
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYAR,Cell growth-regulating nucleolar protein,18014,68,1.73 [1.51-1.99],1.0704622418660308e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYN,Tyrosine-protein kinase Lyn,18344,71,1.03 [0.80-1.32],0.8256817216904271
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYPD1,Ly6/PLAUR domain-containing protein 1,18039,70,0.46 [0.25-0.85],0.0128937487219758
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYPD3,Ly6/PLAUR domain-containing protein 3,18337,72,2.52 [1.54-4.13],0.0002343332846047
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYPD8,Ly6/PLAUR domain-containing protein 8,18014,68,1.42 [1.10-1.83],0.0070163924761184
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYPLA2,Acyl-protein thioesterase 2,15523,61,1.08 [0.88-1.33],0.4493056047570061
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,15599,60,1.03 [0.82-1.30],0.785086565907304
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,16032,63,1.52 [0.45-5.20],0.5013723338617417
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYZL2,Lysozyme-like protein 2,15454,61,0.95 [0.48-1.88],0.882880265048453
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LZTFL1,Leucine zipper transcription factor-like protein 1,15659,64,1.25 [0.90-1.73],0.1897472076364222
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",M6PR,Cation-dependent mannose-6-phosphate receptor,15560,59,1.36 [0.81-2.28],0.2450347946055051
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,18227,71,1.90 [1.60-2.27],8.049228408444399e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAEA,E3 ubiquitin-protein transferase MAEA,18014,68,1.30 [0.79-2.15],0.3002443156074118
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAG,Myelin-associated glycoprotein,15599,60,1.05 [0.63-1.75],0.8623662941387029
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAGEA3,Melanoma-associated antigen 3,15731,62,0.88 [0.68-1.13],0.3129278341081603
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAGED1,Melanoma-associated antigen D1,18014,68,1.83 [1.32-2.54],0.0003133266430733
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAMDC2,MAM domain-containing protein 2,16007,62,1.30 [0.66-2.57],0.443732027278193
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAMDC4,Apical endosomal glycoprotein,15951,63,0.92 [0.59-1.41],0.6952219772069694
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",15560,59,11.79 [4.64-29.98],2.203892270329938e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAN2B2,Epididymis-specific alpha-mannosidase,16007,62,0.87 [0.59-1.31],0.5151445415355881
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",15454,61,1.22 [0.77-1.93],0.400700244640322
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MANF,Mesencephalic astrocyte-derived neurotrophic factor,18492,70,0.96 [0.81-1.13],0.616248274364108
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MANSC1,MANSC domain-containing protein 1,18477,72,0.59 [0.28-1.26],0.1713578582507919
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MANSC4,MANSC domain-containing protein 4,15485,61,1.12 [0.79-1.58],0.527201929738432
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,15523,61,0.66 [0.30-1.42],0.2868666229500247
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,15485,61,0.96 [0.65-1.43],0.8478300580559356
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAP2,Microtubule-associated protein 2,15980,64,2.27 [1.76-2.94],2.7409940909477166e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,15956,64,1.40 [0.98-2.02],0.0668984705032081
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,18427,71,1.02 [0.82-1.26],0.8696501637562755
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,18014,68,1.22 [0.99-1.50],0.0584145210008879
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,18256,71,0.99 [0.82-1.20],0.9255321350353154
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAPK13,Mitogen-activated protein kinase 13,15454,61,1.98 [1.49-2.62],2.080166939170536e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAPK9,Mitogen-activated protein kinase 9,18427,71,1.24 [0.76-2.02],0.3872032835698565
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAPKAPK2,MAP kinase-activated protein kinase 2,15731,62,1.17 [0.85-1.61],0.3465793004380005
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAPRE3,Microtubule-associated protein RP/EB family member 3,15454,61,1.02 [0.86-1.20],0.8469103917411478
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAPT,Microtubule-associated protein tau,18039,70,0.81 [0.56-1.17],0.2585624546520667
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MARCO,Macrophage receptor MARCO,18432,70,2.81 [1.23-6.42],0.0139046889870818
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MARS1,"Methionine--tRNA ligase, cytoplasmic",15632,64,1.18 [0.89-1.57],0.240865704601099
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MASP1,Mannan-binding lectin serine protease 1,18256,71,0.75 [0.31-1.86],0.5386600905818872
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MATN2,Matrilin-2,18432,70,1.18 [0.57-2.45],0.6472098434077866
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MATN3,Matrilin-3,18250,71,0.53 [0.28-1.01],0.0532135927349218
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAVS,Mitochondrial antiviral-signaling protein,18014,68,1.09 [0.86-1.38],0.4836695539947018
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAX,Protein max,18039,70,0.97 [0.79-1.19],0.7603286227422439
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MB,Myoglobin,18663,72,1.05 [0.73-1.52],0.7830595713640656
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MBL2,Mannose-binding protein C,15817,62,1.04 [0.83-1.29],0.7546273330365321
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MCAM,Cell surface glycoprotein MUC18,18520,69,1.81 [0.98-3.34],0.0559736529433258
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",15987,64,0.82 [0.44-1.53],0.5249262648298676
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MCEMP1,Mast cell-expressed membrane protein 1,15528,61,0.91 [0.68-1.21],0.5154915789793922
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MCFD2,Multiple coagulation factor deficiency protein 2,18335,70,0.92 [0.57-1.49],0.7458947572239754
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MCTS1,Malignant T-cell-amplified sequence 1,15956,64,0.80 [0.31-2.11],0.657430554974259
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,18284,71,0.96 [0.71-1.30],0.8087153192247254
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MDH1,"Malate dehydrogenase, cytoplasmic",15946,63,1.49 [0.86-2.59],0.1544623630726068
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MDK,Midkine,18414,72,0.80 [0.52-1.23],0.3156721805155653
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MDM1,Nuclear protein MDM1,15599,60,0.57 [0.25-1.31],0.1854106499362852
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",15560,59,1.18 [0.90-1.55],0.2222923873230798
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MED18,Mediator of RNA polymerase II transcription subunit 18,18014,68,1.02 [0.77-1.35],0.8893804951499554
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MED21,Mediator of RNA polymerase II transcription subunit 21,15485,61,1.00 [0.61-1.65],0.9928512249802974
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MEGF10,Multiple epidermal growth factor-like domains protein 10,18402,70,0.72 [0.42-1.24],0.2360857815218988
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MEGF11,Multiple epidermal growth factor-like domains protein 11,15485,61,1.02 [0.47-2.18],0.9639322664221136
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MEGF9,Multiple epidermal growth factor-like domains protein 9,18603,72,1.90 [0.74-4.86],0.1834151786013158
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MELTF,Melanotransferrin,16007,62,0.87 [0.39-1.94],0.7281073276538428
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MENT,Protein MENT,15659,64,0.75 [0.27-2.07],0.5735243433273184
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MEP1A,Meprin A subunit alpha,15956,64,0.84 [0.60-1.16],0.2901027187875997
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MEP1B,Meprin A subunit beta,18432,70,0.91 [0.76-1.09],0.3048373811485539
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MEPE,Matrix extracellular phosphoglycoprotein,18402,70,1.32 [0.53-3.30],0.5514529241671879
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MERTK,Tyrosine-protein kinase Mer,18653,71,2.69 [1.19-6.08],0.0172168307039512
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MESD,LRP chaperone MESD,18432,70,0.96 [0.81-1.14],0.665095262862176
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MET,Hepatocyte growth factor receptor,18479,71,1.86 [0.64-5.46],0.2569327782328574
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",METAP1,Methionine aminopeptidase 1,18039,70,1.24 [0.62-2.47],0.5427434543519141
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",18427,71,0.97 [0.75-1.25],0.7856539283678399
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",METAP2,Methionine aminopeptidase 2,18583,70,1.34 [0.91-1.98],0.1372980373216561
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MFAP3,Microfibril-associated glycoprotein 3,18109,70,0.87 [0.54-1.41],0.5841215821180874
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MFAP3L,Microfibrillar-associated protein 3-like,15599,60,0.94 [0.63-1.41],0.7754325705546127
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MFAP4,Microfibril-associated glycoprotein 4,15659,64,1.15 [0.55-2.41],0.7165461051386373
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MFAP5,Microfibrillar-associated protein 5,18663,72,0.91 [0.54-1.52],0.7052003606746011
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MFGE8,Lactadherin,18432,70,0.77 [0.48-1.25],0.2946786676480727
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MGLL,Monoglyceride lipase,18471,70,0.91 [0.72-1.15],0.4365130503655633
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MGMT,Methylated-DNA--protein-cysteine methyltransferase,18427,71,1.15 [0.96-1.38],0.1420524205968586
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MIA,Melanoma-derived growth regulatory protein,18477,72,1.01 [0.57-1.78],0.9723816491960044
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MICALL2,MICAL-like protein 2,15599,60,0.95 [0.65-1.39],0.7955905478302615
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,18427,71,0.96 [0.85-1.10],0.5765662328481096
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MIF,Macrophage migration inhibitory factor,18397,70,1.21 [0.88-1.67],0.2455019033932253
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MILR1,Allergin-1,18124,68,1.73 [1.17-2.55],0.0057531425614143
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,15951,63,1.03 [0.82-1.29],0.7884241126961783
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MINK1,Misshapen-like kinase 1,15980,64,0.99 [0.77-1.28],0.941390545887276
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MITD1,MIT domain-containing protein 1,18284,71,1.04 [0.84-1.30],0.7127448354959545
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MKI67,Proliferation marker protein Ki-67,15528,61,1.26 [0.76-2.08],0.3789838193879008
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MLLT1,Protein ENL,15454,61,1.17 [0.84-1.62],0.3531518305910144
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MLN,Promotilin,18427,71,1.01 [0.80-1.28],0.9125738173696996
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MME,Neprilysin,18344,71,1.04 [0.79-1.36],0.7971274179661788
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MMP1,Interstitial collagenase,17818,67,0.96 [0.76-1.22],0.7505139252225411
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MMP10,Stromelysin-2,18378,69,1.05 [0.72-1.52],0.8069212887729804
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,18475,69,1.25 [0.86-1.83],0.2476751774175301
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MMP13,Collagenase 3,18039,70,0.99 [0.51-1.93],0.97678464419739
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MMP15,Matrix metalloproteinase-15,16007,62,1.25 [0.86-1.81],0.2471773485805997
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MMP3,Stromelysin-1,18432,70,1.15 [0.76-1.76],0.5063229566931442
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MMP7,Matrilysin,18085,70,1.15 [0.74-1.79],0.523185544945763
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MMP8,Neutrophil collagenase,18567,71,1.25 [0.95-1.65],0.1087003559742293
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MMP9,Matrix metalloproteinase-9,18411,69,1.36 [0.95-1.93],0.0918719713792009
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",15485,61,0.79 [0.46-1.33],0.3747691838786114
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MN1,Transcriptional activator MN1,15599,60,0.63 [0.37-1.08],0.0942581567421612
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MNAT1,CDK-activating kinase assembly factor MAT1,15731,62,1.59 [1.12-2.25],0.0090366850920074
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MNDA,Myeloid cell nuclear differentiation antigen,18403,70,1.05 [0.86-1.28],0.6420909869892859
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MOCS2,Molybdopterin synthase catalytic subunit,15659,64,1.35 [0.95-1.91],0.0939036387596786
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MOG,Myelin-oligodendrocyte glycoprotein,18606,70,1.46 [0.78-2.72],0.2332047400400916
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MORC3,MORC family CW-type zinc finger protein 3,15980,64,3.29 [2.26-4.78],4.2119389619991957e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MORF4L1,Mortality factor 4-like protein 1,15731,62,1.53 [1.04-2.25],0.0325464927665393
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MORF4L2,Mortality factor 4-like protein 2,15454,61,2.00 [1.30-3.07],0.0015096638429153
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MORN4,MORN repeat-containing protein 4,15454,61,1.16 [0.90-1.51],0.2462950478343414
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MPHOSPH8,M-phase phosphoprotein 8,18109,70,1.29 [1.00-1.68],0.0533430192396198
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MPI,Mannose-6-phosphate isomerase,18344,71,1.22 [0.96-1.55],0.0996157071657018
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,18471,70,0.90 [0.69-1.17],0.4421611607186945
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MPO,Myeloperoxidase,18432,70,0.99 [0.63-1.57],0.9724233825059608
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MPRIP,Myosin phosphatase Rho-interacting protein,15924,63,0.73 [0.41-1.28],0.2688384769776006
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MRC1,Macrophage mannose receptor 1,16029,64,1.86 [0.82-4.22],0.1367865898478573
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MRI1,Methylthioribose-1-phosphate isomerase,15599,60,1.45 [0.98-2.14],0.0632633813154651
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MRPL24,"39S ribosomal protein L24, mitochondrial",15485,61,0.90 [0.45-1.78],0.7552422112970466
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MRPL28,"39S ribosomal protein L28, mitochondrial",15987,64,0.80 [0.36-1.77],0.5797605900118904
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MRPL46,"39S ribosomal protein L46, mitochondrial",18039,70,0.77 [0.34-1.75],0.5346938993856049
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MRPL52,"39S ribosomal protein L52, mitochondrial",15416,61,0.79 [0.30-2.11],0.6392505521954542
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",15987,64,0.74 [0.49-1.12],0.1506924700036348
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MRPS16,"28S ribosomal protein S16, mitochondrial",15528,61,1.00 [0.43-2.36],0.99547147961672
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MSLN,Mesothelin,18314,71,1.45 [1.04-2.02],0.0295036801990898
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MSLNL,Mesothelin-like protein,15599,60,0.86 [0.43-1.73],0.6691828812169331
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MSMB,Beta-microseminoprotein,18413,69,1.08 [0.80-1.47],0.6024867114221863
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MSR1,Macrophage scavenger receptor types I and II,18597,71,1.25 [0.79-1.97],0.34182294955909
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MSRA,Mitochondrial peptide methionine sulfoxide reductase,18477,72,0.94 [0.70-1.25],0.6497883509709446
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MST1,Hepatocyte growth factor-like protein,15801,63,1.00 [0.70-1.41],0.9788501774357397
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MSTN,Growth/differentiation factor 8,18109,70,0.83 [0.56-1.23],0.3631386853267517
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MTDH,Protein LYRIC,15528,61,1.39 [1.08-1.79],0.0098304013341181
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",15980,64,0.99 [0.38-2.57],0.9830152320679338
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,15731,62,1.20 [0.97-1.48],0.0921854967428944
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MTIF3,"Translation initiation factor IF-3, mitochondrial",15956,64,0.92 [0.70-1.22],0.5696612395013643
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MTPN,Myotrophin,18109,70,1.02 [0.54-1.94],0.9504587834600025
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MTR,Methionine synthase,15485,61,1.21 [0.90-1.62],0.2028106534190909
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MTSS1,Protein MTSS 1,15956,64,1.17 [0.94-1.44],0.1582276745350807
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MTSS2,Protein MTSS 2,15951,63,0.99 [0.78-1.26],0.9251537623533478
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MTUS1,Microtubule-associated tumor suppressor 1,15731,62,1.15 [0.76-1.73],0.5103387991009001
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MUC13,Mucin-13,18039,70,0.94 [0.62-1.42],0.75582971929287
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MUC16,Mucin-16,18344,71,1.06 [0.94-1.20],0.3075296728557096
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MUC2,Mucin-2,16018,64,0.80 [0.61-1.04],0.0953553446458089
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MUCL3,Mucin-like protein 3,15454,61,0.67 [0.32-1.43],0.3041925510189046
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MVK,Mevalonate kinase,18124,68,1.12 [0.87-1.46],0.3743877150164691
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MXRA8,Matrix remodeling-associated protein 8,15659,64,0.80 [0.36-1.75],0.5754652282773522
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYBPC1,"Myosin-binding protein C, slow-type",16007,62,0.90 [0.64-1.25],0.5261752022466345
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYBPC2,"Myosin-binding protein C, fast-type",15560,59,0.88 [0.63-1.21],0.4234092259293172
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,15987,64,1.81 [1.45-2.25],1.1417866879344209e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYDGF,Myeloid-derived growth factor,16007,62,0.99 [0.78-1.27],0.965909055503026
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYH4,Myosin-4,15485,61,0.59 [0.30-1.18],0.1378779190414838
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYH7B,Myosin-7B,15454,61,0.35 [0.16-0.76],0.0078393245359686
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYH9,Myosin-9,16018,64,1.08 [0.87-1.33],0.4859995361977096
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",15485,61,1.00 [0.53-1.89],0.9964775210650818
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYL3,Myosin light chain 3,15560,59,0.96 [0.69-1.34],0.8308879469238393
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYL4,Myosin light chain 4,15560,59,1.32 [0.88-1.98],0.1727356419085259
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYL6B,Myosin light chain 6B,15599,60,1.01 [0.78-1.32],0.9291229664536484
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",15599,60,0.71 [0.41-1.26],0.243397215317732
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYO6,Unconventional myosin-VI,15987,64,1.11 [0.62-1.99],0.7264317877552803
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYO9B,Unconventional myosin-IXb,18124,68,1.18 [0.87-1.59],0.2817543329446689
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYOC,Myocilin,18432,70,0.74 [0.46-1.18],0.1995292163398575
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYOM1,Myomesin-1,15523,61,0.62 [0.32-1.23],0.1715252625904685
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYOM2,Myomesin-2,15485,61,0.74 [0.44-1.23],0.2427532570681802
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYOM3,Myomesin-3,15659,64,0.88 [0.68-1.13],0.310540755776003
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MZB1,Marginal zone B- and B1-cell-specific protein,18453,70,0.58 [0.38-0.89],0.0120426504942415
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MZT1,Mitotic-spindle organizing protein 1,18014,68,1.09 [0.73-1.62],0.6878839056054653
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAA10,N-alpha-acetyltransferase 10,15485,61,1.01 [0.62-1.65],0.965751645368438
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAA80,N-alpha-acetyltransferase 80,15599,60,1.00 [0.82-1.23],0.9841706511028272
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAAA,N-acylethanolamine-hydrolyzing acid amidase,18204,71,1.15 [0.82-1.62],0.410883806813651
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NACC1,Nucleus accumbens-associated protein 1,15951,63,1.86 [1.41-2.45],1.1136008490326031e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NADK,NAD kinase,18432,70,1.02 [0.70-1.48],0.9102134761131904
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAGA,Alpha-N-acetylgalactosaminidase,15501,61,0.77 [0.45-1.30],0.3228921736741456
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAGK,N-acetyl-D-glucosamine kinase,15532,59,2.23 [1.54-3.25],2.4216156878499303e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,15659,64,5.70 [2.28-14.23],0.0001918989187776
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAMPT,Nicotinamide phosphoribosyltransferase,18014,68,1.04 [0.70-1.54],0.8351359517704867
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAP1L4,Nucleosome assembly protein 1-like 4,15918,64,2.08 [1.11-3.89],0.0217592774409571
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAPRT,Nicotinate phosphoribosyltransferase,15980,64,1.35 [0.70-2.62],0.3689621921106527
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NARS1,"Asparagine--tRNA ligase, cytoplasmic",15987,64,1.57 [0.93-2.64],0.0931280980857722
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NBL1,Neuroblastoma suppressor of tumorigenicity 1,18477,72,1.44 [0.67-3.11],0.3478068867121257
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NBN,Nibrin,18124,68,2.11 [1.85-2.42],1.065312252483144e-27
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NCAM1,Neural cell adhesion molecule 1,18520,69,1.40 [0.74-2.63],0.3023524953344849
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NCAM2,Neural cell adhesion molecule 2,18432,70,1.16 [0.53-2.52],0.7075376906710645
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NCAN,Neurocan core protein,18597,71,1.24 [0.71-2.16],0.4536771548800609
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NCF2,Neutrophil cytosol factor 2,18388,71,1.07 [0.84-1.35],0.581153197369318
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NCK2,Cytoplasmic protein NCK2,18492,70,0.95 [0.78-1.16],0.6170208457625954
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NCLN,Nicalin,18124,68,0.80 [0.48-1.36],0.4172477806388556
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NCR1,Natural cytotoxicity triggering receptor 1,18402,71,0.93 [0.53-1.64],0.8134432105794329
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,15956,64,1.67 [0.87-3.20],0.1226002534132521
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NCS1,Neuronal calcium sensor 1,18606,70,1.06 [0.50-2.24],0.8796809817342015
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NDRG1,Protein NDRG1,18039,70,1.13 [0.84-1.50],0.4208838073943411
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,15951,63,0.67 [0.40-1.15],0.146059034299049
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,15499,61,1.35 [0.70-2.62],0.3767239395982611
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,15956,64,0.93 [0.71-1.22],0.6184073306856275
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",18014,68,0.87 [0.63-1.19],0.3716388214188831
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NEB,Nebulin,15485,61,0.55 [0.25-1.20],0.1344573835692211
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NECAP2,Adaptin ear-binding coat-associated protein 2,15485,61,0.85 [0.57-1.28],0.4404656971247611
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NECTIN1,Nectin-1,15528,61,1.61 [0.96-2.69],0.0695388582114013
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,18412,70,1.95 [1.04-3.66],0.0378793056745384
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NECTIN4,Nectin-4,18477,72,1.32 [0.70-2.46],0.3911455647038454
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,15528,61,1.47 [0.85-2.56],0.1659538963841962
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NEDD9,Enhancer of filamentation 1,15528,61,1.55 [0.91-2.61],0.1036434318762119
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NEFL,Neurofilament light polypeptide,17987,70,1.37 [0.90-2.07],0.144157222573396
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NEK7,Serine/threonine-protein kinase Nek7,15731,62,0.80 [0.54-1.18],0.2564045918601363
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NELL1,Protein kinase C-binding protein NELL1,18477,72,0.54 [0.33-0.88],0.0127292039451033
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NELL2,Protein kinase C-binding protein NELL2,18492,70,1.43 [0.71-2.87],0.3172735311348862
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NENF,Neudesin,15951,63,1.04 [0.85-1.27],0.7229357719392794
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NEO1,Neogenin,15987,64,1.79 [0.82-3.88],0.1425848029813163
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NEXN,Nexilin,16029,64,0.93 [0.66-1.33],0.6971743470772694
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFASC,Neurofascin,18653,71,0.88 [0.42-1.85],0.7396093577716674
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFAT5,Nuclear factor of activated T-cells 5,15528,61,1.08 [0.82-1.44],0.5822044563852913
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",18427,71,1.42 [1.16-1.75],0.0007078855639139
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",18124,68,1.09 [0.77-1.53],0.6359372460517828
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFE2,Transcription factor NF-E2 45 kDa subunit,15560,59,1.08 [0.77-1.52],0.6447507294519592
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFIC,Nuclear factor 1 C-type,15987,64,1.12 [0.72-1.75],0.6157502649764184
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFKB1,Nuclear factor NF-kappa-B p105 subunit,15485,61,1.94 [1.42-2.65],3.577243191586477e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFKB2,Nuclear factor NF-kappa-B p100 subunit,15731,62,1.07 [0.72-1.60],0.7343369985142497
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,18014,68,3.78 [2.89-4.94],1.625303661990104e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",15956,64,1.09 [0.86-1.37],0.4784365982037791
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFX1,Transcriptional repressor NF-X1,15485,61,1.43 [1.05-1.95],0.0244762664105986
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFYA,Nuclear transcription factor Y subunit alpha,15485,61,2.48 [1.98-3.12],4.2639313183913166e-15
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NGF,Beta-nerve growth factor,18284,71,0.94 [0.17-5.12],0.941902982963764
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NGFR,Tumor necrosis factor receptor superfamily member 16,16007,62,0.96 [0.41-2.24],0.9294853861320248
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NGRN,Neugrin,15980,64,2.47 [1.29-4.73],0.0061904741860127
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NHLRC3,NHL repeat-containing protein 3,15291,61,2.99 [1.34-6.67],0.0073748438553658
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NID1,Nidogen-1,18465,68,0.79 [0.43-1.43],0.4308518835408392
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NID2,Nidogen-2,18432,70,0.92 [0.69-1.22],0.5605533256991664
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NINJ1,Ninjurin-1,18014,68,0.98 [0.65-1.48],0.9291376305756638
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NIT1,Deaminated glutathione amidase,15560,59,1.56 [0.85-2.85],0.1530045328404332
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NIT2,Omega-amidase NIT2,15947,62,1.13 [0.81-1.58],0.4764003298523249
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NLGN1,Neuroligin-1,15599,60,0.81 [0.51-1.28],0.3660858150219883
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NLGN2,Neuroligin-2,15523,61,0.47 [0.22-1.00],0.049219193455625
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NME1,Nucleoside diphosphate kinase A,15528,61,1.20 [0.39-3.74],0.7499043684473137
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NME3,Nucleoside diphosphate kinase 3,18432,70,0.71 [0.27-1.85],0.487228143958369
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NMI,N-myc-interactor,15885,63,1.22 [0.89-1.68],0.2156554033675201
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,18284,71,1.83 [1.63-2.06],9.759613312485294e-24
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NMRK2,Nicotinamide riboside kinase 2,15454,61,1.10 [0.61-1.99],0.7532433794738574
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,15987,64,0.98 [0.68-1.41],0.8988626295625206
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOMO1,Nodal modulator 1,18432,70,1.92 [0.79-4.69],0.1498101197223538
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOP56,Nucleolar protein 56,15485,61,0.79 [0.59-1.07],0.1298804475296658
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOS1,"Nitric oxide synthase, brain",18039,70,0.89 [0.61-1.30],0.5380393204333758
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOS2,"Nitric oxide synthase, inducible",15485,61,0.67 [0.34-1.33],0.2575618910996373
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",18039,70,1.61 [1.23-2.10],0.0005350572433068
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,18663,72,4.13 [2.09-8.17],4.470322849068502e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOTCH2,Neurogenic locus notch homolog protein 2,16018,64,0.91 [0.30-2.75],0.8731780149888483
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOTCH3,Neurogenic locus notch homolog protein 3,18663,72,1.02 [0.55-1.92],0.9423144673680088
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,15754,61,2.73 [1.59-4.71],0.0002927328425118
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPDC1,Neural proliferation differentiation and control protein 1,18432,70,1.94 [1.12-3.35],0.017684740909046
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPHS1,Nephrin,15528,61,0.45 [0.21-0.97],0.0426307112194065
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPHS2,Podocin,15528,61,0.97 [0.76-1.25],0.8339044982442747
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPL,N-acetylneuraminate lyase,16007,62,0.97 [0.57-1.65],0.9154808809801334
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPPB,Natriuretic peptides B,18109,70,1.15 [0.98-1.34],0.0825746991247833
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPPC,C-type natriuretic peptide,18427,71,0.75 [0.49-1.16],0.1947935959425591
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPR1,Atrial natriuretic peptide receptor 1,15485,61,0.76 [0.38-1.50],0.429682180210968
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPTN,Neuroplastin,18014,68,0.61 [0.40-0.93],0.0223404452339237
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPTX1,Neuronal pentraxin-1,18432,70,0.68 [0.40-1.16],0.1536646571404631
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPTX2,Neuronal pentraxin-2,16018,64,0.39 [0.20-0.76],0.0060867533525746
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPTXR,Neuronal pentraxin receptor,18432,70,0.74 [0.39-1.42],0.3693188224042565
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPY,Pro-neuropeptide Y,18606,70,0.82 [0.60-1.13],0.2299480813280485
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,18432,70,4.38 [2.29-8.37],8.050615330116158e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NRGN,Neurogranin,16029,64,0.93 [0.72-1.22],0.6133578187041646
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NRN1,Neuritin,15987,64,0.45 [0.18-1.11],0.08325779315428
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NRP1,Neuropilin-1,18553,69,1.53 [0.70-3.33],0.2823968268366569
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,18432,70,2.20 [1.15-4.21],0.0171799780107459
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NRTN,Neurturin,18124,68,0.73 [0.46-1.16],0.1849262400065613
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NRXN3,Neurexin-3,15599,60,0.78 [0.35-1.74],0.5479373202081438
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NSFL1C,NSFL1 cofactor p47,18597,71,1.24 [0.90-1.71],0.1845649584334979
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",16007,62,1.29 [0.93-1.80],0.1323336742775841
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NT5C1A,Cytosolic 5'-nucleotidase 1A,15980,64,1.99 [1.28-3.10],0.0023309873576794
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NT5C3A,Cytosolic 5'-nucleotidase 3A,18389,70,1.07 [0.84-1.38],0.5845875521814162
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NT5E,5'-nucleotidase,18477,72,1.02 [0.69-1.50],0.9383485760422108
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NTF3,Neurotrophin-3,18427,71,0.84 [0.46-1.55],0.5778010915878957
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NTF4,Neurotrophin-4,18014,68,0.59 [0.27-1.26],0.1697176903522071
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NTRK2,BDNF/NT-3 growth factors receptor,18432,70,0.65 [0.28-1.52],0.3230326984256016
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NTRK3,NT-3 growth factor receptor,18597,71,1.03 [0.39-2.74],0.9576676932492232
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NTproBNP,N-terminal prohormone of brain natriuretic peptide,18432,70,1.19 [1.00-1.41],0.0490714866476678
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUB1,NEDD8 ultimate buster 1,18427,71,1.16 [0.91-1.48],0.2221361358417591
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,15951,63,1.11 [0.89-1.37],0.3515003608039131
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUCB2,Nucleobindin-2,18578,70,0.75 [0.42-1.35],0.3318525939307306
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUDC,Nuclear migration protein nudC,18653,71,1.17 [0.84-1.63],0.3577803111903542
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,15560,59,1.61 [0.80-3.26],0.1832496743419934
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,15485,61,0.89 [0.52-1.53],0.6792127948804257
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUDT16,U8 snoRNA-decapping enzyme,15931,64,1.04 [0.79-1.37],0.7557564695638163
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],18344,71,0.89 [0.61-1.30],0.5390723755102217
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUDT5,ADP-sugar pyrophosphatase,18432,70,1.42 [0.95-2.12],0.0901914695898968
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUMB,Protein numb homolog,15528,61,1.03 [0.77-1.39],0.8203773942929453
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NUP50,Nuclear pore complex protein Nup50,15485,61,0.89 [0.39-2.02],0.7827347161780999
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NXPE4,NXPE family member 4,15485,61,0.64 [0.26-1.57],0.3321174473956927
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NXPH1,Neurexophilin-1,18039,70,0.72 [0.41-1.29],0.2698430053118166
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NXPH3,Neurexophilin-3,15528,61,0.51 [0.23-1.12],0.0957123778499211
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OBP2B,Odorant-binding protein 2b,18226,71,0.77 [0.54-1.09],0.1417010576875754
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,15987,64,1.99 [1.32-3.00],0.0010912372946207
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ODAM,Odontogenic ameloblast-associated protein,18009,70,1.10 [0.76-1.59],0.6244901897281403
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OFD1,Oral-facial-digital syndrome 1 protein,15731,62,0.93 [0.62-1.40],0.7230116165780097
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OGA,Protein O-GlcNAcase,15956,64,1.65 [1.19-2.29],0.0027498336065817
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,18344,71,4.10 [2.50-6.72],2.42909966603854e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OGN,Mimecan,18432,70,1.08 [0.66-1.78],0.7564559927619392
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,15731,62,1.11 [0.78-1.57],0.561348678872361
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OLFM4,Olfactomedin-4,15070,62,0.87 [0.71-1.05],0.1444638362566575
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OLR1,Oxidized low-density lipoprotein receptor 1,18250,70,0.98 [0.69-1.40],0.9136103016360042
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OMD,Osteomodulin,18492,70,0.79 [0.48-1.32],0.3758129547349552
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OMG,Oligodendrocyte-myelin glycoprotein,18344,71,0.89 [0.66-1.21],0.4695641426473774
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OMP,Olfactory marker protein,15523,61,0.77 [0.43-1.38],0.378639067291576
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OPHN1,Oligophrenin-1,15980,64,0.97 [0.78-1.22],0.821018345486112
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OPLAH,5-oxoprolinase,15560,59,1.44 [1.03-2.03],0.0354274191245873
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OPTC,Opticin,18344,71,0.62 [0.37-1.05],0.0732384615672431
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,15971,63,3.66 [1.27-10.56],0.0162292001871702
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OSBPL2,Oxysterol-binding protein-related protein 2,15980,64,0.95 [0.49-1.85],0.8876556716750622
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OSCAR,Osteoclast-associated immunoglobulin-like receptor,18432,70,1.07 [0.58-1.98],0.824580988729471
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OSM,Oncostatin-M,18334,71,1.28 [0.95-1.73],0.1098212913266775
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OSMR,Oncostatin-M-specific receptor subunit beta,18553,69,1.67 [0.56-4.94],0.35511042272849
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OSTN,Osteocrin,15599,60,0.80 [0.40-1.60],0.532918983709267
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OTOA,Otoancorin,15523,61,0.44 [0.22-0.88],0.0204838823604798
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OTUD6B,Deubiquitinase OTUD6B,15956,64,1.15 [0.77-1.73],0.4937174743302805
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OTUD7B,OTU domain-containing protein 7B,15987,64,1.05 [0.72-1.54],0.7892529990689874
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",15560,59,1.05 [0.74-1.50],0.7685692886838497
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OXT,Oxytocin-neurophysin 1,18597,71,0.93 [0.80-1.07],0.3154274383970321
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",P4HB,Protein disulfide-isomerase,18334,71,0.81 [0.47-1.39],0.4419584908829445
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PACS2,Phosphofurin acidic cluster sorting protein 2,15485,61,0.97 [0.65-1.46],0.894023742728902
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PADI2,Protein-arginine deiminase type-2,18124,68,0.72 [0.44-1.16],0.1732498322506922
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PADI4,Protein-arginine deiminase type-4,18009,70,0.94 [0.70-1.27],0.6943553131002562
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAEP,Glycodelin,18284,71,1.12 [0.93-1.36],0.2240709122535574
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,15987,64,1.06 [0.88-1.28],0.5228433231124093
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",15731,62,1.08 [0.67-1.74],0.7462278192414129
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,18109,70,1.33 [0.94-1.88],0.1117639762993142
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAGR1,PAXIP1-associated glutamate-rich protein 1,15560,59,1.46 [0.89-2.41],0.1353239526223439
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,15427,61,1.62 [1.13-2.33],0.0085652581254583
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAK4,Serine/threonine-protein kinase PAK 4,18039,70,0.80 [0.55-1.16],0.2364323486569627
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PALLD,Palladin,15528,61,0.60 [0.27-1.32],0.2037797953163219
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PALM,Paralemmin-1,15859,64,1.81 [0.95-3.45],0.0690973826989097
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PALM2,Paralemmin-2,15980,64,1.69 [0.98-2.92],0.0572991361242594
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PALM3,Paralemmin-3,15485,61,1.19 [0.93-1.52],0.1742855649289857
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAM,Peptidyl-glycine alpha-amidating monooxygenase,18581,71,1.18 [0.55-2.53],0.6692939854586806
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAMR1,Inactive serine protease PAMR1,18432,70,0.34 [0.16-0.75],0.0070781394453095
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAPPA,Pappalysin-1,18124,68,0.85 [0.54-1.35],0.4949908322964156
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PARD3,Partitioning defective 3 homolog,15731,62,0.91 [0.65-1.29],0.601056284048476
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PARK7,Parkinson disease protein 7,18432,70,1.20 [0.80-1.81],0.3782015533178052
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,18427,71,1.96 [1.76-2.19],1.189386140401973e-33
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAXX,Protein PAXX,15659,64,1.44 [0.89-2.35],0.1396246744627053
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PBK,Lymphokine-activated killer T-cell-originated protein kinase,15454,61,1.33 [0.61-2.92],0.4700284725571491
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PBLD,Phenazine biosynthesis-like domain-containing protein,18039,70,0.95 [0.62-1.45],0.8126802496680989
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,15956,64,2.13 [1.27-3.56],0.0041959217331943
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCARE,Photoreceptor cilium actin regulator,15523,61,0.79 [0.53-1.16],0.2228715959973788
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,15624,64,1.28 [0.80-2.07],0.3038633021705313
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCBP2,Poly(rC)-binding protein 2,15987,64,1.24 [0.90-1.72],0.190700881120555
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCDH1,Protocadherin-1,18588,71,0.86 [0.30-2.43],0.7731358291678214
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCDH12,Protocadherin-12,15987,64,1.42 [0.56-3.60],0.4536953084594419
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,18432,70,1.59 [0.92-2.77],0.0994708194115635
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCDH7,Protocadherin-7,15956,64,0.74 [0.34-1.59],0.443626676036123
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCDH9,Protocadherin-9,15956,64,9.46 [5.42-16.49],2.345317274272668e-15
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCDHB15,Protocadherin beta-15,15951,63,1.22 [0.69-2.17],0.4931561786697482
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCNA,Proliferating cell nuclear antigen,15454,61,0.79 [0.49-1.27],0.3335064388010054
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCSK7,Proprotein convertase subtilisin/kexin type 7,15951,63,1.55 [1.13-2.11],0.0059749312994202
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCSK9,Proprotein convertase subtilisin/kexin type 9,18663,72,1.44 [0.86-2.40],0.1628095686663204
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCYT2,Ethanolamine-phosphate cytidylyltransferase,15956,64,1.05 [0.76-1.45],0.7524519241627539
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDAP1,28 kDa heat- and acid-stable phosphoprotein,16007,62,1.00 [0.78-1.28],0.9861124628049952
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,18574,70,6.40 [4.90-8.37],5.945096613405115e-42
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDCD1LG2,Programmed cell death 1 ligand 2,18344,71,1.58 [0.83-2.99],0.1639338117298501
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDCD5,Programmed cell death protein 5,18597,71,1.29 [0.91-1.83],0.1563535203605841
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDCD6,Programmed cell death protein 6,18432,70,1.07 [0.78-1.48],0.6569283741530614
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDCL2,Phosducin-like protein 2,15454,61,1.49 [1.10-2.02],0.0105785422925989
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",15454,61,0.71 [0.39-1.30],0.2692348462710821
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",15485,61,1.05 [0.71-1.55],0.8179383026593945
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",15659,64,0.99 [0.79-1.25],0.9477263522792088
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDGFA,Platelet-derived growth factor subunit A,18663,72,0.70 [0.53-0.93],0.0129012513927486
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDGFB,Platelet-derived growth factor subunit B,18492,70,0.77 [0.60-0.97],0.0282729840085122
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDGFC,Platelet-derived growth factor C,18014,68,1.01 [0.46-2.23],0.9854241340195368
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDGFRA,Platelet-derived growth factor receptor alpha,18432,70,1.39 [0.66-2.92],0.3798402833667796
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDGFRB,Platelet-derived growth factor receptor beta,18663,72,1.52 [0.82-2.81],0.1795822663438576
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDIA2,Protein disulfide-isomerase A2,15454,61,0.94 [0.50-1.75],0.8437131754855225
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDIA3,Protein disulfide-isomerase A3,15659,64,0.57 [0.20-1.59],0.2823303575193044
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDIA4,Protein disulfide-isomerase A4,16018,64,1.02 [0.69-1.51],0.920205856677312
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDIA5,Protein disulfide-isomerase A5,15454,61,0.89 [0.58-1.38],0.6099536857209463
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDLIM5,PDZ and LIM domain protein 5,15987,64,1.14 [0.93-1.41],0.2052114221905844
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDLIM7,PDZ and LIM domain protein 7,18492,70,0.99 [0.83-1.17],0.885331599207174
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",18014,68,0.96 [0.61-1.50],0.8588564468372157
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDRG1,p53 and DNA damage-regulated protein 1,15599,60,1.08 [0.69-1.69],0.7447504978446944
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,15454,61,0.75 [0.39-1.45],0.3851826236558205
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDZD2,PDZ domain-containing protein 2,15485,61,0.97 [0.63-1.50],0.9038445216248716
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,15528,61,1.28 [0.77-2.11],0.3432086924986226
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PEAR1,Platelet endothelial aggregation receptor 1,18663,72,1.52 [0.62-3.77],0.3612473701950713
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PEBP1,Phosphatidylethanolamine-binding protein 1,18432,70,1.51 [1.07-2.13],0.0183170088274523
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PECAM1,Platelet endothelial cell adhesion molecule,18432,70,1.06 [0.53-2.12],0.8709610356690033
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PECR,Peroxisomal trans-2-enoyl-CoA reductase,15560,59,1.08 [0.44-2.64],0.8734989487444629
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PENK,Proenkephalin-A,15659,64,0.78 [0.35-1.76],0.5536866524500184
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PEPD,Xaa-Pro dipeptidase,16029,64,1.16 [0.47-2.91],0.7453957284880557
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PER3,Period circadian protein homolog 3,15528,61,0.97 [0.79-1.18],0.7364391142590724
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PF4,Platelet factor 4,15908,62,0.85 [0.66-1.09],0.1964535397518578
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PFDN2,Prefoldin subunit 2,18039,70,1.10 [0.75-1.62],0.6121247755784869
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PFDN4,Prefoldin subunit 4,15454,61,0.85 [0.51-1.42],0.5311166337770654
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PFDN6,Prefoldin subunit 6,15599,60,1.06 [0.73-1.51],0.7713397227471248
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",18318,71,1.56 [1.22-1.99],0.0003580754710619
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PGA4,Pepsin A-4,16029,64,0.82 [0.62-1.09],0.1756091775156636
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",16007,62,1.02 [0.64-1.62],0.9271407196963388
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,18653,71,1.96 [0.98-3.94],0.0585381690842252
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PGLYRP1,Peptidoglycan recognition protein 1,18572,71,0.85 [0.51-1.41],0.5243413808024899
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,15835,62,0.58 [0.26-1.30],0.1882887354238859
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PGLYRP4,Peptidoglycan recognition protein 4,15485,61,0.36 [0.19-0.69],0.002024447576907
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PGM2,Phosphoglucomutase-2,15599,60,0.75 [0.44-1.28],0.2966766621135916
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PGR,Progesterone receptor,15528,61,0.92 [0.69-1.21],0.5504186285450732
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PHACTR2,Phosphatase and actin regulator 2,15987,64,1.02 [0.82-1.25],0.8883848208533317
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PHLDB1,Pleckstrin homology-like domain family B member 1,15956,64,1.39 [0.89-2.17],0.151121022957388
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PHLDB2,Pleckstrin homology-like domain family B member 2,15454,61,1.15 [0.92-1.43],0.2264972837704913
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,18284,71,0.66 [0.34-1.28],0.2195599690564682
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,15659,64,1.55 [0.88-2.74],0.132018654678098
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PI16,Peptidase inhibitor 16,16029,64,0.60 [0.22-1.60],0.3072899026904714
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PI3,Elafin,18194,70,1.21 [0.84-1.73],0.2990279536056451
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",15987,64,1.50 [1.14-1.97],0.0035578269628685
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PIGR,Polymeric immunoglobulin receptor,18204,68,0.85 [0.47-1.55],0.5947034291600499
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,18427,71,2.94 [2.35-3.68],6.160911165748098e-21
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,18432,70,3.82 [2.26-6.43],4.919438372508837e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,15528,61,1.29 [0.89-1.88],0.1808241559868289
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PILRA,Paired immunoglobulin-like type 2 receptor alpha,18432,70,1.39 [0.83-2.30],0.2093114268289928
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PILRB,Paired immunoglobulin-like type 2 receptor beta,18432,70,1.22 [0.83-1.80],0.3022579522360106
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,15659,64,0.72 [0.53-1.00],0.0486958728655936
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PITHD1,PITH domain-containing protein 1,15427,61,1.03 [0.76-1.42],0.8300119139940305
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PKD1,Polycystin-1,16007,62,0.88 [0.35-2.20],0.7886782133252657
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PKD2,Polycystin-2,15485,61,1.30 [0.90-1.87],0.1693183748433828
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PKLR,Pyruvate kinase PKLR,18437,70,1.40 [1.04-1.89],0.0280970700746518
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PKN3,Serine/threonine-protein kinase N3,15731,62,0.86 [0.61-1.22],0.4018021949639799
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLA2G10,Group 10 secretory phospholipase A2,18284,71,0.91 [0.64-1.31],0.6253217359842305
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLA2G15,Phospholipase A2 group XV,18477,72,2.60 [1.29-5.24],0.0076351742817743
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLA2G1B,Phospholipase A2,18637,71,0.73 [0.46-1.16],0.185961141845092
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLA2G2A,"Phospholipase A2, membrane associated",18417,70,0.89 [0.58-1.38],0.6149483469623294
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLA2G4A,Cytosolic phospholipase A2,18492,70,0.95 [0.75-1.21],0.7064705041288393
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLA2G7,Platelet-activating factor acetylhydrolase,18432,70,1.08 [0.56-2.06],0.8217261058863135
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLAT,Tissue-type plasminogen activator,18603,72,1.16 [0.77-1.75],0.4668527704503104
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLAU,Urokinase-type plasminogen activator,18432,70,1.08 [0.53-2.20],0.8336750606080391
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,18288,69,1.85 [0.89-3.84],0.0983415230693083
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLB1,"Phospholipase B1, membrane-associated",15980,64,0.98 [0.66-1.47],0.9240904580865787
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",15528,61,0.79 [0.40-1.53],0.4761727734123233
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",15980,64,1.03 [0.81-1.32],0.804475653394448
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLEKHO1,Pleckstrin homology domain-containing family O member 1,15980,64,1.51 [1.09-2.09],0.0120355728764736
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLG,Plasminogen,15637,61,0.95 [0.30-3.01],0.9266638088569964
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLIN1,Perilipin-1,18039,70,0.97 [0.52-1.81],0.9217548965865014
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLIN3,Perilipin-3,18432,70,0.94 [0.57-1.55],0.8080422747143943
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLPBP,Pyridoxal phosphate homeostasis protein,18432,70,1.15 [0.84-1.57],0.3802027395328493
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLSCR3,Phospholipid scramblase 3,15952,64,1.13 [0.75-1.72],0.5595906042073759
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLTP,Phospholipid transfer protein,18604,71,1.13 [0.64-1.99],0.6663625440980323
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLXDC1,Plexin domain-containing protein 1,18014,68,0.66 [0.31-1.43],0.2947621568148325
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLXDC2,Plexin domain-containing protein 2,15980,64,0.78 [0.32-1.94],0.5985273603013164
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLXNA4,Plexin-A4,18427,71,0.92 [0.71-1.19],0.5283977560597755
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,18580,72,2.40 [1.10-5.24],0.0281142355295832
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLXNB3,Plexin-B3,18370,69,0.62 [0.40-0.97],0.0358405894132841
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,18356,70,0.93 [0.84-1.04],0.1928721271612957
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PMCH,Pro-MCH,15485,61,0.73 [0.46-1.15],0.1755283829974178
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PMM2,Phosphomannomutase 2,15485,61,0.75 [0.49-1.15],0.1866812212941561
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PMS1,PMS1 protein homolog 1,15599,60,2.06 [1.66-2.56],6.621090968239888e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PMVK,Phosphomevalonate kinase,18011,70,1.03 [0.84-1.25],0.7794216455221843
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PNLIP,Pancreatic triacylglycerol lipase,16029,64,0.88 [0.60-1.27],0.4800043305183908
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PNLIPRP1,Inactive pancreatic lipase-related protein 1,15980,64,1.09 [0.81-1.45],0.5780704780829737
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PNLIPRP2,Pancreatic lipase-related protein 2,18402,70,1.02 [0.95-1.10],0.5397695273156402
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PNMA1,Paraneoplastic antigen Ma1,15560,59,0.91 [0.58-1.43],0.6765362957799296
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PNMA2,Paraneoplastic antigen Ma2,15523,61,2.10 [1.61-2.74],4.44977138683501e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",18124,68,0.78 [0.61-0.99],0.0430172058426421
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PODXL,Podocalyxin,18344,71,0.66 [0.17-2.60],0.5507436198192162
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PODXL2,Podocalyxin-like protein 2,18477,72,1.41 [0.68-2.94],0.3551959973915323
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,15528,61,1.85 [1.35-2.53],0.0001243149322708
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",POLR2A,DNA-directed RNA polymerase II subunit RPB1,15528,61,1.22 [0.55-2.71],0.6250122013198789
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",18344,71,2.83 [2.29-3.49],3.189996113210883e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",POMC,Pro-opiomelanocortin,15560,59,1.00 [0.70-1.42],0.998503369401078
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PON1,Serum paraoxonase/arylesterase 1,16029,64,0.81 [0.35-1.89],0.6219591349122093
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PON2,Serum paraoxonase/arylesterase 2,18109,70,1.04 [0.57-1.90],0.8871887642263107
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PON3,Serum paraoxonase/lactonase 3,18492,70,2.29 [0.99-5.31],0.0538646827872643
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",POSTN,Periostin,16018,64,0.40 [0.21-0.77],0.0056492471653326
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPBP,Platelet basic protein,15907,62,0.70 [0.53-0.93],0.0132814712453593
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPCDC,Phosphopantothenoylcysteine decarboxylase,18597,71,1.28 [0.83-1.99],0.2687987131953251
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPIB,Peptidyl-prolyl cis-trans isomerase B,18444,70,0.94 [0.76-1.17],0.5944189739992878
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPIE,Peptidyl-prolyl cis-trans isomerase E,15731,62,1.24 [0.91-1.69],0.1817737854342404
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",16018,64,1.03 [0.72-1.49],0.8638217201177065
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPL,Periplakin,15528,61,1.44 [0.77-2.69],0.2582475047882916
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPM1A,Protein phosphatase 1A,18014,68,1.06 [0.55-2.05],0.8668907937779644
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPM1B,Protein phosphatase 1B,15528,61,0.63 [0.35-1.13],0.1178897298248534
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPM1F,Protein phosphatase 1F,16007,62,0.99 [0.63-1.57],0.9694047229000804
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPME1,Protein phosphatase methylesterase 1,18344,71,1.35 [0.95-1.92],0.090673522252301
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,15951,63,1.11 [0.83-1.47],0.4898988596094171
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,18477,72,1.06 [0.86-1.32],0.5814561226354867
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,15731,62,1.27 [0.97-1.65],0.0773456728185473
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,15987,64,0.85 [0.62-1.16],0.3062293761138674
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,15987,64,0.80 [0.41-1.56],0.5165192745957299
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPP1R2,Protein phosphatase inhibitor 2,18432,70,1.20 [0.93-1.55],0.1705064175834152
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPP1R9B,Neurabin-2,18653,71,1.23 [0.99-1.54],0.0583555840464794
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,15956,64,1.08 [0.88-1.31],0.4590977514656154
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPP3R1,Calcineurin subunit B type 1,18284,71,0.81 [0.48-1.37],0.436487473164832
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPT1,Palmitoyl-protein thioesterase 1,15599,60,1.01 [0.73-1.40],0.9462523256510048
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPY,Pancreatic prohormone,18368,72,0.90 [0.73-1.11],0.3160733026961508
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,18014,68,1.93 [1.67-2.23],1.5968983793860793e-18
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRAME,Melanoma antigen preferentially expressed in tumors,15454,61,1.55 [0.67-3.57],0.3068943334641844
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRAP1,Proline-rich acidic protein 1,16018,64,1.32 [0.70-2.48],0.394980005396518
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRC1,Protein regulator of cytokinesis 1,15951,63,0.65 [0.30-1.41],0.2722535312749319
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRCP,Lysosomal Pro-X carboxypeptidase,18545,71,1.46 [0.77-2.77],0.2494884125253388
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRDX1,Peroxiredoxin-1,17910,70,1.06 [0.84-1.34],0.6026320238651041
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRDX2,Peroxiredoxin-2,15769,64,1.25 [0.87-1.81],0.2304081499012459
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",18124,68,1.09 [0.81-1.47],0.5481696844625119
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRDX5,"Peroxiredoxin-5, mitochondrial",18653,71,1.01 [0.73-1.38],0.9703445360967524
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRDX6,Peroxiredoxin-6,18606,70,1.02 [0.72-1.43],0.916951208269178
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PREB,Prolactin regulatory element-binding protein,18124,68,1.43 [0.72-2.87],0.3090478480246897
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRELP,Prolargin,18402,70,1.02 [0.41-2.56],0.9671147624272856
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRG2,Bone marrow proteoglycan,16018,64,0.98 [0.61-1.57],0.9439314125756147
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRG3,Proteoglycan 3,16018,64,0.51 [0.32-0.81],0.0043561457939226
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,18124,68,1.27 [0.87-1.84],0.2102943130824479
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,15599,60,0.70 [0.30-1.65],0.4156337725826993
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,18432,70,0.87 [0.68-1.13],0.2998722443245439
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,15945,63,1.36 [1.01-1.85],0.0457707183024573
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRKCQ,Protein kinase C theta type,18124,68,0.65 [0.36-1.17],0.1495523081710746
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRKD2,Serine/threonine-protein kinase D2,15485,61,1.36 [0.89-2.09],0.1591690430423493
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRKG1,cGMP-dependent protein kinase 1,15659,64,1.02 [0.84-1.23],0.8474052735451689
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,18014,68,2.21 [1.71-2.86],1.4998005397628623e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRL,Prolactin,18597,71,1.02 [0.77-1.35],0.8737260643079381
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRND,Prion-like protein doppel,15980,64,1.17 [0.72-1.91],0.5166167149058891
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PROC,Vitamin K-dependent protein C,18498,69,0.81 [0.35-1.86],0.6185471973626251
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PROCR,Endothelial protein C receptor,15485,61,1.19 [0.63-2.25],0.5895187363371832
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PROK1,Prokineticin-1,18427,71,0.52 [0.33-0.81],0.0039030657369553
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PROS1,Vitamin K-dependent protein S,16032,63,0.41 [0.17-1.00],0.0501580067670931
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRR4,Proline-rich protein 4,15549,64,1.03 [0.73-1.45],0.8621099666407426
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRR5,Proline-rich protein 5,15528,61,0.90 [0.51-1.58],0.7026033435980396
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,15560,59,3.63 [2.15-6.13],1.4672810485890638e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRSS2,Trypsin-2,18520,69,1.02 [0.70-1.48],0.9176721678944982
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRSS22,Brain-specific serine protease 4,15528,61,0.56 [0.25-1.28],0.1715494685891542
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRSS27,Serine protease 27,18372,70,0.97 [0.57-1.65],0.917484635754483
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRSS53,Serine protease 53,15980,64,1.23 [0.67-2.24],0.5031643637876659
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRSS8,Prostasin,18349,69,1.74 [1.06-2.86],0.0273574056649788
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,18039,70,0.93 [0.77-1.12],0.4297596406950718
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRTG,Protogenin,18606,70,0.90 [0.38-2.11],0.8078007991167355
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRTN3,Myeloblastin,17978,70,0.84 [0.53-1.34],0.4632595182408774
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRUNE2,Protein prune homolog 2,15731,62,0.96 [0.41-2.24],0.9208252855335536
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSAP,Prosaposin,15878,62,1.36 [0.58-3.21],0.4809807498996912
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSAPL1,Proactivator polypeptide-like 1,15956,64,1.26 [0.79-2.01],0.3388155817679326
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSCA,Prostate stem cell antigen,15956,64,1.05 [0.95-1.16],0.3228203060990855
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSG1,Pregnancy-specific beta-1-glycoprotein 1,18284,71,1.00 [0.83-1.21],0.9927351162534794
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSIP1,PC4 and SFRS1-interacting protein,18427,71,1.99 [1.73-2.29],1.7211620978069631e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSMA1,Proteasome subunit alpha type-1,18014,68,0.95 [0.59-1.55],0.8453859625034867
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSMC3,26S proteasome regulatory subunit 6A,15454,61,1.81 [0.97-3.39],0.0623627158496283
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSMD1,26S proteasome non-ATPase regulatory subunit 1,15987,64,1.22 [0.79-1.90],0.3756352256537095
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSMD5,26S proteasome non-ATPase regulatory subunit 5,15599,60,0.73 [0.41-1.30],0.281549726816737
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSMD9,26S proteasome non-ATPase regulatory subunit 9,18344,71,1.27 [0.89-1.80],0.1830106642181031
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSME1,Proteasome activator complex subunit 1,18253,70,1.55 [0.89-2.71],0.123371722317302
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSME2,Proteasome activator complex subunit 2,18209,71,1.62 [0.92-2.85],0.0953204314400267
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSMG3,Proteasome assembly chaperone 3,18427,71,1.58 [1.07-2.32],0.0218634815125598
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSMG4,Proteasome assembly chaperone 4,15528,61,1.50 [1.06-2.12],0.0214866565906264
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSPN,Persephin,18427,71,0.70 [0.56-0.89],0.0027136461636685
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSRC1,Proline/serine-rich coiled-coil protein 1,18014,68,0.81 [0.55-1.20],0.3012818952199593
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,15104,63,0.99 [0.79-1.24],0.938361160993762
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",18039,70,0.81 [0.40-1.64],0.5511767574920952
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,18323,68,2.93 [1.80-4.78],1.554216787999686e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTGES2,Prostaglandin E synthase 2,15415,61,0.94 [0.59-1.48],0.7776551616580322
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTGR1,Prostaglandin reductase 1,16007,62,0.77 [0.57-1.04],0.0860620798456622
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTH,Parathyroid hormone,15599,60,0.98 [0.72-1.33],0.8839358673595744
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,18427,71,1.10 [0.66-1.84],0.7216578799980483
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTK7,Inactive tyrosine-protein kinase 7,18039,70,0.55 [0.34-0.91],0.0201240865251322
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTN,Pleiotrophin,18109,70,1.16 [0.76-1.77],0.5022297248468933
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTP4A3,Protein tyrosine phosphatase type IVA 3,15528,61,1.05 [0.65-1.68],0.8493306099074898
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,18284,71,1.72 [1.37-2.16],2.8858101323642126e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,18471,70,1.08 [0.85-1.38],0.5171347347233997
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,15501,60,0.93 [0.48-1.80],0.8272483600171677
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRB,Receptor-type tyrosine-protein phosphatase beta,16007,62,0.48 [0.21-1.09],0.0799398520079538
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,16018,64,14.63 [9.58-22.33],1.8186381778330472e-35
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRF,Receptor-type tyrosine-protein phosphatase F,18663,72,1.51 [0.73-3.12],0.2630531303627633
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRH,Receptor-type tyrosine-protein phosphatase H,15956,64,1.69 [1.09-2.62],0.0187489824027457
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,15956,64,1.37 [0.50-3.77],0.5390337953329813
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRM,Receptor-type tyrosine-protein phosphatase mu,18395,71,0.79 [0.33-1.87],0.5844690442870822
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,18223,71,1.59 [0.86-2.95],0.1399080020661672
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRR,Receptor-type tyrosine-protein phosphatase R,15980,64,1.28 [0.69-2.34],0.433090626900646
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRS,Receptor-type tyrosine-protein phosphatase S,18663,72,3.52 [1.60-7.72],0.0016889536864265
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,16007,62,0.46 [0.21-1.02],0.0565394195526051
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,15659,64,0.98 [0.65-1.47],0.9142865924566146
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTS,6-pyruvoyl tetrahydrobiopterin synthase,17945,69,1.74 [1.27-2.38],0.0005733631673807
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTTG1,Securin,15731,62,1.24 [0.75-2.07],0.4073238861550466
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTX3,Pentraxin-related protein PTX3,18427,71,1.88 [1.12-3.13],0.0160255389184117
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PVALB,Parvalbumin alpha,18531,70,0.86 [0.72-1.03],0.1040505937682112
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PVR,Poliovirus receptor,18597,71,0.78 [0.43-1.39],0.3970714505781361
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PXDNL,Peroxidasin-like protein,15951,63,0.90 [0.56-1.43],0.649105480806805
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PXN,Paxillin,18039,70,1.09 [0.74-1.61],0.6742486455420172
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PYDC1,Pyrin domain-containing protein 1,15560,59,1.44 [0.85-2.44],0.1706892589428841
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PYY,Peptide YY,15485,61,1.11 [0.87-1.40],0.3981891509235439
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PZP,Pregnancy zone protein,16032,63,0.74 [0.35-1.56],0.4303681316249259
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",QDPR,Dihydropteridine reductase,18340,70,1.12 [0.68-1.84],0.6604378637663116
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",QPCT,Glutaminyl-peptide cyclotransferase,18447,71,0.97 [0.44-2.10],0.9293508901858824
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",QSOX1,Sulfhydryl oxidase 1,15711,61,1.51 [1.08-2.09],0.0147146355149318
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB10,Ras-related protein Rab-10,16007,62,0.88 [0.55-1.40],0.5845035197602914
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB11FIP3,Rab11 family-interacting protein 3,16007,62,0.98 [0.79-1.23],0.8904542124551431
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB27B,Ras-related protein Rab-27B,16007,62,0.98 [0.73-1.32],0.90290979337192
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB2B,Ras-related protein Rab-2B,15951,63,1.10 [0.74-1.62],0.6445103672077696
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB33A,Ras-related protein Rab-33A,15485,61,0.98 [0.67-1.43],0.9073526539300988
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB37,Ras-related protein Rab-37,18124,68,0.59 [0.41-0.85],0.0041857536618955
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB39B,Ras-related protein Rab-39B,15485,61,0.94 [0.70-1.27],0.7032345493439986
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,15523,61,0.54 [0.29-0.99],0.0463210913439884
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB44,Ras-related protein Rab-44,15951,63,0.92 [0.52-1.62],0.7639915872235582
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB6A,Ras-related protein Rab-6A,18427,71,0.94 [0.58-1.51],0.7930338165900366
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB6B,Ras-related protein Rab-6B,18039,70,0.96 [0.61-1.51],0.8492690541219627
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RABEP1,Rab GTPase-binding effector protein 1,15659,64,1.39 [1.03-1.88],0.0328107334651324
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RABEPK,Rab9 effector protein with kelch motifs,18014,68,0.82 [0.54-1.24],0.342419382053774
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RABGAP1L,Rab GTPase-activating protein 1-like,18124,68,1.71 [1.26-2.33],0.0006746367187684
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAC3,Ras-related C3 botulinum toxin substrate 3,15599,60,0.46 [0.24-0.87],0.017547361526928
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAD23B,UV excision repair protein RAD23 homolog B,18014,68,1.01 [0.63-1.61],0.9709942307420102
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAD51,DNA repair protein RAD51 homolog 1,15731,62,1.23 [0.88-1.73],0.2337442362191195
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RALB,Ras-related protein Ral-B,15528,61,1.00 [0.44-2.28],0.998497660522184
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RALY,RNA-binding protein Raly,15951,63,1.98 [1.56-2.52],1.5554687539350015e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RANBP1,Ran-specific GTPase-activating protein,15560,59,1.26 [0.79-2.01],0.3252848804935855
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RANBP2,E3 SUMO-protein ligase RanBP2,15523,61,1.11 [0.53-2.31],0.7838676931251177
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RANGAP1,Ran GTPase-activating protein 1,18014,68,0.85 [0.52-1.40],0.5260940462509152
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAP1A,Ras-related protein Rap-1A,15528,61,0.84 [0.55-1.29],0.4320427323829034
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAPGEF2,Rap guanine nucleotide exchange factor 2,15731,62,0.93 [0.58-1.50],0.7689103320871229
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RARRES1,Retinoic acid receptor responder protein 1,18014,68,0.61 [0.28-1.34],0.2192982733068165
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RARRES2,Retinoic acid receptor responder protein 2,18553,69,0.85 [0.54-1.33],0.4788876396593375
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RASA1,Ras GTPase-activating protein 1,18039,70,1.14 [0.62-2.12],0.6703974566758939
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,15454,61,0.90 [0.50-1.61],0.7177762983856791
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RASSF2,Ras association domain-containing protein 2,18014,68,1.62 [1.38-1.90],6.1181280973445725e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,15987,64,1.59 [0.99-2.55],0.0559799796981233
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBKS,Ribokinase,18014,71,1.71 [1.15-2.55],0.0081761408097507
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBM17,Splicing factor 45,15987,64,1.00 [0.73-1.36],0.9758801742919584
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBM19,Probable RNA-binding protein 19,15485,61,1.99 [1.56-2.53],2.219290311729396e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBM25,RNA-binding protein 25,15454,61,0.78 [0.44-1.37],0.3819225490120359
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBP1,Retinol-binding protein 1,15599,60,1.17 [0.87-1.56],0.3036114390123491
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBP2,Retinol-binding protein 2,18344,71,1.03 [0.79-1.35],0.8188334752425771
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBP5,Retinol-binding protein 5,18344,71,1.66 [1.17-2.35],0.004437636690279
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBP7,Retinoid-binding protein 7,15956,64,1.15 [0.80-1.64],0.4514272906236708
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBPMS,RNA-binding protein with multiple splicing,15528,61,1.07 [0.75-1.52],0.7091856074522962
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBPMS2,RNA-binding protein with multiple splicing 2,15560,59,1.06 [0.83-1.35],0.6605493020017268
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RCC1,Regulator of chromosome condensation,15951,63,1.41 [1.01-1.97],0.0432024229967814
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RCOR1,REST corepressor 1,18109,70,1.20 [0.79-1.82],0.4001130421415326
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,15560,59,1.62 [0.51-5.18],0.4147560481490424
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REEP4,Receptor expression-enhancing protein 4,15987,64,1.25 [0.88-1.78],0.2118314395598652
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REG1A,Lithostathine-1-alpha,18344,68,1.50 [1.03-2.18],0.0352515249084092
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REG1B,Lithostathine-1-beta,18663,72,1.42 [1.04-1.96],0.0298180914379925
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REG3A,Regenerating islet-derived protein 3-alpha,18663,72,1.06 [0.77-1.47],0.7085670130203281
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REG3G,Regenerating islet-derived protein 3-gamma,15951,63,0.99 [0.54-1.82],0.965604285782834
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REG4,Regenerating islet-derived protein 4,18432,70,1.03 [0.68-1.56],0.9002353389866264
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RELB,Transcription factor RelB,15528,61,0.46 [0.23-0.93],0.0303589513586702
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,18432,70,3.32 [1.88-5.88],3.587102588445565e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REN,Renin,18432,70,0.75 [0.56-0.99],0.0437705837478962
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REPS1,RalBP1-associated Eps domain-containing protein 1,15528,61,1.10 [0.59-2.03],0.7700091732913054
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REST,RE1-silencing transcription factor,15454,61,0.97 [0.48-1.98],0.9416659695361376
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,18344,71,0.83 [0.47-1.46],0.5098258962906979
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RETN,Resistin,18400,71,0.93 [0.57-1.52],0.7693115435412892
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REXO2,"Oligoribonuclease, mitochondrial",15485,61,0.41 [0.19-0.89],0.0241059089310235
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RFC4,Replication factor C subunit 4,15951,63,2.77 [1.31-5.85],0.00782211574345
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RGCC,Regulator of cell cycle RGCC,15987,64,0.93 [0.68-1.27],0.6286370621925812
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,15731,62,0.78 [0.49-1.25],0.3005774182772323
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RGMA,Repulsive guidance molecule A,18597,71,1.88 [0.99-3.59],0.054193704435947
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RGMB,RGM domain family member B,18597,71,2.50 [1.25-5.02],0.009897521425192
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RGS10,Regulator of G-protein signaling 10,15987,64,0.99 [0.66-1.48],0.9680572089616324
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RGS8,Regulator of G-protein signaling 8,18124,68,0.95 [0.67-1.35],0.7878384207025779
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RHOC,Rho-related GTP-binding protein RhoC,18189,71,0.99 [0.83-1.18],0.9224771254219334
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RICTOR,Rapamycin-insensitive companion of mTOR,15528,61,0.52 [0.25-1.10],0.0883281229646077
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,15659,64,1.45 [0.93-2.26],0.1011407921337971
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RILP,Rab-interacting lysosomal protein,18557,70,1.13 [0.79-1.61],0.496363281096349
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RILPL2,RILP-like protein 2,16007,62,1.00 [0.78-1.28],0.98689006467643
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,15485,61,0.50 [0.28-0.89],0.0181579725826957
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RLN1,Prorelaxin H1,15987,64,0.58 [0.23-1.43],0.2361378652484488
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RLN2,Prorelaxin H2,15635,64,0.62 [0.37-1.03],0.0670969812890459
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNASE1,Ribonuclease pancreatic,16029,64,1.15 [0.45-2.93],0.7622267482603088
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNASE10,Inactive ribonuclease-like protein 10,15560,59,0.96 [0.57-1.64],0.8898400090405154
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNASE3,Eosinophil cationic protein,18343,70,0.94 [0.78-1.15],0.5589231070764138
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNASE4,Ribonuclease 4,15521,60,1.37 [0.58-3.26],0.4719882440058891
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,15919,61,1.97 [1.36-2.84],0.0003123820102385
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNASEH2A,Ribonuclease H2 subunit A,15987,64,1.23 [0.81-1.86],0.33425407707588
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,18577,71,3.03 [1.56-5.88],0.0010259621938665
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,15560,59,3.90 [2.10-7.24],1.5574567627101162e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNF168,E3 ubiquitin-protein ligase RNF168,15528,61,1.80 [1.23-2.62],0.0024333645671501
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNF31,E3 ubiquitin-protein ligase RNF31,15528,61,0.98 [0.49-1.94],0.9505542832621048
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNF4,E3 ubiquitin-protein ligase RNF4,15731,62,0.86 [0.57-1.29],0.4625280842269175
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNF41,E3 ubiquitin-protein ligase NRDP1,18014,68,1.33 [0.98-1.80],0.0689734461709184
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNF43,E3 ubiquitin-protein ligase RNF43,15731,62,0.79 [0.47-1.35],0.394933643271643
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNF5,E3 ubiquitin-protein ligase RNF5,15560,59,1.03 [0.73-1.46],0.870588412817284
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,18432,70,4.62 [2.20-9.69],5.131669063739409e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ROBO2,Roundabout homolog 2,18597,71,2.40 [0.99-5.82],0.0521801875447705
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ROBO4,Roundabout homolog 4,15560,59,1.42 [0.35-5.72],0.6218824788261879
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,18432,70,7.02 [3.86-12.76],1.7008941551624095e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RP2,Protein XRP2,18344,71,1.03 [0.63-1.68],0.9046939155477476
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RPA2,Replication protein A 32 kDa subunit,15528,61,1.69 [0.98-2.93],0.0593347884275131
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RPE,Ribulose-phosphate 3-epimerase,15731,62,1.25 [0.93-1.69],0.1420282319132365
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RPGR,X-linked retinitis pigmentosa GTPase regulator,15599,60,1.07 [0.59-1.93],0.8308472046844962
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RPL14,60S ribosomal protein L14,15560,59,5.53 [3.52-8.69],1.2511108843584897e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RPS10,40S ribosomal protein S10,15485,61,0.54 [0.25-1.14],0.104234814720735
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RRAS,Ras-related protein R-Ras,15599,60,0.98 [0.81-1.20],0.8751294156768405
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,18014,68,1.64 [1.25-2.16],0.0003898427206562
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,18014,68,1.53 [1.12-2.07],0.0068264638659064
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RRP15,RRP15-like protein,15523,61,1.05 [0.80-1.37],0.7249528968801403
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RSPO1,R-spondin-1,18284,71,0.96 [0.52-1.80],0.9066236178866072
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RSPO3,R-spondin-3,18606,70,1.04 [0.48-2.25],0.9172144143537042
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RTBDN,Retbindin,18344,71,0.55 [0.26-1.15],0.111178623468242
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RTKN2,Rhotekin-2,15485,61,0.59 [0.30-1.13],0.1097369057330885
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",15987,64,1.10 [0.85-1.42],0.4794234224446954
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RTN4R,Reticulon-4 receptor,18606,70,2.04 [1.22-3.43],0.0069381643030491
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RUVBL1,RuvB-like 1,18014,68,1.02 [0.83-1.26],0.8514506816710492
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RWDD1,RWD domain-containing protein 1,18597,71,1.10 [0.79-1.54],0.567332828323081
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RYR1,Ryanodine receptor 1,15485,61,0.42 [0.17-1.04],0.059394596141741
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",S100A11,Protein S100-A11,18297,70,0.96 [0.61-1.52],0.8715300378733181
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",S100A12,Protein S100-A12,18166,71,1.09 [0.82-1.44],0.5695097427203951
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",S100A13,Protein S100-A13,15528,61,1.81 [1.03-3.18],0.0383944973656871
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",S100A14,Protein S100-A14,15987,64,0.69 [0.41-1.16],0.1589118674094624
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",S100A16,Protein S100-A16,18009,70,0.88 [0.61-1.28],0.5034989651716164
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",S100A3,Protein S100-A3,15951,63,1.42 [1.04-1.94],0.027929507400728
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",S100A4,Protein S100-A4,18477,72,0.91 [0.63-1.32],0.6159900970202965
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",S100G,Protein S100-G,15987,64,0.74 [0.43-1.25],0.2605291888262481
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",S100P,Protein S100-P,18109,70,0.73 [0.47-1.14],0.1635963959621228
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SAA4,Serum amyloid A-4 protein,16032,63,1.31 [0.76-2.27],0.334197209456174
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SAFB2,Scaffold attachment factor B2,15987,64,2.16 [1.53-3.06],1.2366868743588692e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SAG,S-arrestin,15523,61,1.16 [0.75-1.81],0.4984444957069331
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SAMD9L,Sterile alpha motif domain-containing protein 9-like,18427,71,1.21 [0.91-1.60],0.1821321217895496
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SAP18,Histone deacetylase complex subunit SAP18,15731,62,0.99 [0.70-1.38],0.935126341732348
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SARG,Specifically androgen-regulated gene protein,15957,61,0.96 [0.77-1.20],0.737374165132785
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SART1,U4/U6.U5 tri-snRNP-associated protein 1,15485,61,2.24 [1.90-2.64],7.146666637244323e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SAT1,Diamine acetyltransferase 1,15485,61,0.85 [0.49-1.49],0.5764264931905868
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SAT2,Thialysine N-epsilon-acetyltransferase,15731,62,1.20 [0.89-1.63],0.2361088376054393
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SATB1,DNA-binding protein SATB1,15987,64,1.07 [0.49-2.32],0.8692001762708281
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SBSN,Suprabasin,15988,64,1.22 [0.63-2.39],0.5515090318793693
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCAMP3,Secretory carrier-associated membrane protein 3,18344,71,1.69 [1.34-2.13],7.142255444942486e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCARA5,Scavenger receptor class A member 5,18597,71,0.67 [0.33-1.36],0.2671084385624996
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCARB1,Scavenger receptor class B member 1,18039,70,1.02 [0.70-1.48],0.9332290369069282
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,17932,69,2.28 [1.31-3.98],0.0037059448042173
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCARF1,Scavenger receptor class F member 1,18663,72,0.97 [0.59-1.59],0.8971000074135107
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCARF2,Scavenger receptor class F member 2,18597,71,2.28 [1.14-4.53],0.0193058271539028
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCG2,Secretogranin-2,18529,70,0.95 [0.50-1.83],0.888099013418795
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCG3,Secretogranin-3,18432,70,0.75 [0.40-1.42],0.3794597986963044
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCGB1A1,Uteroglobin,18438,69,1.30 [0.86-1.95],0.2121184742717634
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCGB2A2,Mammaglobin-A,15485,61,0.64 [0.25-1.62],0.3438037562284214
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCGB3A1,Secretoglobin family 3A member 1,15659,64,1.11 [0.44-2.79],0.8256267358771234
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCGB3A2,Secretoglobin family 3A member 2,18471,70,0.84 [0.63-1.12],0.2281231670358001
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCGN,Secretagogin,18124,68,1.53 [0.96-2.41],0.0706531525526691
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCIN,Adseverin,15523,61,0.93 [0.65-1.31],0.6677683223095111
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCLY,Selenocysteine lyase,18557,70,1.50 [0.98-2.30],0.0648180457317377
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCN2A,Sodium channel protein type 2 subunit alpha,15523,61,0.68 [0.37-1.27],0.2237278844896647
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCN2B,Sodium channel subunit beta-2,15599,60,0.52 [0.19-1.40],0.1962200881999191
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCN3A,Sodium channel protein type 3 subunit alpha,15599,60,0.78 [0.36-1.70],0.5317344155887549
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCN3B,Sodium channel subunit beta-3,15523,61,0.95 [0.55-1.64],0.8592281351957052
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCN4B,Sodium channel subunit beta-4,15560,59,0.97 [0.54-1.75],0.915561186667596
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCP2,Non-specific lipid-transfer protein,18014,68,0.97 [0.72-1.30],0.8235268135418028
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCPEP1,Retinoid-inducible serine carboxypeptidase,15510,59,0.98 [0.59-1.62],0.9285978417790198
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCRG1,Scrapie-responsive protein 1,16007,62,0.85 [0.34-2.14],0.7349873681320509
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCRIB,Protein scribble homolog,15560,59,1.32 [1.07-1.63],0.0091397604220822
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCRN1,Secernin-1,18427,71,1.60 [1.17-2.19],0.0035050161822583
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCT,Secretin,15599,60,1.03 [0.61-1.73],0.920317895300576
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,18432,70,0.92 [0.53-1.59],0.7669291395258468
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,18432,70,0.50 [0.37-0.66],1.83694084715836e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SDCCAG8,Serologically defined colon cancer antigen 8,15951,63,1.29 [1.04-1.60],0.0188067836862561
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SDHB,Succinate dehydrogenase,15956,64,1.38 [1.03-1.85],0.03227264990839
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,15659,64,4.08 [3.35-4.95],2.6312487769848905e-45
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEC31A,Protein transport protein Sec31A,15560,59,1.22 [0.87-1.70],0.2516324436682104
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEL1L,Protein sel-1 homolog 1,15560,59,1.39 [0.80-2.44],0.244169971152717
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SELE,E-selectin,18663,72,0.96 [0.64-1.46],0.8649904773134879
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SELENOP,Selenoprotein P,16032,63,0.84 [0.29-2.46],0.7557133570589734
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,16032,63,10.30 [6.76-15.68],1.5942536569191218e-27
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SELP,P-selectin,18520,69,0.81 [0.55-1.19],0.281007956326171
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SELPLG,P-selectin glycoprotein ligand 1,18427,71,2.75 [1.52-4.96],0.0007828103908915
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEMA3F,Semaphorin-3F,18432,70,1.79 [0.81-3.95],0.1483310857352471
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEMA3G,Semaphorin-3G,15659,64,2.06 [1.35-3.14],0.0008156128432927
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEMA4C,Semaphorin-4C,18344,71,1.83 [1.19-2.82],0.0059383836215279
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEMA4D,Semaphorin-4D,18597,71,2.15 [1.06-4.34],0.0332136102830101
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEMA6C,Semaphorin-6C,15528,61,0.78 [0.28-2.15],0.625836347707484
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,18603,72,5.82 [4.27-7.93],6.696356949803479e-29
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEPTIN3,Neuronal-specific septin-3,15987,64,0.69 [0.49-0.97],0.0324694139894138
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEPTIN7,Septin-7,15731,62,0.92 [0.56-1.50],0.7267900887159051
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,15948,64,2.36 [1.44-3.87],0.0006837757305567
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEPTIN9,Septin-9,18344,71,3.06 [2.10-4.44],5.039367769638272e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINA1,Alpha-1-antitrypsin,15738,62,4.66 [0.76-28.54],0.096079479397937
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINA11,Serpin A11,18663,72,0.91 [0.55-1.50],0.7154449841631983
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINA12,Serpin A12,17915,68,0.82 [0.64-1.07],0.1395713773515505
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINA3,Alpha-1-antichymotrypsin,15988,62,1.60 [0.38-6.78],0.5227054099117057
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINA4,Kallistatin,15742,61,0.79 [0.28-2.25],0.6609324366967353
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINA5,Plasma serine protease inhibitor,15796,62,1.07 [0.48-2.38],0.8716814969863533
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINA6,Corticosteroid-binding globulin,16032,63,5.35 [1.29-22.22],0.0210910571461549
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINA7,Thyroxine-binding globulin,16032,63,1.34 [0.37-4.89],0.6552363136962012
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,18266,71,0.63 [0.47-0.84],0.0018498032939473
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINB1,Leukocyte elastase inhibitor,18376,69,0.98 [0.77-1.25],0.8887179546862954
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINB5,Serpin B5,18109,70,1.14 [0.73-1.78],0.5699856354104711
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINB6,Serpin B6,18535,71,0.99 [0.69-1.42],0.945522342532194
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINB8,Serpin B8,18653,71,1.58 [1.29-1.94],9.651878880882162e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINB9,Serpin B9,18284,71,1.21 [0.63-2.32],0.5677637726867916
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINC1,Antithrombin-III,16007,63,1.97 [0.39-9.99],0.4123401206498708
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPIND1,Heparin cofactor 2,16007,63,1.29 [0.56-3.00],0.5490253680278112
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINE1,Plasminogen activator inhibitor 1,18663,72,0.71 [0.52-0.95],0.0237507552249966
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINE2,Glia-derived nexin,16007,62,0.63 [0.43-0.94],0.0243268244218002
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINF1,Pigment epithelium-derived factor,15796,63,1.42 [0.58-3.47],0.4460969848454245
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINF2,Alpha-2-antiplasmin,15729,63,1.17 [0.19-7.11],0.8651576617092516
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPING1,Plasma protease C1 inhibitor,16007,63,1.34 [0.36-5.00],0.6594526569998073
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINH1,Serpin H1,15731,62,1.12 [0.93-1.36],0.2257780970515408
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINI1,Neuroserpin,15632,64,1.32 [0.59-2.98],0.5003731520340685
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINI2,Serpin I2,15956,64,1.09 [0.72-1.65],0.6740638863327938
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,18039,70,0.96 [0.69-1.35],0.8211284821691398
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SETMAR,Histone-lysine N-methyltransferase SETMAR,18216,70,3.37 [2.14-5.30],1.518353603813772e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEZ6,Seizure protein 6 homolog,15599,60,1.73 [0.88-3.38],0.1110047219486258
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEZ6L,Seizure 6-like protein,18477,72,1.37 [0.65-2.91],0.4066988341446051
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEZ6L2,Seizure 6-like protein 2,18344,71,1.27 [0.53-3.04],0.5849842715515035
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SF3B4,Splicing factor 3B subunit 4,18344,71,1.03 [0.78-1.37],0.8110311555934502
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SFRP1,Secreted frizzled-related protein 1,18217,71,0.43 [0.25-0.74],0.0023998160596898
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SFRP4,Secreted frizzled-related protein 4,15659,64,0.95 [0.52-1.76],0.8730099791857694
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SFTPA1,Pulmonary surfactant-associated protein A1,18014,68,0.97 [0.65-1.45],0.8745065666065596
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SFTPA2,Pulmonary surfactant-associated protein A2,18014,68,1.28 [0.86-1.90],0.2247594027180996
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SFTPD,Pulmonary surfactant-associated protein D,18432,70,0.94 [0.69-1.29],0.7091959037887552
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SGSH,N-sulphoglucosamine sulphohydrolase,15757,60,0.85 [0.54-1.34],0.4853764331080663
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SH2B3,SH2B adapter protein 3,18014,68,0.92 [0.74-1.14],0.4486556758758949
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SH2D1A,SH2 domain-containing protein 1A,18427,71,1.14 [0.82-1.58],0.4275996934597468
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,15523,61,0.69 [0.40-1.17],0.1655454424577624
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SH3BP1,SH3 domain-binding protein 1,15956,64,1.44 [1.02-2.04],0.0399228235214849
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SH3GL3,Endophilin-A3,15636,62,1.02 [0.76-1.36],0.9140121447667086
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SH3GLB2,Endophilin-B2,15980,64,1.43 [1.01-2.02],0.0440736938350404
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SHBG,Sex hormone-binding globulin,16029,64,0.89 [0.53-1.49],0.663313287240177
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SHC1,SHC-transforming protein 1,15454,61,0.78 [0.61-1.01],0.0568354781705239
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SHD,SH2 domain-containing adapter protein D,15457,61,0.89 [0.63-1.26],0.5242339686281361
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SHH,Sonic hedgehog protein,15528,61,0.86 [0.47-1.57],0.6214944147080493
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,16018,64,2.61 [1.42-4.79],0.0019916948326262
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SHMT1,"Serine hydroxymethyltransferase, cytosolic",18471,70,1.06 [0.83-1.37],0.6367685020391178
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SHPK,Sedoheptulokinase,15731,62,0.78 [0.40-1.55],0.4803832047758669
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIAE,Sialate O-acetylesterase,18448,72,0.80 [0.51-1.27],0.3498087603190846
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,18492,70,2.79 [1.85-4.20],8.840226551507495e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,18427,71,0.59 [0.34-1.04],0.0691563661561569
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC15,Sialic acid-binding Ig-like lectin 15,18039,70,1.00 [0.75-1.33],0.9970415764389556
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC5,Sialic acid-binding Ig-like lectin 5,18432,70,1.57 [1.21-2.04],0.0006933387660268
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,18606,70,8.64 [6.52-11.46],7.829402916901134e-51
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC7,Sialic acid-binding Ig-like lectin 7,18432,70,1.10 [0.51-2.36],0.8032136502796021
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,15560,59,3.05 [1.87-5.00],9.036210745820729e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC9,Sialic acid-binding Ig-like lectin 9,18580,70,0.96 [0.48-1.92],0.9060458064016474
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIL1,Nucleotide exchange factor SIL1,15560,59,0.74 [0.29-1.88],0.5285731548100351
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,18481,71,1.57 [1.04-2.39],0.0332329329772015
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIRPB1,Signal-regulatory protein beta-1,18368,70,1.18 [0.76-1.84],0.4664128595982182
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIRT1,NAD-dependent protein deacetylase sirtuin-1,15528,61,1.28 [1.05-1.56],0.0131048975787113
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIRT2,NAD-dependent protein deacetylase sirtuin-2,18344,71,1.02 [0.80-1.30],0.8679807769151642
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",18039,70,0.61 [0.37-1.00],0.0497674612323472
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIT1,Signaling threshold-regulating transmembrane adapter 1,18124,68,2.75 [1.93-3.92],2.4264673548611578e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SKAP1,Src kinase-associated phosphoprotein 1,18256,71,1.21 [0.91-1.61],0.1787788844579707
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SKAP2,Src kinase-associated phosphoprotein 2,18492,70,0.96 [0.78-1.17],0.6645957880450142
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SKIV2L,Helicase SKI2W,15485,61,0.65 [0.30-1.37],0.2560301195893373
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLA2,Src-like-adapter 2,15987,64,0.92 [0.73-1.15],0.452673537609243
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLAMF1,Signaling lymphocytic activation molecule,18124,68,1.08 [0.75-1.57],0.6644737040487699
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,18014,68,4.66 [3.72-5.84],8.783286014247877e-41
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLAMF7,SLAM family member 7,18427,71,0.69 [0.48-1.00],0.047158927475379
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,18014,68,2.64 [1.84-3.78],1.2388730500732157e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC12A2,Solute carrier family 12 member 2,15485,61,1.14 [0.48-2.71],0.7740262978250092
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC13A1,Solute carrier family 13 member 1,15951,63,0.55 [0.29-1.06],0.0731173770544569
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC16A1,Monocarboxylate transporter 1,18039,70,1.21 [0.86-1.68],0.2721114552738432
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC1A4,Neutral amino acid transporter A,15599,60,0.76 [0.43-1.35],0.352499041634689
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC27A4,Long-chain fatty acid transport protein 4,18039,70,1.26 [0.97-1.62],0.0798168196392199
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC28A1,Sodium/nucleoside cotransporter 1,15454,61,0.91 [0.58-1.43],0.6856067510762082
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC34A3,Sodium-dependent phosphate transport protein 2C,15454,61,0.88 [0.50-1.56],0.6618211230175775
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC39A14,Zinc transporter ZIP14,18039,70,1.54 [0.95-2.50],0.0824971963621518
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC39A5,Zinc transporter ZIP5,18427,71,1.36 [0.97-1.91],0.0770092949785627
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC44A4,Choline transporter-like protein 4,15599,60,0.79 [0.50-1.25],0.3076493484324907
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC4A1,Band 3 anion transport protein,16018,64,1.37 [0.85-2.19],0.1908601043480153
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC51B,Organic solute transporter subunit beta,15485,61,0.74 [0.49-1.11],0.1436906519495245
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,15659,64,1.00 [0.76-1.33],0.9861297168060792
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,15956,64,1.16 [0.78-1.74],0.4660328923615024
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",15454,61,1.05 [0.69-1.59],0.821401522137955
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLIT2,Slit homolog 2 protein,18039,70,0.92 [0.61-1.40],0.7082510407235576
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLITRK1,SLIT and NTRK-like protein 1,15528,61,1.72 [0.83-3.53],0.1419698539205368
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,18606,70,2.39 [1.50-3.83],0.0002618805360162
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLITRK6,SLIT and NTRK-like protein 6,18109,70,1.39 [0.78-2.49],0.2631978720664285
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLK,STE20-like serine/threonine-protein kinase,15731,62,0.83 [0.56-1.22],0.3362078198784623
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLMAP,Sarcolemmal membrane-associated protein,15956,64,1.15 [0.87-1.52],0.3410660549878307
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLURP1,Secreted Ly-6/uPAR-related protein 1,15905,64,0.65 [0.31-1.38],0.2632778784709397
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMAD1,Mothers against decapentaplegic homolog 1,18014,68,0.89 [0.68-1.16],0.3807771058409384
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMAD2,Mothers against decapentaplegic homolog 2,15951,63,1.06 [0.75-1.49],0.739456519139071
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMAD3,Mothers against decapentaplegic homolog 3,15951,63,1.37 [0.89-2.11],0.1561537534294041
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMAD5,Mothers against decapentaplegic homolog 5,18344,71,0.32 [0.13-0.75],0.0094768600596841
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMARCA2,Probable global transcription activator SNF2L2,18039,70,0.84 [0.61-1.15],0.2806760564118385
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMC3,Structural maintenance of chromosomes protein 3,15454,61,1.12 [0.73-1.73],0.6016285328095765
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMNDC1,Survival of motor neuron-related-splicing factor 30,15956,64,2.21 [1.94-2.52],1.4579526044783269e-33
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMOC1,SPARC-related modular calcium-binding protein 1,18606,70,1.43 [0.76-2.70],0.2657917365437431
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMOC2,SPARC-related modular calcium-binding protein 2,18492,70,1.02 [0.59-1.76],0.9510849010339396
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMPD1,Sphingomyelin phosphodiesterase,18504,71,0.74 [0.48-1.13],0.1610944039321054
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMPD3,Sphingomyelin phosphodiesterase 3,15528,61,0.68 [0.37-1.24],0.2081585569966144
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,18458,70,0.89 [0.65-1.21],0.4465269878741481
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,15951,63,0.66 [0.41-1.04],0.0758497349468618
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMS,Spermine synthase,15523,61,1.14 [0.81-1.61],0.4498266639280404
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMTN,Smoothelin,15948,64,1.03 [0.79-1.34],0.8318043897200246
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNAP23,Synaptosomal-associated protein 23,18432,70,0.91 [0.72-1.15],0.4172944478535398
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNAP25,Synaptosomal-associated protein 25,15523,61,1.41 [0.87-2.29],0.1611867466251998
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNAP29,Synaptosomal-associated protein 29,18477,72,0.97 [0.78-1.22],0.8265021481696238
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNAPIN,SNARE-associated protein Snapin,15987,64,1.51 [1.04-2.21],0.0316311358663056
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNCA,Alpha-synuclein,15659,64,0.95 [0.77-1.17],0.6397081227097887
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNCG,Gamma-synuclein,18284,71,0.95 [0.69-1.30],0.7398294584533648
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",15560,59,0.62 [0.26-1.44],0.2649860104251567
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNRPB2,U2 small nuclear ribonucleoprotein B'',15980,64,0.40 [0.18-0.93],0.0336677342149547
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNU13,NHP2-like protein 1,15485,61,1.83 [1.51-2.21],3.664248008404077e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNX15,Sorting nexin-15,15659,64,1.32 [0.86-2.02],0.2060166136557803
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNX18,Sorting nexin-18,15956,64,1.69 [1.15-2.48],0.0077211740675513
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNX2,Sorting nexin-2,15951,63,1.29 [1.03-1.62],0.0298715529279665
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNX5,Sorting nexin-5,15560,59,2.12 [1.07-4.20],0.0306920641457154
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNX9,Sorting nexin-9,18432,70,1.31 [0.97-1.76],0.0816755543475101
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SOD1,Superoxide dismutase [Cu-Zn],18090,68,1.09 [0.70-1.71],0.6950679534070441
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SOD2,"Superoxide dismutase [Mn], mitochondrial",18432,70,1.43 [0.85-2.38],0.1743291310278513
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SOD3,Extracellular superoxide dismutase,16029,64,0.68 [0.37-1.25],0.2090327753262411
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SORBS1,Sorbin and SH3 domain-containing protein 1,15987,64,0.99 [0.54-1.83],0.9794098348983284
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SORCS2,VPS10 domain-containing receptor SorCS2,18014,68,2.14 [1.19-3.83],0.010713300064609
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SORD,Sorbitol dehydrogenase,18524,70,1.02 [0.75-1.39],0.8974928720135117
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SORT1,Sortilin,18412,70,0.92 [0.53-1.62],0.7768425077146386
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SOST,Sclerostin,18412,70,0.91 [0.53-1.56],0.72180227354669
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,15599,60,1.12 [0.71-1.77],0.6120290628336746
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SOX2,Transcription factor SOX-2,15949,64,1.31 [0.53-3.26],0.5631970497941918
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SOX9,Transcription factor SOX-9,15599,60,1.83 [0.73-4.62],0.1989573605684535
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,15987,64,1.45 [0.74-2.83],0.2795282152880241
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPAG1,Sperm-associated antigen 1,15987,64,0.97 [0.64-1.47],0.8790196575801269
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPARC,SPARC,18477,72,0.79 [0.60-1.04],0.0903986766347719
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPARCL1,SPARC-like protein 1,18456,69,1.76 [1.06-2.91],0.0279415921513509
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPART,Spartin,15659,64,0.94 [0.68-1.29],0.7023564214574838
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPESP1,Sperm equatorial segment protein 1,16007,62,2.06 [1.09-3.88],0.0259413594426946
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINK1,Serine protease inhibitor Kazal-type 1,18432,70,1.33 [0.81-2.18],0.2649923364924384
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINK2,Serine protease inhibitor Kazal-type 2,15659,64,0.61 [0.30-1.25],0.1771435310825885
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINK4,Serine protease inhibitor Kazal-type 4,18427,71,1.31 [0.97-1.77],0.0773700925861104
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINK5,Serine protease inhibitor Kazal-type 5,18432,70,0.60 [0.32-1.12],0.1092539496899685
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINK6,Serine protease inhibitor Kazal-type 6,18606,70,1.00 [0.67-1.49],0.9973405855240814
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINK8,Serine protease inhibitor Kazal-type 8,15485,61,1.20 [0.65-2.21],0.5614850053041744
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,18365,69,5.19 [3.12-8.62],2.161025473149068e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINT2,Kunitz-type protease inhibitor 2,18492,70,0.76 [0.44-1.30],0.3105391186025654
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINT3,Kunitz-type protease inhibitor 3,15956,64,0.85 [0.74-0.97],0.0150063557745581
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPOCK1,Testican-1,18284,71,0.59 [0.35-1.01],0.0525580577996817
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPON1,Spondin-1,18432,70,0.63 [0.32-1.23],0.1752791765720692
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPON2,Spondin-2,18350,69,1.24 [0.66-2.31],0.4985473578879015
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPP1,Osteopontin,18632,71,1.07 [0.66-1.75],0.7707467674742896
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",15528,61,1.06 [0.60-1.86],0.8499104843250825
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPRING1,SREBP regulating gene protein,15454,61,1.55 [1.22-1.96],0.0003467709985358
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPRR1B,Cornifin-B,15731,62,1.14 [0.89-1.46],0.2993418542654795
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPRR3,Small proline-rich protein 3,15980,64,0.80 [0.55-1.18],0.2676980245115765
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPRY2,Protein sprouty homolog 2,18124,68,0.96 [0.76-1.22],0.723195202631616
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",15523,61,2.54 [1.78-3.63],2.6317856482928055e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPTLC1,Serine palmitoyltransferase 1,15980,64,0.87 [0.44-1.70],0.6784645727975698
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SRC,Proto-oncogene tyrosine-protein kinase Src,18448,72,0.94 [0.79-1.11],0.4444466330687526
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SRP14,Signal recognition particle 14 kDa protein,18344,71,2.77 [2.28-3.36],5.111241523415993e-25
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SRPK2,SRSF protein kinase 2,18427,71,1.49 [1.21-1.83],0.0001954942910265
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SRPX,Sushi repeat-containing protein SRPX,16007,62,0.67 [0.37-1.22],0.1909272152957027
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SSB,Lupus La protein,18039,70,1.18 [0.90-1.55],0.2267762011674989
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",15528,61,0.77 [0.35-1.70],0.5181132424009227
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,18412,70,0.95 [0.80-1.13],0.5925679356403921
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,18520,69,0.75 [0.46-1.23],0.2535068195574276
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SSH3,Protein phosphatase Slingshot homolog 3,15454,61,0.89 [0.37-2.14],0.7857481770163461
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SSNA1,Sjoegren syndrome nuclear autoantigen 1,15956,64,1.35 [0.87-2.09],0.1755461584817224
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ST13,Hsc70-interacting protein,15659,64,1.30 [0.84-2.01],0.2358760328537354
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",18344,71,1.76 [1.27-2.46],0.0007496678493549
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",18663,72,1.07 [0.54-2.11],0.8491547967041588
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",15528,61,0.52 [0.24-1.14],0.1021920636736846
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STAB2,Stabilin-2,16018,64,0.93 [0.39-2.20],0.8681600998337198
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STAM,Signal transducing adapter molecule 1,15951,63,1.02 [0.53-1.97],0.9514196297621698
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STAMBP,STAM-binding protein,18256,71,1.14 [0.82-1.59],0.4339724928040857
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STAT2,Signal transducer and activator of transcription 2,15528,61,1.51 [1.12-2.03],0.0063598529978277
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STAT5B,Signal transducer and activator of transcription 5B,18344,71,0.98 [0.84-1.14],0.7840201533036817
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,15454,61,0.92 [0.62-1.37],0.6984202340307836
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,18597,71,9.21 [7.32-11.59],8.300976688652306e-80
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STC2,Stanniocalcin-2,18410,70,4.93 [2.05-11.83],0.0003573422392381
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STEAP4,Metalloreductase STEAP4,15523,61,0.64 [0.40-1.03],0.0638718948607133
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STIP1,Stress-induced-phosphoprotein 1,18397,70,1.28 [0.93-1.75],0.1283947256004186
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STK11,Serine/threonine-protein kinase STK11,18109,70,0.98 [0.73-1.31],0.8735622378864868
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STK24,Serine/threonine-protein kinase 24,18039,70,0.90 [0.64-1.28],0.5591540707732718
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STK4,Serine/threonine-protein kinase 4,18432,70,0.92 [0.72-1.18],0.5209434264409183
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STOML2,"Stomatin-like protein 2, mitochondrial",15454,61,1.20 [0.98-1.48],0.0824957144900956
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STX16,Syntaxin-16,18014,68,0.97 [0.66-1.43],0.8793349013463706
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STX1B,Syntaxin-1B,15599,60,0.96 [0.50-1.81],0.8904432964870822
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STX3,Syntaxin-3,15980,64,0.82 [0.40-1.65],0.5715479275122051
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STX4,Syntaxin-4,18344,71,1.16 [0.85-1.59],0.3352645348997324
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STX5,Syntaxin-5,15528,61,1.08 [0.60-1.96],0.797304101715528
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STX6,Syntaxin-6,18014,68,0.98 [0.70-1.37],0.8832894315048274
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STX7,Syntaxin-7,15528,61,2.62 [1.62-4.24],8.829709837864227e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STX8,Syntaxin-8,18427,71,1.16 [0.76-1.78],0.4852927438918538
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STXBP1,Syntaxin-binding protein 1,15987,64,0.99 [0.73-1.34],0.9338900685759044
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STXBP3,Syntaxin-binding protein 3,18014,68,1.17 [0.74-1.87],0.5060797036685477
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SUGP1,SURP and G-patch domain-containing protein 1,15956,64,2.10 [1.34-3.31],0.0012977714881458
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SUGT1,Protein SGT1 homolog,18014,68,1.12 [0.85-1.47],0.4241104776935702
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SULT1A1,Sulfotransferase 1A1,18597,71,0.95 [0.81-1.12],0.5568292224153757
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SULT2A1,Bile salt sulfotransferase,18427,71,1.16 [0.83-1.62],0.383573165905144
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SUMF1,Formylglycine-generating enzyme,15528,61,0.66 [0.37-1.19],0.1672428172901796
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,18597,71,1.20 [0.80-1.81],0.3760663489181087
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SUOX,"Sulfite oxidase, mitochondrial",15987,64,1.33 [0.94-1.86],0.1038203577266637
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SUSD1,Sushi domain-containing protein 1,18109,70,0.76 [0.50-1.16],0.2027753452219014
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SUSD2,Sushi domain-containing protein 2,18432,70,1.11 [0.53-2.33],0.775740067795669
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SUSD4,Sushi domain-containing protein 4,15951,63,1.49 [0.89-2.51],0.128563900105222
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SUSD5,Sushi domain-containing protein 5,15587,63,1.53 [0.75-3.13],0.239404845577754
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SV2A,Synaptic vesicle glycoprotein 2A,15599,60,0.79 [0.51-1.24],0.3062742226171782
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,15956,64,2.90 [2.34-3.60],3.258622798573132e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SYAP1,Synapse-associated protein 1,15659,64,0.81 [0.52-1.26],0.3490040487945811
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,15523,61,0.66 [0.38-1.14],0.1328259973437129
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SYT1,Synaptotagmin-1,15980,64,1.17 [0.71-1.94],0.5333097299177416
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SYTL4,Synaptotagmin-like protein 4,16007,62,1.00 [0.71-1.39],0.9886473529081856
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,15731,62,1.08 [0.86-1.36],0.5179226475548101
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TACC3,Transforming acidic coiled-coil-containing protein 3,18344,71,0.98 [0.82-1.17],0.8278506914035424
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TACSTD2,Tumor-associated calcium signal transducer 2,16338,64,0.83 [0.38-1.80],0.6294511386714976
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TADA3,Transcriptional adapter 3,15951,63,1.09 [0.60-1.96],0.7812876162126338
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TAFA5,Chemokine-like protein TAFA-5,18344,71,0.83 [0.46-1.51],0.5443934777197061
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TAGLN3,Transgelin-3,15454,61,1.14 [0.78-1.66],0.5113727442346468
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TALDO1,Transaldolase,15969,63,1.23 [0.72-2.09],0.4443549901683311
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TANK,TRAF family member-associated NF-kappa-B activator,18124,68,1.33 [1.00-1.78],0.0513294751828169
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TAP1,Antigen peptide transporter 1,15731,62,0.46 [0.24-0.85],0.0136435675374387
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TARBP2,RISC-loading complex subunit TARBP2,18039,70,1.14 [0.87-1.49],0.3357498189312827
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",15599,60,0.73 [0.47-1.12],0.1464953344012611
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",15951,63,1.62 [0.97-2.72],0.067706909391311
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TAX1BP1,Tax1-binding protein 1,15980,64,2.53 [1.94-3.28],4.464741416514124e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TBC1D17,TBC1 domain family member 17,18039,70,1.25 [0.81-1.94],0.3101141132994018
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TBC1D23,TBC1 domain family member 23,18344,71,0.96 [0.76-1.22],0.742492834278117
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TBC1D5,TBC1 domain family member 5,18427,71,1.17 [0.91-1.49],0.2267367845987113
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TBCA,Tubulin-specific chaperone A,15659,64,1.09 [0.82-1.46],0.5400699730324783
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TBCB,Tubulin-folding cofactor B,18284,71,1.02 [0.83-1.26],0.839225963335313
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TBCC,Tubulin-specific chaperone C,18284,71,0.92 [0.71-1.20],0.5536260540648194
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TBL1X,F-box-like/WD repeat-containing protein TBL1X,18014,68,0.95 [0.74-1.22],0.6966977840039221
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TBR1,T-box brain protein 1,15599,60,0.78 [0.42-1.47],0.4478969449783555
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,18261,71,2.92 [2.55-3.34],6.384388373840558e-54
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCL1B,T-cell leukemia/lymphoma protein 1B,18109,70,0.92 [0.68-1.24],0.5716097117666861
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCN1,Transcobalamin-1,15711,61,1.06 [0.53-2.11],0.8628889376830514
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCN2,Transcobalamin-2,18632,71,1.87 [1.03-3.40],0.0406482647425162
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,16007,62,2.87 [2.24-3.69],1.7573046103395416e-16
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCP11,T-complex protein 11 homolog,15731,62,0.90 [0.56-1.46],0.6797056587435915
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCTN3,Tectonic-3,16007,62,2.05 [0.93-4.49],0.0740395033272652
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TDGF1,Teratocarcinoma-derived growth factor 1,18039,70,1.11 [0.97-1.27],0.1433582532960808
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TDO2,"Tryptophan 2,3-dioxygenase",15599,60,1.22 [0.68-2.18],0.5141685502007005
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,15951,63,1.77 [1.49-2.10],6.249156002713087e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TDRKH,Tudor and KH domain-containing protein,18039,70,1.33 [1.06-1.66],0.0145780387858471
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TEF,Thyrotroph embryonic factor,15485,61,0.78 [0.42-1.45],0.4287563278806483
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TEK,Angiopoietin-1 receptor,18477,72,2.07 [0.83-5.17],0.1188260348643514
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TERF1,Telomeric repeat-binding factor 1,15528,61,1.82 [0.89-3.74],0.1015582449749327
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TET2,Methylcytosine dioxygenase TET2,15702,62,0.92 [0.70-1.21],0.5520588769464116
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TEX101,Testis-expressed protein 101,15599,60,1.17 [0.79-1.74],0.4226797108579823
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TEX33,Testis-expressed protein 33,15731,62,0.97 [0.50-1.87],0.9182309327962774
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TF,Serotransferrin,16032,63,0.61 [0.20-1.85],0.3799999302523985
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TFAP2A,Transcription factor AP-2-alpha,15523,61,0.90 [0.58-1.39],0.6422995348337099
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TFF1,Trefoil factor 1,18355,69,0.85 [0.64-1.13],0.271075753772475
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TFF2,Trefoil factor 2,18471,70,0.92 [0.63-1.33],0.648150991180606
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TFF3,Trefoil factor 3,18438,69,1.33 [0.79-2.24],0.2796484604990202
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TFPI,Tissue factor pathway inhibitor,18406,68,0.91 [0.45-1.83],0.7860202186762311
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TFPI2,Tissue factor pathway inhibitor 2,18423,72,1.29 [0.85-1.98],0.2345911639584433
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TFRC,Transferrin receptor protein 1,18521,69,2.52 [1.59-3.99],8.02634188420102e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TG,Thyroglobulin,15951,63,0.74 [0.57-0.97],0.0273544113934754
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGFA,Protransforming growth factor alpha,18427,71,1.63 [1.08-2.45],0.0187847611563786
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGFB1,Transforming growth factor beta-1 proprotein,18620,71,1.13 [0.67-1.92],0.6399377481433937
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGFB2,Transforming growth factor beta-2 proprotein,15951,63,1.33 [0.89-1.99],0.1614922347884193
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGFBI,Transforming growth factor-beta-induced protein ig-h3,18349,68,1.79 [0.82-3.90],0.1408251306034081
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGFBR1,TGF-beta receptor type-1,15528,61,1.75 [0.83-3.68],0.1379619430977149
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,18477,72,1.87 [1.08-3.22],0.0250428907683236
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGFBR3,Transforming growth factor beta receptor type 3,18663,72,1.76 [0.88-3.50],0.1093915911346059
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGM2,Protein-glutamine gamma-glutamyltransferase 2,18399,69,1.37 [1.03-1.81],0.0289143249613475
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGOLN2,Trans-Golgi network integral membrane protein 2,16029,64,3.54 [1.64-7.66],0.0013264773819477
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THAP12,52 kDa repressor of the inhibitor of the protein kinase,15427,61,1.31 [1.06-1.61],0.0113621940933561
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,18432,70,2.66 [1.77-4.00],2.440421341551386e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THBS2,Thrombospondin-2,18432,70,0.88 [0.50-1.57],0.6735839142410847
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THBS4,Thrombospondin-4,18465,68,0.71 [0.44-1.14],0.158081126244158
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THOP1,Thimet oligopeptidase,18349,70,2.12 [1.21-3.73],0.0090077132361621
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THPO,Thrombopoietin,18109,70,1.32 [0.77-2.25],0.3103250604502124
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THRAP3,Thyroid hormone receptor-associated protein 3,15485,61,1.05 [0.85-1.31],0.6303399491686119
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THSD1,Thrombospondin type-1 domain-containing protein 1,15410,61,1.17 [0.58-2.35],0.6610388811888933
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THTPA,Thiamine-triphosphatase,15912,63,1.10 [0.83-1.45],0.4989121387907865
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THY1,Thy-1 membrane glycoprotein,18597,71,2.32 [1.16-4.64],0.0176927230480869
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIA1,Nucleolysin TIA-1 isoform p40,17905,69,1.02 [0.86-1.22],0.8237979254691578
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIE1,Tyrosine-protein kinase receptor Tie-1,18663,72,1.97 [1.04-3.76],0.0382570553628528
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",18011,70,1.98 [1.44-2.71],2.205337943422221e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,15731,62,0.50 [0.24-1.06],0.0717683223950175
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,18520,69,3.06 [2.02-4.64],1.3619091317792166e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,16007,62,1.01 [0.55-1.85],0.9784812547480596
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,15980,64,1.29 [0.99-1.70],0.0629651111006456
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIMP1,Metalloproteinase inhibitor 1,18263,68,0.84 [0.39-1.83],0.6591567014765614
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIMP2,Metalloproteinase inhibitor 2,16007,62,0.90 [0.35-2.31],0.8345332776559856
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIMP3,Metalloproteinase inhibitor 3,18492,70,0.93 [0.78-1.09],0.3645550677048164
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIMP4,Metalloproteinase inhibitor 4,18432,70,0.67 [0.38-1.17],0.1583805279179931
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TINAGL1,Tubulointerstitial nephritis antigen-like,18383,70,2.70 [1.06-6.89],0.0377784480882484
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TJAP1,Tight junction-associated protein 1,18477,72,1.10 [0.86-1.41],0.4633556278189706
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TJP3,Tight junction protein ZO-3,15523,61,0.74 [0.38-1.44],0.3818289044218008
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TK1,"Thymidine kinase, cytosolic",15731,62,1.71 [1.22-2.39],0.0020269969190385
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TLR1,Toll-like receptor 1,15528,61,2.92 [1.42-6.00],0.0036219190744254
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TLR2,Toll-like receptor 2,15731,62,1.75 [0.62-4.89],0.2875364970687261
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TLR3,Toll-like receptor 3,18653,71,0.86 [0.62-1.20],0.3707866221447207
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TLR4,Toll-like receptor 4,15528,61,1.42 [0.61-3.31],0.4174404339366085
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,15599,60,1.20 [0.80-1.81],0.3821473692714776
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMED1,Transmembrane emp24 domain-containing protein 1,15731,62,0.95 [0.60-1.50],0.8183445284118274
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMED10,Transmembrane emp24 domain-containing protein 10,15485,61,0.75 [0.51-1.12],0.1628684690677929
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMED4,Transmembrane emp24 domain-containing protein 4,15485,61,0.68 [0.38-1.20],0.1818700369910432
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMED8,Protein TMED8,15956,64,1.08 [0.85-1.36],0.5284199124986206
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMEM106A,Transmembrane protein 106A,15951,63,1.18 [0.86-1.62],0.3064763829292805
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMEM132A,Transmembrane protein 132A,15560,59,0.73 [0.48-1.09],0.1212649956475235
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMEM25,Transmembrane protein 25,15987,64,1.13 [0.70-1.82],0.6170430328060914
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMOD4,Tropomodulin-4,15454,61,1.10 [0.60-2.04],0.7524260621736196
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMPRSS11B,Transmembrane protease serine 11B,15523,61,0.54 [0.33-0.87],0.012255738175713
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMPRSS11D,Transmembrane protease serine 11D,15948,64,0.70 [0.37-1.33],0.274757838801413
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMPRSS15,Enteropeptidase,18344,71,0.76 [0.60-0.97],0.0269413584125878
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMPRSS5,Transmembrane protease serine 5,18196,71,0.98 [0.57-1.70],0.9448491264266946
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMSB10,Thymosin beta-10,18432,70,1.63 [1.25-2.12],0.0003489291520231
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNC,Tenascin,18520,69,1.73 [1.14-2.64],0.0104841984407549
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,18084,70,2.10 [1.65-2.67],1.4232596052426291e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,15956,64,1.16 [0.74-1.84],0.5160444646406572
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,18124,68,1.40 [0.83-2.36],0.2031328704216141
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,15659,64,0.84 [0.56-1.25],0.3913353159635182
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,18284,71,0.44 [0.22-0.90],0.0249126215037212
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,18284,71,1.55 [1.31-1.84],3.466946482580712e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,18476,71,1.12 [0.73-1.74],0.5977551075652092
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,18653,71,1.29 [0.76-2.18],0.3444228219426107
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,18402,70,1.83 [0.93-3.63],0.081729780639277
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,18477,72,1.36 [0.78-2.40],0.2797734140784367
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,18432,70,4.35 [3.60-5.26],3.862531204197715e-52
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,18124,68,4.06 [3.44-4.79],2.040906845988937e-61
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,18432,70,2.60 [1.45-4.64],0.0013136660104853
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,15659,64,4.03 [2.41-6.74],1.0298309037809184e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,18606,70,1.96 [1.11-3.46],0.0211104741092992
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,18432,70,2.64 [1.49-4.68],0.0008592232029657
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,18432,70,2.00 [1.59-2.51],2.887931556959417e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,18597,71,2.57 [1.28-5.16],0.0078172788663354
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,18620,71,6.02 [4.22-8.58],3.3552362113020624e-23
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,18284,71,1.34 [0.96-1.88],0.0869701343139734
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,18597,71,2.84 [2.06-3.90],1.4203561009675422e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,18284,71,4.68 [4.09-5.36],1.282540922118068e-110
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF10,Tumor necrosis factor ligand superfamily member 10,18653,71,1.07 [0.47-2.46],0.8670954968364097
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF11,Tumor necrosis factor ligand superfamily member 11,18427,71,1.11 [0.79-1.57],0.5423693363998707
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF12,Tumor necrosis factor ligand superfamily member 12,18653,71,0.55 [0.26-1.17],0.1220735685730897
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF13,Tumor necrosis factor ligand superfamily member 13,18492,70,0.60 [0.37-0.99],0.0458172626144999
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,18632,72,0.45 [0.30-0.67],9.05595920053646e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF14,Tumor necrosis factor ligand superfamily member 14,18284,71,0.96 [0.67-1.39],0.8458816619686249
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,16018,64,3.71 [2.50-5.51],6.821748943269124e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNIP1,TNFAIP3-interacting protein 1,15980,64,1.62 [1.28-2.06],7.575654525572106e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNN,Tenascin-N,16018,64,0.88 [0.51-1.53],0.652417992383608
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNNI3,"Troponin I, cardiac muscle",18109,70,1.05 [0.81-1.36],0.7023644761314445
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNPO1,Transportin-1,15731,62,1.55 [0.83-2.90],0.171750325877285
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNR,Tenascin-R,18284,71,0.98 [0.59-1.62],0.937106136711832
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNXB,Tenascin-X,18432,70,0.55 [0.24-1.24],0.1509738698916394
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,16007,62,1.02 [0.75-1.40],0.8806021439424099
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TOP1,DNA topoisomerase 1,15956,64,0.90 [0.74-1.09],0.2696901237547965
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TOP1MT,"DNA topoisomerase I, mitochondrial",15454,61,0.81 [0.46-1.44],0.4806031838061098
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TOP2B,DNA topoisomerase 2-beta,15528,61,1.99 [1.56-2.53],2.1400336084182847e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TOR1AIP1,Torsin-1A-interacting protein 1,15560,59,1.44 [1.03-2.03],0.0347609156194765
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TP53,Cellular tumor antigen p53,18014,68,2.25 [1.77-2.86],2.787892943386265e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TP53BP1,TP53-binding protein 1,15528,61,1.94 [1.52-2.48],9.63310967228617e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TP53I3,Quinone oxidoreductase PIG3,15317,62,1.10 [0.69-1.76],0.6790419608784284
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TP53INP1,Tumor protein p53-inducible nuclear protein 1,18109,70,1.48 [0.88-2.50],0.1382407478340185
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TP73,Tumor protein p73,15599,60,2.00 [0.99-4.05],0.0535092843385837
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPBGL,Trophoblast glycoprotein-like,15599,60,0.40 [0.18-0.88],0.0232993801241962
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPD52L2,Tumor protein D54,15659,64,0.95 [0.76-1.19],0.6589053012892239
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPK1,Thiamin pyrophosphokinase 1,16007,62,4.63 [2.11-10.13],0.0001259239693597
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPM3,Tropomyosin alpha-3 chain,15485,61,0.66 [0.36-1.22],0.1854720258780283
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPMT,Thiopurine S-methyltransferase,18014,68,0.88 [0.64-1.20],0.4194391989662629
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPP1,Tripeptidyl-peptidase 1,18285,69,0.92 [0.57-1.47],0.7155752066799901
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPPP2,Tubulin polymerization-promoting protein family member 2,15731,62,0.87 [0.62-1.24],0.4531625417161036
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPPP3,Tubulin polymerization-promoting protein family member 3,18039,70,0.68 [0.36-1.29],0.2397530641621738
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPR,Nucleoprotein TPR,15485,61,1.68 [1.38-2.06],3.569211040309483e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPRKB,EKC/KEOPS complex subunit TPRKB,15454,61,1.17 [0.86-1.58],0.3077962124051575
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPSAB1,Tryptase alpha/beta-1,18627,71,1.31 [0.87-1.95],0.1965537904095223
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPSD1,Tryptase delta,15987,64,1.26 [0.75-2.11],0.3829363945497289
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPSG1,Tryptase gamma,15528,61,0.68 [0.25-1.80],0.4360132804896039
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPT1,Translationally-controlled tumor protein,18124,68,0.77 [0.51-1.16],0.2111652558348862
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRAF2,TNF receptor-associated factor 2,18427,71,1.31 [0.98-1.75],0.0678098283755882
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRAF3,"TNF receptor-associated factor 3, Isoform 2",15528,61,2.06 [1.50-2.83],8.347512120399166e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,15485,61,0.75 [0.40-1.41],0.3766957510833748
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,15731,62,1.15 [0.89-1.50],0.2886005228885904
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TREH,Trehalase,16018,64,1.23 [0.89-1.72],0.2135780571396466
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TREM2,Triggering receptor expressed on myeloid cells 2,18402,70,1.42 [0.97-2.08],0.0687890917818414
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TREML1,Trem-like transcript 1 protein,16029,64,0.76 [0.47-1.21],0.2412708562725241
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,18432,70,9.44 [6.47-13.75],1.6406427983251878e-31
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRIAP1,TP53-regulated inhibitor of apoptosis 1,18606,70,1.37 [0.99-1.89],0.0574144638743318
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRIM21,E3 ubiquitin-protein ligase TRIM21,18427,71,0.94 [0.70-1.26],0.6825211103669007
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRIM24,Transcription intermediary factor 1-alpha,15704,62,1.52 [1.12-2.05],0.0071905382839068
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,15956,64,1.28 [1.03-1.60],0.0273718641367242
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRIM26,Tripartite motif-containing protein 26,15454,61,1.08 [0.72-1.63],0.7097640729383168
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRIM40,E3 ubiquitin ligase TRIM40,15599,60,0.86 [0.60-1.23],0.4127664146677393
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRIM5,Tripartite motif-containing protein 5,18427,71,1.10 [0.86-1.40],0.4584749591339842
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRIM58,E3 ubiquitin-protein ligase TRIM58,15951,63,1.14 [0.87-1.51],0.3436113368141253
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRPV3,Transient receptor potential cation channel subfamily V member 3,15485,61,0.56 [0.30-1.04],0.0666913254385624
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TSC1,Hamartin,15528,61,0.73 [0.47-1.15],0.1767339428881324
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TSC22D1,TSC22 domain family protein 1,15987,64,1.09 [0.76-1.56],0.6374881623953914
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TSHB,Thyrotropin subunit beta,18432,70,1.10 [0.82-1.47],0.5357006817431702
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TSLP,Thymic stromal lymphopoietin,18109,70,1.09 [0.79-1.52],0.5904229649822239
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TSNAX,Translin-associated protein X,15485,61,1.26 [0.69-2.30],0.4463284907994354
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TSPAN1,Tetraspanin-1,18109,70,0.85 [0.63-1.13],0.2635577127834252
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TSPAN15,Tetraspanin-15,15485,61,0.62 [0.33-1.18],0.1471828177525974
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TSPAN7,Tetraspanin-7,15523,61,0.75 [0.53-1.05],0.0929972085579026
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TSPAN8,Tetraspanin-8,15956,64,0.84 [0.65-1.09],0.1878221906818352
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TSPYL1,Testis-specific Y-encoded-like protein 1,15528,61,1.42 [0.82-2.47],0.2137572365940104
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TST,Thiosulfate sulfurtransferase,18010,70,1.09 [0.82-1.44],0.5651949845496713
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TTF2,Transcription termination factor 2,15599,60,1.33 [0.84-2.12],0.2230035889301921
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TTN,Titin,15485,61,1.16 [0.84-1.59],0.3594083480791792
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TTR,Transthyretin,15868,62,0.46 [0.18-1.21],0.1150505952802393
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TUBB3,Tubulin beta-3 chain,15523,61,0.83 [0.35-1.99],0.6774966565434279
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TWF2,Twinfilin-2,16018,64,1.06 [0.80-1.41],0.6612274979847228
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TXK,Tyrosine-protein kinase TXK,15731,62,0.99 [0.72-1.37],0.9731929324962708
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TXLNA,Alpha-taxilin,18284,71,1.39 [1.09-1.77],0.007570277688478
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TXN,Thioredoxin,15771,61,1.71 [1.13-2.58],0.0110560594356234
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TXNDC15,Thioredoxin domain-containing protein 15,18477,72,0.72 [0.34-1.53],0.3889545011082366
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TXNDC5,Thioredoxin domain-containing protein 5,18597,71,1.03 [0.76-1.40],0.8402102726040114
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TXNDC9,Thioredoxin domain-containing protein 9,15980,64,0.95 [0.60-1.51],0.829382456512191
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TXNL1,Thioredoxin-like protein 1,15496,61,1.05 [0.84-1.32],0.6561482476703591
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",18432,70,1.02 [0.64-1.61],0.946090917745536
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TYMP,Thymidine phosphorylase,18318,69,1.01 [0.73-1.39],0.9692465714834526
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TYRO3,Tyrosine-protein kinase receptor TYRO3,18432,70,1.32 [0.63-2.79],0.4607140214129127
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",15528,61,1.39 [0.93-2.08],0.1119382305916276
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UBAC1,Ubiquitin-associated domain-containing protein 1,18344,71,2.07 [1.13-3.81],0.0190574291452491
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UBE2B,Ubiquitin-conjugating enzyme E2 B,15951,63,1.53 [0.74-3.16],0.2536090033351895
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,16007,62,1.40 [0.95-2.05],0.0859257338825451
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,15528,61,0.65 [0.39-1.09],0.1044229616596208
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UBQLN3,Ubiquilin-3,15485,61,0.74 [0.42-1.29],0.2836295757442343
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UBXN1,UBX domain-containing protein 1,15659,64,1.15 [0.81-1.62],0.4389430375123506
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,15956,64,1.02 [0.86-1.21],0.8215028754905188
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UGDH,UDP-glucose 6-dehydrogenase,15485,61,1.04 [0.83-1.32],0.726408034223265
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UHRF2,E3 ubiquitin-protein ligase UHRF2,15485,61,1.31 [0.71-2.39],0.3892309662479437
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,18284,71,2.39 [1.50-3.80],0.0002301978930305
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UMOD,Uromodulin,18599,72,0.77 [0.54-1.12],0.1723443676322758
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UNC5D,Netrin receptor UNC5D,15528,61,0.95 [0.37-2.46],0.9211647326350368
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UNC79,Protein unc-79 homolog,15454,61,1.32 [0.88-1.97],0.1785597598184471
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UNG,Uracil-DNA glycosylase,15951,63,1.42 [0.84-2.42],0.1935737616597924
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UPB1,Beta-ureidopropionase,16007,62,0.96 [0.73-1.27],0.7929632658618084
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UPK3A,Uroplakin-3a,15523,61,1.28 [0.81-2.01],0.2839722218171633
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UPK3BL1,Uroplakin-3b-like protein 1,15693,62,0.61 [0.31-1.19],0.1454766750023699
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UROD,Uroporphyrinogen decarboxylase,15659,64,0.84 [0.58-1.21],0.3467515930419808
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UROS,Uroporphyrinogen-III synthase,15599,60,1.03 [0.71-1.50],0.8578036755045858
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",USO1,General vesicular transport factor p115,18344,71,1.05 [0.83-1.33],0.7050664416541391
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",USP25,Ubiquitin carboxyl-terminal hydrolase 25,15951,63,1.48 [1.07-2.06],0.0177037037358031
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",USP28,Ubiquitin carboxyl-terminal hydrolase 28,15980,64,2.24 [1.12-4.46],0.0223803366608055
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",USP47,Ubiquitin carboxyl-terminal hydrolase 47,15485,61,0.99 [0.75-1.32],0.9566260489655196
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",USP8,Ubiquitin carboxyl-terminal hydrolase 8,18109,70,1.24 [1.00-1.54],0.0501683713365426
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UXS1,UDP-glucuronic acid decarboxylase 1,18014,68,1.03 [0.68-1.56],0.8801514871403109
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VAMP5,Vesicle-associated membrane protein 5,18109,70,1.26 [0.90-1.74],0.1739933857037727
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VAMP8,Vesicle-associated membrane protein 8,15528,61,1.18 [0.90-1.56],0.2371408950426508
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VASH1,Tubulinyl-Tyr carboxypeptidase 1,18427,71,0.91 [0.70-1.18],0.4613042877387624
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VASN,Vasorin,18162,68,1.49 [0.69-3.25],0.3139748862973156
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VASP,Vasodilator-stimulated phosphoprotein,16029,64,0.94 [0.67-1.31],0.7094034394392188
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,18344,71,0.76 [0.25-2.26],0.6158768021811744
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VAV3,Guanine nucleotide exchange factor VAV3,15523,61,1.09 [0.85-1.40],0.5145271843085799
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,18498,69,6.90 [3.75-12.68],5.112902033108282e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VCAN,Versican core protein,18597,71,1.60 [0.81-3.14],0.1767752149586974
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VCPKMT,Protein-lysine methyltransferase METTL21D,15454,61,0.96 [0.71-1.31],0.8139670130733814
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VEGFA,Vascular endothelial growth factor A,18598,71,1.02 [0.70-1.47],0.9244486996645178
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VEGFB,Vascular endothelial growth factor B,15528,61,0.46 [0.20-1.06],0.0687259507995344
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VEGFC,Vascular endothelial growth factor C,18477,72,0.61 [0.42-0.89],0.0095408476699302
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VEGFD,Vascular endothelial growth factor D,18626,71,0.75 [0.46-1.23],0.2585464287401749
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VGF,Neurosecretory protein VGF,15987,64,1.25 [0.58-2.70],0.5762897862993159
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VIM,Vimentin,18109,70,0.91 [0.77-1.07],0.2343519627106741
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VIPR1,Vasoactive intestinal polypeptide receptor 1,15560,59,0.81 [0.27-2.44],0.7085550998585384
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VIT,Vitrin,16007,62,0.89 [0.47-1.69],0.726326660641393
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VMO1,Vitelline membrane outer layer protein 1 homolog,18344,71,1.31 [0.94-1.82],0.1167638898176221
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VNN1,Pantetheinase,16029,64,1.20 [0.85-1.70],0.2884275565523718
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VNN2,Vascular non-inflammatory molecule 2,18344,71,1.36 [0.85-2.17],0.2043762300390003
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VPS28,Vacuolar protein sorting-associated protein 28 homolog,15731,62,0.86 [0.58-1.26],0.4390167105270088
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VPS37A,Vacuolar protein sorting-associated protein 37A,18344,71,1.05 [0.81-1.37],0.706777607343788
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VPS4B,Vacuolar protein sorting-associated protein 4B,15951,63,1.03 [0.80-1.33],0.7968441358648978
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VPS53,Vacuolar protein sorting-associated protein 53 homolog,18344,71,1.02 [0.78-1.33],0.9008733554159196
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VSIG10,V-set and immunoglobulin domain-containing protein 10,15951,63,0.95 [0.46-1.96],0.8938829840116724
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,15485,61,1.08 [0.53-2.21],0.8385425903777182
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,15951,63,1.07 [0.74-1.55],0.7185125174654208
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,18410,70,1.82 [1.14-2.93],0.0129766214499275
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,18403,70,0.90 [0.63-1.29],0.5776003682085884
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VSNL1,Visinin-like protein 1,15980,64,1.83 [1.14-2.95],0.0129023430087179
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VSTM1,V-set and transmembrane domain-containing protein 1,18039,70,1.01 [0.67-1.53],0.9589694870606458
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VSTM2B,V-set and transmembrane domain-containing protein 2B,15731,62,1.17 [0.69-1.98],0.5601639008919832
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,18109,70,0.80 [0.54-1.20],0.2805376942985741
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,18597,71,0.94 [0.70-1.27],0.7048086917022944
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VTCN1,V-set domain-containing T-cell activation inhibitor 1,18014,68,0.83 [0.41-1.69],0.6112451868835868
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,15659,64,1.15 [0.76-1.73],0.5107933547696135
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VWA1,von Willebrand factor A domain-containing protein 1,18583,70,1.70 [1.04-2.76],0.0335690712343439
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VWA5A,von Willebrand factor A domain-containing protein 5A,15454,61,0.81 [0.55-1.21],0.310292017562403
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VWC2,Brorin,18222,71,0.95 [0.56-1.61],0.8544711048683908
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VWC2L,von Willebrand factor C domain-containing protein 2-like,15987,64,0.83 [0.45-1.51],0.5373015657134907
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VWF,von Willebrand factor,18663,72,1.36 [1.03-1.79],0.0301720339624519
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WARS,"Tryptophan--tRNA ligase, cytoplasmic",18432,70,1.84 [1.07-3.17],0.0275514284121406
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WAS,Wiskott-Aldrich syndrome protein,18124,68,1.06 [0.77-1.47],0.7214066452960929
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WASF1,Wiskott-Aldrich syndrome protein family member 1,18109,70,1.07 [0.86-1.34],0.5502865700158603
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WASF3,Wiskott-Aldrich syndrome protein family member 3,18039,70,1.02 [0.79-1.32],0.8605904679475607
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WASHC3,WASH complex subunit 3,15980,64,1.27 [0.96-1.69],0.0937787851035749
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WASL,Neural Wiskott-Aldrich syndrome protein,15528,61,0.74 [0.46-1.19],0.2146118714699177
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WDR46,WD repeat-containing protein 46,15951,63,1.19 [0.61-2.32],0.6041844235481209
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WFDC1,WAP four-disulfide core domain protein 1,15615,62,1.08 [0.71-1.64],0.726371709996138
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WFDC12,WAP four-disulfide core domain protein 12,18571,70,0.93 [0.66-1.31],0.6760337281037161
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,17503,69,1.84 [1.16-2.91],0.0097975769361281
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",18216,70,2.16 [1.35-3.44],0.0012815831795078
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",18432,70,1.17 [0.62-2.20],0.636376326340516
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WIF1,Wnt inhibitory factor 1,18606,70,0.84 [0.45-1.57],0.5803051964183958
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WNT9A,Protein Wnt-9a,18124,68,1.44 [0.72-2.89],0.3023623303562678
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,18284,71,1.30 [0.88-1.92],0.1813426377461216
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",XCL1,Lymphotactin,18606,70,1.59 [1.20-2.12],0.0014140871743885
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",XG,Glycoprotein Xg,18574,71,1.76 [0.97-3.21],0.0633622225383292
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",XIAP,E3 ubiquitin-protein ligase XIAP,15528,61,1.48 [1.00-2.19],0.0517997072220617
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",XPNPEP2,Xaa-Pro aminopeptidase 2,18477,72,0.91 [0.76-1.10],0.3353955424980212
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",XRCC4,DNA repair protein XRCC4,18039,70,1.52 [0.95-2.46],0.0836792406082373
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",YAP1,Transcriptional coactivator YAP1,15980,64,2.59 [1.43-4.71],0.0018002904525603
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",15956,64,1.05 [0.89-1.24],0.5746362903727026
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",YES1,Tyrosine-protein kinase Yes,18344,71,0.99 [0.83-1.19],0.9375226643444174
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",YJU2,Splicing factor YJU2,15951,63,3.34 [2.11-5.27],2.560112918218885e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",YOD1,Ubiquitin thioesterase OTU1,15485,61,1.41 [0.96-2.07],0.0770715889549433
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",YTHDF3,YTH domain-containing family protein 3,18124,68,1.01 [0.79-1.30],0.930376447840052
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",YWHAQ,14-3-3 protein theta,15659,64,1.07 [0.77-1.48],0.6823812343738743
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",YY1,Transcriptional repressor protein YY1,15528,61,1.72 [0.78-3.79],0.1816421556064598
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,15528,61,2.80 [2.16-3.63],8.927538401159256e-15
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZBTB16,Zinc finger and BTB domain-containing protein 16,18014,68,1.11 [0.84-1.49],0.4630504793694796
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,18109,70,0.68 [0.22-2.12],0.5073547760035628
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZCCHC8,Zinc finger CCHC domain-containing protein 8,15485,61,1.41 [1.06-1.86],0.0181689341124016
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZFYVE19,Abscission/NoCut checkpoint regulator,15956,64,1.10 [0.84-1.44],0.4913027099719022
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,15980,64,2.94 [2.50-3.46],3.84070758158628e-39
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZNF174,Zinc finger protein 174,15528,61,1.32 [0.79-2.20],0.2866943972024354
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZNF75D,Zinc finger protein 75D,15731,62,0.95 [0.63-1.45],0.8276166428307011
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZNF830,Zinc finger protein 830,15951,63,0.89 [0.64-1.26],0.5244838447682298
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZNRD2,Protein ZNRD2,15956,64,1.76 [1.33-2.33],7.868652045432441e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,15951,63,0.96 [0.61-1.50],0.8496312002510494
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZP3,Zona pellucida sperm-binding protein 3,15560,59,0.95 [0.87-1.04],0.2934292872386114
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZP4,Zona pellucida sperm-binding protein 4,15454,61,0.58 [0.21-1.55],0.273274149336419
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZPR1,Zinc finger protein ZPR1,15523,61,0.91 [0.68-1.21],0.5055949693294322
